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5I. Scope of the study
I.1. The four subdivisions of clinical microbiology.
During the nineteenth century Koch’s postulates provided  the criteria to confirm the germ
theory of Pasteur indicating that microorganisms are the cause of several human and animal
diseases.
Following these discoveries the field of clinical microbiology was established. 
The field of clinical microbiology can be split into four subdivisions based on the nature of 
the microorganisms investigated.
Historically microbiology started in 1677 with the discovery of bacteria under the microscope
of Antonie van Leeuwenhoek. Bacteria are prokaryotic organisms, present in every 
environmental condition on Earth. Some of these are able to infect the human body and these 
organisms are the interest of clinical bacteriological testing.
Secondly there is virology, the study of the viruses. Viruses are a totally different biological 
entity unable to replicate autonomously. They are not living cells because they only possess 
genomic material (DNA or RNA) and proteins but lack ribosomes and have no cell 
membrane. Therefore they depend on the infected cell’s biosynthetic machinery for protein 
synthesis. This dependence on the infected host, makes viruses obligate parasites. 
A third division is mycology, the study of fungi, which are eukaryotic organisms known as 
yeasts (unicellular) and molds (multicellular). Fungi have an important mutual characteristic: 
they are saprophytic pathogens not ingesting food, but absorbing dissolved nutrients from the 
environment. Only a few are of clinical importance, like the dermatophytes infecting hair and 
skin and the members of the genera Candida and Aspergillus.
Finally there is parasitology, which can be seperated in two groups. The first is the micro-
parasitology, studying protozoa, which are unicellular eukaryotic microorganisms that lack a 
cell wall. They are generally colourless and motile. Two well-known diseases are malaria and 
toxoplasmosis caused by respectively Plasmodium falciparum and Toxoplasma gondii.
Secondly there are the multicellular parasites, which are larger but are historically included in 
clinical microbiology, because the diagnosis is made on microscopic investigation of samples
on the presence of e.g. their eggs. Examples are worms (nematodes (roundworms), trematodes
6(flukes) and cestodes (tapeworms)) and small insects like lices (Pediculosis capitis and
Pediculosis pubis) and mites (Sarcoptes scabiei).
This doctoral work is focused on the fields of bacteriology and mycology, for which culture 
techniques are well established and for which culture is usually easy and fast, in opposition to 
viruses and protozoans. 
I.2. The four tasks of the bacteriology and mycology laboratory.
Four general tasks can be recognized within clinical microbiology. The first objective is to 
answer the question: is there a pathogen present in the sample? This is called detection, 
whereby the presence of a microorganism will be checked. 
The second objective is to specify the nature of the detected organism. This is called 
identification, whereby the organism will be specified towards a genus and a species name.
The third objective is antibiotic (or antifungal) susceptibility testing. Hereby the efficacy of 
different antibiotics (antifungals) to eradicate the bacteria or fungi (bactericidal activity) or to 
stop their replication (bacteriostatic activity) will be evaluated.
Finally there is the field of typing, whereby the relationship between different isolates is 
investigated. This leads towards essential information used to exclude outbreaks or investigate
them to determine whether a central source or patient-to-patient transmission caused the
outbreak.
It must be noticed that detection and identification are not always seperated. For instance, in 
case selective media or species specific primers are used, detection and identification occur 
simultaneously when growth is observed on the selective medium or when a positive 
amplification signal is obtained. However, in most cases broad range media are used, 
whereafter the clinical microbiologist decides which of the colonies need further study and 
identification, or universal primers are used, for which amplification simply points to the 
presence of bacteria, whereafter additional hybridization, restriction digestion or specific 
amplification are needed for final identification. 
This doctoral work is focused on identification of bacteria and fungi. The possibilities of 
detection, susceptibility testing and typing have been studied occasionally and will be dealt 
with when appropriate. 
7II. Aim of the research
The aim of the research was basically the development of PCR-based DNA-fingerprinting 
techniques for the identification of cultured bacteria and fungi in the routine clinical 
microbiology laboratory, and to evaluate their use. 
The emphasis on PCR-based identification of cultured organisms may seem odd at first, since 
PCR has been considered from the very beginning as a very specific and sensitive alternative
to culture-based detection and not as an approach to be used in combination with culture.
This approach is chosen because molecular techniques for detection of pathogens and for the 
determination of antibiotic resistance have several disadvantages and/or are too specialized.
Phenotypic identification has as limitations that - even for some of the major pathogenic 
species and certainly for less-frequently occuring or less well-known pathogens -  it is 
frequently cumbersome and unreliable. Moreover, in the past decades a wide variety of
bacteria traditionally thought to be simple components of the normal body flora have been
implicated in infections, most frequently in aged, debilitated or immunocompromized
patients, and several of these are difficult to identify with phenotypic techniques well. 
8III. Rationale for the development of culture-dependent PCR-based 
identification.
In order to provide with a rationale basis for the development of culture dependent PCR-based
identification methods, it is necessary to first pinpoint the several problems and shortcomings
that exist for both DNA/RNA-based detection and susceptibility testing of bacteria and fungi 
as well as for phenotypical identifications.
III.1. Nucleotide based detection and its shortcomings for routine use.
III.1.1. Principles of DNA-based detection. 
In the field of detection the task is to reveal as rapidly, as accurately and as sensitively as 
possible the presence of a certain pathogen in the clinical sample. For this purpose molecular
techniques appeared to be very interesting because they posses the possibility to start from
low numbers of bacteria. Besides intensive research in non-profit organizations on PCR-based
detection, also commercial companies have established research on this topic, because 
diagnostic tests for direct detection are marketable. Two sorts of molecular techniques are 
suitable for DNA-based detections. 
III.1.1.1. DNA-hybridization techniques.
Hybridization tests are reactions whereby small synthetic manufactured oligonucleotides 
(probes) complement with a target region in the genome of the organism. The hybridization 
event then is visualized using a label on the oligonucleotide. 
A well-known application is FISH (fluorescent in situ hybridization) (Bond and Banfield, 
2001; Franks et al., 1998). Since the sensitivity is strongly dependent on the amount of 
starting material, signal amplification techniques were developed to increase sensitivity. After
hybridization, other oligonucleotides are added, coupling towards the target-oligo hybrid, 
constructing a complex structure resulting in a more intense signal: branched DNA (Nolte, 
1998) and the detection system used in the Hybrid Capture
¤
 system (Pretorius et al., 2002). 
III.1.1.2. DNA-amplification techniques
These techniques have nucleic acids as target, which are exponentially amplified to a level 
notable through simple agarose gel electrophoresis and ethidiumbromide staining. The most 
9common and well-known technique is the Polymerase Chain Reaction (PCR) (Mullis and 
Faloona, 1987).  PCR makes possible the exponential amplification of DNA regions in 
between the primer annealing sites, in a couple of hours. Diagnostic applications were 
described soon thereafter (Saiki et al., 1988) and with the introduction of a thermostable DNA 
polymerase isolated from the bacterium Thermus aquaticus (the Taq DNA polymerase) (Saiki 
et al., 1988b) PCR became widely used.
The PCR protocol involves cycles of heating the sample for denaturing, annealing of the 
primers, and elongation of the primers by a thermostable DNA polymerase. This 3 
temperature cyclus is repeated approximately 30 times and gives an exponential doubling of 
the region between the primer annealing sites in every cycle starting from cycle 2. The final 
result is a high amount of duplicates of the target DNA, which can be visualized by gel 
electrophoresis and ethidiumbromide staining. 
Other amplification protocols are: nucleic acid sequence based amplification (NASBA) 
(Compton, 1991), Ligase chain reaction (LCR) (Barany, 1991), Q beta amplification (Lizardi
and Kramer, 1991), self-sustained sequence replication (3SR) (Fahy et al., 1991) and strand 
displacement amplification (Walker et al., 1992). 
III.1.1.2.1 Species-specific amplification.
Several publications deal with the detection of a single species directly from the sample. For 
this purpose a wide variety of species-specific genes and primers have been used (Gynzbergen
et al., 1995). Different technologies have been established to gain time; e.g. faster cyclers 
(Bergeron et al., 2000) or to gain sensitivity; e.g.  immunocapture (Peng et al., 2002). All this 
makes direct detection more promising, but the availability of these techniques is usually 
restricted to specialized groups (in particulary difficult or slow growing species), the tests are 
expensive and technically complex or labor-intensive. All this makes that the cost of the test
is, currently and probably still in the near future, not compensated by the gain of information
and time.
III.1.1.2.2. Universal or broad-range amplifications.
When using primers complementary with conserved regions of a gene that is present in all or 
in most bacteria/fungi (e.g. 16S rRNA gene or 18S rRNA gene) it is possible to amplify this 
region whatever bacterium or fungus is present. 
The regions used as target have to fulfill some major conditions: (i) to contain a constant
sequence for all members, useful as primer binding site; (ii) to have interspecies variability in 
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the amplified region between the two primer-sites, so that this characteristic can be used to 
discriminate between species; (iii) to have a slow mutation rate so that it’s sequence is 
constant for a given species. This is mostly the case for genes coding for a compound
essential in DNA replication, transcription and translation or for house-keeping genes. 
Several regions in the chromosome can be used as a target for universal or broad-range 
amplifications. The best known for bacteria is the 16S rRNA gene (Wilson et al., 1990) and 
18S rRNA gene for eucaryotes like the fungi (Takashima and Nakase, 1999). Discrimination 
between the different organisms can be carried out using post-amplification species-specific
hybridizations.
Other universal PCRs generate fingerprints, which are not suited for detection, because mixed
fingerprints obtained by amplification of different organisms are not interpretable. Another 
disadvantage is that with lower sensitivity sometimes partial fingerprints are obtained, making
interpretation more difficult.
DNA-fingerprinting PCRs are better suited for identification of cultured organisms and will 
be discussed later (III.3).
III.1.2. Problems of PCR-based detection.
After almost two decades of worldwide research, the use of molecular detection systems in 
clinical microbiology remains restricted nearly exclusively to the field of virology. Several 
factors make that DNA-technology for the detection of bacteria will remain applicable only 
for slowly growing bacteria like Mycobacterium tuberculosis and C. trachomatis . 
The applicability in the fields of bacteriology and mycology is totally different than for
virology (Table 1). 
III.1.2.1. Culture of bacteria and fungi is easy, fast and flexible.
Most of the pathogenic bacteria can be cultured on simple media after overnight incubation. 
When using an appropriate medium, only 24 hours of incubation are needed, in contrast to 
virus culture. DNA/RNA-based detection consists of several steps including efficient 
DNA/RNA-extraction, an amplification reaction and the detection of the PCR products.
Compared to bacterial culture, the gain in time is minimal, and the process is much more 
laborious. Culture is also more flexible because it is impractical to start the DNA-
amplification process for one or a few samples, while inoculation of a culture medium can be 
done at any time for a single sample.
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III.2.2. Culture provides a semi-quantitative estimate.
The obtained culture delivers living cells that can be used for identification, but also gives 
additional information. It gives an indication towards the quantification of the organism in the 
sample, and an overview of the different species in mixed samples. For example: throat and 
faeces are routine clinical samples containing a wide variety of bacteria. 
To obtain the same amount of information using DNA-technology quantitative amplification
of very different bacteria should be carried out. 
III.1.2.3. A wide variety of bacterial pathogens need to be covered.
The number of bacterial organisms able to cause infection is so diverse that setting up a direct 
detection technique able to cover whatever pathogen in a clinical sample needs such a large 
collection of species-specific primers or probes that it is hardly possible to achieve. DNA-
arrays seem to offer a solution at first sight, but the simultaneous amplification of DNA of 
different bacteria can quite often generate noise instead of signal and competition between the 
different targets present may inhibit the amplification of several species.
III.1.2.4. Antibiotic susceptibility testing will remain culture-based.
During the last 50 years the treatment of bacterial infections changed dramatically due to the 
introduction of antibiotics, starting with penicillin by Fleming in 1928 (Chain et al., 1993). 
But after half a century of administrating antibiotics to patients, resistance has emerged in 
almost every possible pathogen. The pressure of antibiotic treatment is selecting those cells 
that have obtained resistance against the antibiotic. Antibiotic resistance can be caused by a 
variety of mechanisms: (i) the presence of an enzyme that inactivates the antimicrobial agent 
(destruction); (ii) the presence of an alternative enzyme for the enzyme that is inhibited by the 
antimicrobial agent (bypass); (iii) modification of the antimicrobial agent’s target, which 
reduces binding of the antimicrobial agent (target); (iv) reduced uptake of the antimicrobial
agent (permeability); (v) active efflux of the antimicrobial agent (permeability); and (vi) 
overexpression of the target of the antimicrobial agent. In addition it is also possible that
resistance is caused by still unknown mechanisms.
The clinical microbiologist should be able to select those antibiotics best suited for
antibiotic/antifungal treatment and therefore antibiotic susceptibility testing is primordial in 
clinical microbiology. The change of culture-based susceptibility testing towards genotypic 
testing is however not obvious, because of the high variety of genes involved in antibiotic 
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resistance and the limited knowledge of the complex processes involved. On the other hand, 
routinely used culture-based antibiotic susceptibility tests are efficient for the determination of
the susceptibility without the need for knowledge of which mechanism is responsible for the 
resistance.
The best known method is the Kirby-Bauer Disk Diffusion method (Figure 1). This method
enables the simultaneous detection of the susceptibility of the strain towards a variety of 
different antibiotics, which may be of very different nature and for which resistance may be 
caused by very different genes and mechanisms. After incubation the susceptibility of the 
strain for every antibiotic separately can be noted and in some cases also synergetic and/or 
antagonistic effects can be observed. 
Figure 1: Kirby-Bauer Disk Diffusion testing.
Legend: Bacteria are cultured in presence of a collection of  paperdisks (each containing
a different antibiotic). If the strain is resistant to a specific antibiotic,
 no inhibition of growth is seen around that disk.
Depending on the mechanism of resistance, different levels of antibiotic resistance are 
possible. A strain with a low level of resistance can still be treated with the antibiotic if the 
dose is high enough. A precise indication of the dose of the antibiotic still effective in the 
treatment of a certain bacterium can be obtained using the E-test. The E-test makes it possible 
to determine the Minimal Inhibitory Concentration (MIC) values of the strain in a simple and 
fast manner (Figure 2). 
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Figure 2: MIC-determination using E-test
Legend: Bacteria are cultured in presence of a paper strip containing a descending
concentration of antibiotic (E-test). The MIC value is detected by reading the
concentration on the strip where the inhibitory zone intersects the strip.
These culture-based methods usually give a fast and (semi-) quantitative answer about the 
efficiency of certain antibiotics.  The replacement of culture-based testing with genomic
testing faces several problems.  The total number of  genes responsible for resistance is high. 
This results in a very large amount of genes to be screened at once, leading towards a high 
amount of different PCRs and laborious post-amplification manipulations with a variety of 
probes or sequencing reactions. 
Besides the known genes and their mutations, there are probably many unknown mechanisms,
resistance genes and mutations. Other resistance mechanisms such as hyperproduction or 
higher efflux are difficult to monitor by genotypic testing and require a quantitative RNA-
based approach. 
In summary, molecular techniques are very useful for fundamental research of resistance 
mechanisms, but are difficult to use for antibiotic resistance testing in a routine microbiology
laboratory. The recent introduction of microarrays makes it possible to test a large number of 
probes (Westin et al., 2001). However, the numerous amplification reactions needed to screen 
all those genes remain the limiting factor.
Even when the problem of the numerous amplifications can be solved, and microarrays with 
the probes to all known resistance genes are available, there is still the lack of information
coming from unknown genes. A final problem is that resistance in several cases depends on 
the level of expression of certain genes (Livermore, 1987; Liu et al., 1992), which requires 
quantitative RNA amplifications.
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Because of those disadvantages, resistance screening is restricted to the search for some
standard resistant markers, like the detection of the mecA gene for methicillin resistance in 
Staphylococcus species (Maes et al., 2002) and the van-genes for vancomycin resistance in 
Enterococcus species (Dutka-Malen et al., 1995; Lu et al., 2001). Because these genes are 
known as the predominant cause of the resistance in that kind of organisms, these tests have 
high predictive values. An additional advantage of the use of the mec and van-PCRs is that in
vitro detection of resistance is sometimes difficult to interpret in those species.
Table 1: Basic differences between Virology and Bacteriology/Mycology
Virology Bacteriology / Mycology 
Culture Difficult and time-consuming Easy, fast and flexible* 
Diversity of 
organisms
Limited number of clinically 
important viruses 
Wide diversity of bacteria and fungi able to 
infect humans.
Limited number of antiviral drugs Wide range of antibiotics 
Growing range of antifungals 
Therapy
control
Good knowledge of mutations
causing resistance 
Already numerous mutations known, but still 
several other regulation mechanisms are 
unknown or can not be detected genotypically 
* Most important exceptions: Mycobacteria and Chlamydia. 
III.1.2.5. Other problems of DNA-based detection: sensitivity and contamination.
The DNA-based methods are always referred to as highly sensitive, but some clinical samples
contain low amounts of bacteria in a rather large volume, making efficient DNA-extraction 
tedious. For example: Stratton (1994) stated that in some cases of sepsis up to 50 ml of blood 
should be cultured to detect the causative organism. Extracting DNA of so few bacterial 
organisms amid a high amount of human DNA seems an impossible task. Still automated
blood culture systems have no problem detecting such low amounts of living bacteria, mostly 
within one day. 
On the other hand, high sensitivity increases the chance for false positives, because of low 
amounts of contaminating bacterial DNA present in the samples. It has been shown that blood 
of healthy people can contain bacterial ribosomal DNA, without any clinical significance 
(Nikkari et al., 2001). 
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Another source of contamination is previously amplified material, which can be present 
because of the high amounts of material obtained by amplification and because of the 
different post-amplification manipulations. Therefore, good monitoring of the overall process 
is needed  (Noordhoek et al., 1994).  And finally, there is the problem of sample collecting 
material and PCR reagents that are not totally free of bacterial DNA (Millar et al., 2002).
So direct detection PCR needs setting up a specialized facility and the availability of 
laboratory and sample collection material completely free of DNA. 
All these obstacles leed to the conclusion that PCR-based direct detection of most bacterial 
(and fungal) pathogens directly from clinical samples is too tedious and too laborious without 
much gain in time and even with less information then can be obtained with culture. 
Only in some cases direct detection could be beneficial, like for slowly-growing pathogens or 
species for which there are no effective culture media. The most important pathogens showing 
those characteristics are Mycobacterium tuberculosis, which is a slow grower (up to three 
weeks for a positive culture) and Chlamydia trachomatis and Mycoplasma pneumoniae,
pathogens routinely detected by serology instead of culture. Other targets are the unculturable 
pathogens (Relman, 1993) with as examples Tropheryma whippelii (Relman et al., 1992) 
causing Whipple’s disease and the hardly culturable pathogens, like Bartonella henselae
(Koehler et al., 1994), the infectious agent causing cat-scratch disease, and others like 
spirochetes, Legionella and Campylobacter.
This is also the reason why commercial companies only for some of those pathogens 
successfully introduced direct detection kits. 
III.1.2.6. Need for grown material for epidemiology control.
The change towards molecular detection has an important disadvantage that no cultivated 
material is present anymore, which is needed for epidemiology control. The demands for 
typing comes mostly afterwards (after several isolates of the same species are seen) and when 
using only molecular techniques for detection, this can result in the unavailability of living 
material.
III.1.3. Conclusion: general problems of DNA-based detection.
It can be stated that PCR-based detection of most bacterial pathogens is not competitive with 
culture-based detection because of higher cost, laboriousness and lower flexibility, for no gain 
in speed and sensitivity. Even if it were possible to develop practically applicable and 
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affordable PCR-based detection of all bacterial pathogens, it will remain impossible to replace 
culture-based susceptibility testing by molecular techniques. Therefore, culture will remain
unavoidable, even in the imaginary case that PCR-based detection would be possible. In what 
follows, we will focus on the development of molecular-based identification of cultured
pathogens.
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III.2. Phenotypic identification of cultured organisms and its shortcomings.
III.2.1. Introduction: the importance of identification.
The isolation of a microorganism from a clinical sample can have several meanings. Some
species are commonly encountered in some parts of the body as commensals and can even 
have beneficial properties, like Lactobacillus in the vagina (Cadieux et al., 2002) and gut, 
leading to applications as probiotics (Gibson and Robertfroid, 1995). However, several 
species are known as pathogenic and are the cause of infections. This makes it important to 
identify an isolate as specifically as possible, to make a decision with regard to therapy and 
prognosis. The better the knowledge of the infectious organism, the better the therapy can be 
directed towards that organism.
Due to presence of a higher number of immunocompromised patients, and due to the 
extensive use of antibiotics, an increasing number of bacterial species is causing diseases in 
humans. This renders the identification based on biochemical properties more difficult.
For yeasts this trend is even more distinct: 15 years ago 80% of the invasive yeast infections 
were due to C. albicans. Nowadays, however, already half of the infections are caused by 
non-C. albicans species (De Pauw, 2002; Nguyen et al., 1996), a phenomenon that is 
presumably related to the extensive prophylactic use of fluconazole (Rex and Sobel, 2000). 
There are also big differences between the natural antifungal resistance patterns of those 
species, and several non-C. albicans species show increased resistance for antifungals 
(Vasquez et al., 2001b).
Moreover, there are differences in pathogenicity between the Candida species: Candida
albicans is known as the most virulent species, but also C. tropicalis and other non-C.
albicans species can be virulent, whereby others are known to be less virulent like C.
parapsilosis (Wingard, 1995; Moran et al., 2002).
All of this makes that accurate identification of yeasts also provides guidelines for therapy 
and that rapid identification may save time in choosing the optimal therapy.
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III.2.2. Overview of different identification technologies.
Identification aims to classify an unknown isolate into a group of bacteria with shared 
phenotypic and genotypic characteristics (a taxon). This can be achieved in several ways.
III.2.2.1. Morphological characteristics
The morphological characteristics used for the identification of bacteria and yeasts, can be 
subdivided in two classes: (i) macroscopic (colony) morphology, consisting of properties, 
noticeable on the culture plate, like the color, shape or scent of the colony and (ii) the 
microscopic (cellular) morphology or properties to be noticed by microscopic investigation, 
like the shape of the bacteria (coccus, bacillus or spirillum) and yeasts and Gram stain: Gram
positive or Gram negative bacteria.
A disadvantage is the low discriminatory power. General groups can be distinguished but 
related species have mostly common morphological characteristics. Also sometimes
misinterpretations can be made by Gram positives known to destain (e.g. Clostridium tertium
(Steyaert et al., 1999)). 
III.2.2.2. Biochemical properties
When testing biochemical characteristics, the organism is checked for its capability to use 
certain carbon sources, or to perform certain enzymatic reactions. Biochemical testing is more
informative than morphological investigation, resulting in a better classification and 
identification.
Biochemical testing originally made use of single tubes or media scoring one or a few 
biochemical characteristics. Since the 1970s commercial multi-well galleries were developed,
for example Api (BioMérieux, Marcy-l’Etoile, France); Crystal (Becton Dickinson, Sparks, 
Md.) and Auxacolor (Sanofi Pasteur, Marnes la Coquette, France). 
These are micromethods employing a collection of different biochemical tests, one per 
microwell that already contains the chemical substrates. After addition of a suspension of the 
organism and incubation, the biochemical profile of the strain is obtained. The Api strip 
generates a 7-digit code based upon the reactions, which can be compared to the database of 
the system, containing all codes corresponding to the species included. The digital code can 
then be converted to a bacterial identification.
There are however disadvantages: (i) many new species are continuously described (Euzeby,
1997) and several of these need other biochemical tests to be discriminated from already 
established species;
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(ii) Biochemical testing has the disadvantage that biochemical properties can be unstable at 
times and vary with environmental changes, like media, temperature, pH, age of culture, 
aerobic or anaerobic cultivation, etc. (Rossello-Mora and Amann, 2001);
(iii) Biochemical profiles of different species can be identical, such that identification of those 
species is difficult by biochemical testing. This is e.g. the case for Pasteurella (Hamilton-
Miller, 1993) and Haemophilus species (Hamilton-Millar and Shah, 1996);
(iv) The tests are read visually and need interpretation so that weak reactions can be 
misinterpreted, leading to misidentification.
Regardless those disadvantages, biochemical testing is mostly still effective (O’Hara et al.,
1992) and very commonly used. New, automated biochemical test systems like Vitek 
(BioMérieux) and Phoenix (Becton Dickinson), which rely on sophisticated technology and 
on automated reading, interpretation algorithms of the color-reactions and growth curves, can 
eliminate some of the disadvantages.
The most automated systems have a panel of different reactions for identification and 
antibiotic resistance testing at once, and have very promising first evaluations (White et al.,
2001; Williams et al., 2001). 
III.2.2.3. Antigenic testing
Identification can be obtained by the strains’ affinity towards a wide collection of different 
antisera or antigens. These tests are not always sufficiently discriminative because cross-
reactions between members of the same genus are common (Houpikian et al., 2002). Another 
drawback is the need for a wide variety of different antisera and antigens. Commercial
agglutination tests are available for a limited number of species, for example: Neisseria
meningitidis (Wellcogen N. meningitidis; Murex, Darford, United Kingdom), Streptococcus
pneumoniae (Streptococcal grouping kit; Oxoid, Basingstoke, United Kingdom) and 
Staphyloccocus aureus (Pastorex Staph-plus; Biorad, Hercules, Ca.). 
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III.2.2.4. Chemotaxonomic methods
With developments in all fields of molecular biology, specialized techniques were developed 
for bacterial identification like (i) SDS-PAGE analysis of whole-cell proteins (Pot et al.,
1994; Premaraj et al., 1999); (ii) gas chromatography of fatty acids (Sasser, 1990; Lehtonen et
al., 1996), (iii) high-performance liquid chromatography of mycolic acids (Butler et al., 1986; 
Butler and Guthertz, 2001), the latter used for identification of mycobacteria; and (iv) spectra 
of the overall molecular composition of the organism, using the Raman spectroscopy
(Maquelin et al., 2000); (v) multivariate analysis of proton magnetic resonance spectroscopic 
data (Bourne et al., 2001); (vi) immunomagnetic separation combined by matrix)ssisted laser 
desorption/ionization time-of-flight (MALDI-TOF) mass spectroscopy (Madonna et al.,
2001); and (vii) Fourier-transform infrared (TF-IR) spectroscopy (Oberreuter et al., 2002; 
Wenning et al., 2002).
The discriminatory power of these techniques is much higher but the techniques are also 
demanding for culture standardization and specialized equipment and seem not to be suited 
for routine applications. The most recent ones, the last four, seem very promising but their 
experience concerning discriminatory capacity and liability is far from sufficient at this
moment.
III.2.3. Conclusion: general problems of phenotypic identification.
Phenotypical methods are based on the investigation of the genomic material in an indirect 
way, as it is expressed in cell-structure, enzymatic activity, etc. All these characteristics are 
dependant on growth conditions, which demands for very standardized test protocols. Except 
for the complex chemotaxonomic methods, which demand for very strict standardization to 
correlate the results, the discrimination power is often too low. For antigenic testing a variety 




DNA-based techniques have as an advantage that the genomic material of an organism is 
investigated in a direct way, independent of culture conditions. 
In chapter III.1.1.2 DNA-amplification techniques are explained. The disadvantages for 
hybridization and species specific amplification for detection, are also disadvantages for 
DNA-based identifications with these techniques. An alternative is amplification with 
universal PCRs and post-amplification hybridization, and most likely by immobilization of 
the probes on a cellulose strip as in the Line Probe Assay (Innogenetics, Ghent, Belgium)
(Tortoli et al., 2001) or on a microarray (Westin et al., 2001), enabling the screening for a 
large variety of organisms at once. However, the problem remains that one can only identify 
those species included in the test. Universal amplification can be carried out using several 
regions in the chromosome for which the best known for bacteria is the 16S rRNA gene
(Wilson et al., 1990). Other regions are gyrB (Yamamoto and Harayama, 1995; Kasai et al.,
1998), the spacer region between 16S and 23S (Gürtler and Stanisch, 1996; Jensen et al.,
1993; Song et al., 2000), the tRNA-spacer (Welsh and McClelland, 1991), the hsp65 gene 
(Telenti et al., 1993),  the rpoB gene (Drancourt and Raoult, 2002) and rep (Gevers et al.,
2001).
For fungi the 18S rRNA (Takashima and Nakase, 1999) and the internally transcribed spacer 
regions - ITS1, in between 18S and 5.8S rRNA genes (Chen et al., 2001.), and ITS2, in 
between 5.8S and 28S rRNA genes (Turenne et al., 1999, Chen et al., 2000) - can be used. 
After universal amplification, analysis of the amplification product is needed to catalogue the 
unknown isolate to assign it to an established group of strains (= taxon, usually a species). 
The maximum information is obtained by total sequence analysis of the fragment. However, 
this technique remains, even with the newer systems, still expensive and laborious, making it 
impractical and too slow for routine identification of isolates. Several other methods are 
applied to investigate fragments for sequence diversity, making the process of identification 
either cheaper, less-laborious and/or faster. If the obtained amplification products of different 
species have different sizes, determination of the fragment lengths leads to identification
(Jensen et al., 1993; Welsh and McClelland, 1991). If the fragment has always the same
length but the sequence is variable, sequence dependent electrophoresis can reveal 
differences. Sequence dependent systems are single-stranded conformational polymorphism
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(SSCP) (Moore et al., 1992), denaturing gradient gel electrophoresis (DGGE) (Muyzer et al.,
1993), temperature gradient gel electrophoresis (TGGE) (Heuer and Smalla, 1997) and 
temporal temperature gradient gel electrophoresis (TTGE)  (Vasquez et al., 2001). 
Sequence differences can also be revealed by restriction analysis, because mutations can lead 
to the appearance or disappearance of restriction sites, changing the restriction pattern (e.g. 
ARDRA, Vaneechoutte et al., 1992).
A recent DNA-fingerprinting technique is fragmentation by uracil-DNA-glycosylase of a 16S 
rRNA sequence, amplified in the presence of dUTP instead of dTTP, creating T-ending 
fragments, and mass-spectrometry analysis with matrix-assisted laser desorption ionisation-
time of flight (MALDI-TOF) (von Wintzingerode et al., 2002). 
III.3.2. Advantages of the use of DNA-based fingerprinting for identification.
PCR-based fingerprinting as an identification tool has several advantages. The technique uses 
DNA as target for the amplification, so that the identification of the strain is culture-condition 
independent.
The identification is based on the comparison of the obtained fingerprint with a library of 
fingerprints. This library can be updated whenever new species are encountered. Another 
advantage of such libraries is that interlaboratory exchange is possible, such that information
gathered in different laboratories can be compared and stored in a mutually accessible,
common library.
As with every bacterial identification technique, there are some drawbacks.
First, universal primers will amplify every organism present. In mixed samples this can lead 
towards non-useful fingerprints in cases where the individual fingerprint consists of several 
bands (e.g. ARDRA, tRNA-PCR). When only one band is expected per fingerprint (e.g. ITS2-
PCR) the approach could be used directly on mixed samples.
The differences between closely related species can be sometimes rather small. Sometimes
minor, but reproducible and significant interspecies differences can be revealed by performing
electrophoresis on high resolution systems like capillaries or sequencing gels, rather than on 
agarose gels.
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IV. Development, update and evaluation of PCR-based DNA-fingerprinting 
techniques for identification of cultured bacteria and fungi. 
IV.1. Introduction.
During this doctoral work, we focused on PCR-based fingerprinting techniques since these 
can be applied for most bacteria and fungi, using a single set of primers and since they are 
applicable in a routine setting due to their technical simplicity.
Three different techniques have either been developed or updated and evaluated.
At first there is ARDRA (amplified ribosomal DNA restriction analysis), where the 
polymorphism is obtained by restriction analysis of the amplicon, i.e. the amplified 16S rRNA 
gene.
Secondly there are two spacer region amplification techniques that result in a fingerprint by 
amplification without post-amplification manipulation. 
tRNA-PCR amplifies the spacer region in between tRNA genes and is an identification 
system for bacteria, whereas ITS2-PCR, which amplifies the spacer region in between the 5.8 
S and 28 S rRNA genes, is an identification system for yeasts.  
The characteristics of these three techniques are summarized in Table 2. 
Table 2: Fingerprinting PCRs of interest.
ARDRA tRNA-PCR ITS2-PCR

















Single band with 
species specific length 









* Currently ITS2-PCR is being updated for identification of molds, using an additional restriction 
digestion step. In this respect, ITS2-PCR + restriction is somewhat comparable with ARDRA 
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IV.2. An overview of the techniques used.
IV.2.1. Amplified ribosomal DNA restriction analysis (ARDRA).
ARDRA was first applied already a decade ago (Vilgalys and Hester, 1990, Jayarao et al.,
1992, Vaneechoutte et al., 1992), and has as target different parts of the rRNA cistron, 
although the 16S rRNA gene (approximately 1500 basepairs) is used in most studies. 
The 16S rRNA gene is found in all bacteria and accumulates mutations at a slow, constant 
rate, and can therefore be used as a molecular clock (Woese et al., 1987). However, 
exceptions were encountered for Aeromonas (Sneath, 1993; Graf, 1999), where mozaique 16S 
rRNA-genes occur, possibly as a result of homologous recombination between species. Some 
parts of the 16S rRNA gene are highly variable and contain signature sequences unique for a 
species. The variability is genus dependent. It is high in for example Mycobacterium,
Clostridium and Acinetobacter, but low in other genera like Enterococcus and Staphylococcus
(Vaneechoutte and Heyndrickx, 2001).
ARDRA consists of the amplification of the 16S rRNA gene by primers directed towards the  
5’ and 3’ regions of the gene, which are conserved throughout the kingdom bacteria. The 
amplicon is subjected to restriction digestions with one to four different restriction enzymes, 
each resulting in a mixture of restriction fragments with different lengths. These fragments are 
separated by agarose gel electrophoresis (Fig. 3). The obtained fingerprint is compared to a 
photograph containing previously observed fingerprints with that enzyme for the known 
species of the genus. To attain a higher discriminatory power, the results of several (mostly 
three) different restriction reactions are combined. This results in a 1 to 4-digit (depending on 
the amount of enzymes used, mostly it is a 3-digit) code, which leads towards identification. 
A disadvantage of the technique is the limitation of the range of organisms restricted to 
members of the same genus, because the choice of restriction enzymes is genus dependent. 
Most of its limitations are related to problems in general with the 16S rRNA gene (see 
Bacterial Systematics, page 67 and followings). 
ARDRA is, however, a fast, easy and cheap identification technique for members of different 
genera, which is illustrated by publications on species differentiation of Corynebacterium
(Vaneechoutte et al., 1996) and Acinetobacter (Dijkshoorn et al., 1998). A complete overview 
can be found  in Vaneechoutte and Heyndrickx (2001). 
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Figure 3: Principle of ARDRA
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IV.2.2. tRNA-intergenic spacer length polymorphism analysis (tRNA-PCR). 
tRNA molecules are the amino-acid transporter molecules in the translation of mRNA to 
proteins. Although 20 different tRNA genes are present in a varying number of alleles in the 
genome, their structure is well conserved in some regions. The sequences at the outer parts of 
the gene are identical for most tRNA genes in most bacteria, such that consensus, universal
primers can be developed (Welsh & McClelland, 1991). In tRNA-PCR the primers are 
outwardly directed such that the intergenic spacers between subsequent tRNA genes are 
amplified. These inter-tRNA gene spacers are different in length, so that amplification results 
in a fingerprint consisting of multiple bands (Figure 4). Moreover, the obtained fingerprints
are mostly species specific, although intraspecific variability exists and some species cannot 
be distinguished from each other. 
Since the differences in length are sometimes very minor, high resolution electrophoresis 
must be used. This can be obtained by adding a fluorescent label to one of the primers and 
analysing the obtained fragments on a capillary electrophoresis system, in this case the ABI 
Prism 310 (Applied Biosystems, Foster City, Ca.) is used, which provides with a one base 
pair resolution. The final result is a digital fingerprint. All those fingerprints are collected in a 
library. If an unknown strain is tested, the obtained fingerprint can be compared to all 
previously obtained fingerprints, resulting in an identification. A software program
Basehopper, especially designed for this application (Ing. Paul Baele, Ghent University),
simplifies this comparison.
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Figure 4: Principle of tRNA-PCR
ĺ consensus primer, outwardly directed 
Ƒ  tRNA gene 
Ŷ interrepeat spacer
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IV.2.3. ITS2 spacer length polymorphism analysis (ITS2-PCR).
The internally transcribed spacer region 2 is the spacer region in between the 5.8S rRNA and 
28S rRNA genes of fungi, and thus part of the ribosomal cistron. The ribosomal cistron has a 
slow mutation rate as mentioned for the 16S rRNA gene of bacteria.
The primers chosen are complementary with conserved regions lying at the 3’ end of the 5.8S 
rRNA gene and the 5’ end of the 28S rRNA gene. The primer pair is universal for all fungi. 
Discrimination between most yeasts is possible due to the length differences of this spacer
region, which are constant for a given species but differ from one species to another. The 
obtained fragment length leads towards identification (Turenne et al., 1999).
Because the fingerprint consists of only one fragment, the discriminatory power is lower than 
for multiple fragment fingerprints. A precise determination of the exact size of the fragment is 
needed for optimal identification. This can be obtained by labelling one primer with a 
fluorescent label, and analysis of the fingerprint on a capillary electrophoresis system (ABI 
Prism 310). The digital fingerprints of different species can be collected in a library, and 
comparison of the fingerprint of an unknown strain to the library results in identification. This 
can be done using the Basehopper software.
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IV.2.4. DNA-sequencing
Sequencing is the technique providing the maximum information for an amplified product. 
Some laboratories are using this technique for reliable identification of unknown bacterial 
strains (Drancourt et al., 2000; Hill et al., 2002; Takashima and Nakase, 1999).
First, an amplification of the 16S rRNA gene or ITS2 region with universal primers is carried 
out. After purification of this amplification product, a sequencing reaction is done. The 
obtained dideoxy terminated fragments are separated and analysed on sequence devices (gel- 
or capillary based). Assembling of different fragments and other analysis on the sequence data 
is carried out using software programs. The obtained sequence can then be compared to all 
known sequences in Genbank using Blast 2.0 (National Center for Biotechnology 
Information, Bethesda, Md. [http://www3.ncbi.nlm.nih.gov/BLAST/). The program returns a 
list of sequences sorted according to descending similarity.
Although the technique is resulting in the maximum on information, there are several 
disadvantages.
The sequences in Genbank are not always of high quality (Turenne et al., 2001), which can be 
solved with the use of the commercial databases like Microseq (Applied Biosytems) (Patel et 
al., 2000) or Ridom (Ribosomal Differentiation of Medical Microorganisms), which are 
databases containing confirmed and validated sequences. This makes the process however 
more expensive. 
A second problem is interpretation of sequence similarities. Sometimes, members of the same
species do not have identical sequences (Harrington and On, 1999). And to the opposite, 
members of different species may have almost identical 16S rRNA gene sequences:
Aeromonas (Graf, 1999), Bacillus, Staphylococcus.
Also, ambiguities can be present due to direct sequencing starting from a strain carrying
different 16S rRNA-alleles (Gürthler, 1999; Reisch et al., 1998). 
Besides these disadvantages, there are still some practical problems: (i) sequencing remains
technically demanding and requires specialized material (consumables, machinery) and 
experienced personnel; (ii) the complete process including analysis is rather laborious, and 
(iii) all this makes that it is more expensive than other techniques. 
Conclusion: Sequencing is a highly discriminatory technique, however, not applicable for 
routine identification. It is a very important tool for the confirmation of presumed
identifications or to identify organisms unidentifiable by other techniques.
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IV.3. Studies.
Our studies aimed to introduce molecular identification techniques in our laboratory as an 
alternative for phenotypical identification techniques. Therefore, the techniques tRNA-PCR 
and ITS2-PCR were introduced and ARDRA (for mycobacteria) was updated. All techniques 
were evaluated for their application as possible useful routine identification techniques. 
If in some cases identification was not possible or questionable, sequencing of either the 16S 
rRNA gene or the ITS2 region, followed by BLAST to Genbank, resulted in an additional and 
mostly reliable identification. The obtained information was used for updating and confirming
the databases of the used techniques. 
IV.3.1. The update and evaluation of ARDRA for Mycobacterium species identification.
De Baere, T., R. de Mendonca, G. Claeys, G. Verschraegen, Mijs, W., R. Verhelst, 
S. Rottiers, L. Van Simaey, C. De Ganck, and M. Vaneechoutte. 2002. Evaluation
of amplified rDNA restriction analysis (ARDRA) for the identification of cultured
mycobacteria in a diagnostic laboratory. BMC Microbiology 2:4.
IV.3.2. The introduction of tRNA-PCR for bacterial species identification, and the study of 
interlaboratory exchangeability of the fingerprints
Baele, M., V. Storms, F. Haesebrouck, L.A. Devriese, M. Gillis, G. Verschraegen, T.
De Baere, and M. Vaneechoutte. 2001. Application and evaluation of the 
interlaboratory reproducibility of tRNA intergenic length polymorphism analysis
(tDNA-PCR) for identification of species of the genus Streptococcus. J. Clin.
Microbiol. 39:1436-1442.
IV.3.3 The evaluation of ITS2-PCR for routine identification of yeasts.
De Baere, T., G. Claeys, D. Swinne, C. Massonet, G. Verschraegen, A. Muylaert,
and M. Vaneechoutte. 2002. Identification of cultured isolates of clinically 
important yeast species using  fluorescent fragment length analysis of the
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Abstract
Background: The development of DNA amplification for the direct detection of M. tuberculosis
from clinical samples has been a major goal of clinical microbiology during the last ten years.
However, the limited sensitivity of most DNA amplification techniques restricts their use to smear
positive samples. On the other hand, the development of automated liquid culture has increased
the speed and sensitivity of cultivation of mycobacteria. We have opted to combine automated
culture with rapid genotypic identification (ARDRA: amplified rDNA restriction analysis) for the
detection resp. identification of all mycobacterial species at once, instead of attempting direct PCR
based detection from clinical samples of M. tuberculosis only.
Results: During 1998–2000 a total of approx. 3500 clinical samples was screened for the presence
of M. tuberculosis. Of the 151 culture positive samples, 61 were M. tuberculosis culture positive. Of
the 30 smear positive samples, 26 were M. tuberculosis positive. All but three of these 151
mycobacterial isolates could be identified with ARDRA within on average 36 hours. The three
isolates that could not be identified belonged to rare species not yet included in our ARDRA
fingerprint library or were isolates with an aberrant pattern.
Conclusions: In our hands, automated culture in combination with ARDRA provides with
accurate, practically applicable, wide range identification of mycobacterial species. The existing
identification library covers most species, and can be easily updated when new species are studied
or described. The drawback is that ARDRA is culture-dependent, since automated culture of M.
tuberculosis takes on average 16.7 days (range 6 to 29 days). However, culture is needed after all to
assess the antibiotic susceptibility of the strains.
Background
Rapid and accurate detection, identification and suscepti-
bility testing of mycobacteria remains important i) be-
cause the overall incidence of tuberculosis is increasing,
also due to the HIV pandemic [1], ii) because of the in-
creasing resistance to antituberculous agents [2] and iii)
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because an increasing number of mycobacterial species
are being recognized as potentially pathogenic [3]. The
importance of M. avium infection has increased in HIV pa-
tients [4], and clinical infections have been described with
species like M. heidelbergense[5], M. conspicuum[6], M.
branderi [7] and M. interjectum[8,9], which have been rec-
ognized only recently.
Current DNA amplification based diagnostic tests are ex-
pensive, have limited senstivity, are usually restricted to
the detection of M. tuberculosis only and provide no or
limited information on susceptibility (e.g. rifampicin on-
ly: RifTB LiPA, Innogenetics, Zwijnaarde, Belgium). There-
fore, the need for culture has not been circumvented. The
CDC decided to restrict the use of genotypic tests to con-
firmation of smear positive samples, so that they cannot
be used to test the large number of specimens processed
for mycobacterial detection every year in an average labo-
ratory [10]. Only recently, the enhanced AMTD (Gen-
Probe, San Diego, CA) gained FDA approval for direct de-
tection of M. tuberculosis from smear-negative samples,
but several problems are reported [e.g. [11], and the high
costs keep restricting its use.
Here, we present our findings with the use of ARDRA [12]
for the identification of Mycobacterium species. The meth-
od consists of amplification of the 16S rRNA gene (rDNA)
and subsequent restriction digestion of the amplicon. The
restriction patterns obtained with different restriction en-
zymes and combination of these patterns into a restriction
profile was shown to enable identification of most clini-
cally important mycobacteria by comparison of the ob-
tained profiles with a library of ARDRA profiles obtained
for reference strains of different species [12]. This PCR-
RFLP analysis of the 16S rRNA gene, was published almost
simultaneously with the more widely used technique
(known as PRA), which is based on the amplification of
the hsp65 gene [13–15].
Results
The initial study describing the applicability of ARDRA for
the identification of mycobacteria [12] used universal bac-
terial primers. However, this sometimes resulted in the
false positive amplification from decontaminated sam-
ples of organisms other than mycobacteria. Therefore
primers were developed, aimed at more specific amplifica-
tion of mycobacteria. During the three year evaluation pe-
riod, of which the results are reported here, amplification
of nonmycobacterial organisms occurred in two cases.
These organisms, namely Corynebacterium glutamicum and
Actinomyces odontolyticum, stained acid fast on direct smear
and are relatives of the mycobacteria.
The restriction patterns obtained with the enzymes HhaI
(isoschizomer of CfoI), MboI and RsaI for the different spe-
cies are numbered arbitrarily and are presented in Figures
1, 2 and 3 respectively. Figures 4,5,6 represent the restric-
tion patterns obtained when digital restriction is carried
out with the same enzymes on published GenBank se-
quences. The combination of these patterns is designed as
ARDRA profiles and these are listed in Table 1. For exam-
ple, strains of the M. tuberculosis complex can be recog-
nized by an ARDRA profile 1-1-1, while M. grodonae
strains have ARDRA profile 8-4-2. For some species the
ARDRA pattern obtained with enzyme is already charac-
teristic, e.g. HhaI 1 is observed only for species of the M.
tuberculosis complex.
Most mycobacterial species could be readily identified by
comparison of the obtained ARDRA profile with the pro-
files from Table 1. The species of the M. tuberculosis com-
plex can not be differentiated on the basis of the 16S
rDNA sequence, and therefore restriction digestion of this
gene could not either. Most of the clinically relevant and
the most abundant species were readily differentiated
from each other. The following species could not be dif-
ferentiated from each other after digestion with HhaI,
MboI, RsaI and BstUI: M. gastri and M. kansasii (1'-4-1-1),
M. bohemicum, M. haemophilum and M. malmoense (1'-4-1-
3), MCRO6 and M. nonchromogenicum (2-6-4-7), M. chelo-
nae group I, M. abscessus and M. immunogenicum (3-3-6-
2'), M. farcinogenes, M. fortuitum, M. senegalense and M.
septicum (4-1-6-7), M. simiae and M. lentiflavum (5-7-6-2'),
M. goodii and M. smegmatis (10-1-2-2'), M. tusciae and M.
flavescens (10-1-6-2'), and finally M. genavense and M. tri-
plex (10-7-6-2').
During 1998–2000, approximately 3500 samples were
sent to the laboratory for direct smear examination and
mycobacterial culture. Of these, 151 specimens, from 149
patients, were culture positive, and 20% of these were also
smear positive. Table 2 summarizes the obtained identifi-
Figure 1
HhaI (CfoI) restriction patterns of amplified mycobacterial
16S rRNA genes. Legend: M: marker (100 base pair ladder,
Fermentas, Vilnius, Lithuania)
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cations. For 148 of the 151 isolates, identification by AR-
DRA was straightforward and was obtained after an
average of 36 hours after receipt of the cultured strain.
Only three difficulties were encountered. One isolate pre-
sented with the ARDRA profile 5-4-6, not present in the
ARDRA library at that time. Sequencing lead to an identi-
fication as M. interjectum[8], a species that was not yet cov-
ered by the library. A second isolate was first misidentified
as M. xenopi (profile 1'-4-3), but later on it was observed
that the HhaI fingerprint differed clearly from the M.
xenopi HhaI 1' pattern by its low molecular size fragments
(Figure 1). This HhaI pattern was designated HhaI 1", re-
sulting in the unique ARDRA profile 1"-4-3. The isolate
was identified as M. heckeshornense by sequencing of the
16S rRNA gene, and can now also be identified by AR-
DRA. The third problematic isolate had ARDRA profile 1-
1-3, again a profile that had never been observed for any
mycobacterial strain studied thus far. Sequencing of the
16S rRNA gave a 99.8 % similarity to the 16S rRNA se-
quence of the type strain of M. tuberculosis. The sequence
revealed a mutation at E. coli position 646 from A to G,
abolishing the RsaI restriction site GTAC at that place. This
mutation shifts the RsaI pattern 1 to RsaI pattern 3 because
the two fragments of resp. 620 and 180 bp are replaced by
a single fragment of 800 bp. Further morphological and
biochemical tests revealed an identification as probably
M. africanum, one of the species of the M. tuberculosis com-
plex. It should be mentioned that M. africanum reference
strains used in a previous study [12], were found to have
the regular M. tuberculosis complex ARDRA profile 1-1-1.
To construct artificial ARDRA patterns for the recently de-
scribed species, we applied the programme RFLP on the
published Genbank sequences. The resulting, theoretical-
ly to be expected, ARDRA profiles are presented in Table 1.
M. tuberculosis was found to be the most prevalent species,
with 40% of the isolates, followed by M. gordonae and M.
xenopi, species mostly isolated form non-pulmonar sam-
ples with low clinical relevance.
Similarity calculation of published sequences and of se-
quences obtained in this study (Figure 8) indicates that
the M. abscessus/M. chelonae complex (M. chehnae, M. ab-
scessus and M. immunogenum) clusters separately from all
other mycobacteria. Portaels et al.[16] described the pres-
ence of four groups within the M. abscessus/M. chelonae
complex, based on the 16S–23S spacer sequences, as used
in the INNO-LiPA Mycobacteria kit (Innogenetics, Zwi-
jnaarde, Belgium). Groups II and IV consisted of genuine
M. chelonae strains, which were usually from environmen-
tal sources. These two groups have characteristic ARDRA
profiles, namely 13-3-6 and 3-3-5. Group III, which was
found to represent genuine M. abscessus and M. chelonae
group I, which most probably corresponds with M. immu-
nogenum, a M. abscessus-like species that was recently de-
scribed as being frequently involved in bronchoscope
related pseudo-outbreaks [17], can not be distinguished
from each other by ARDRA (profile 3-3-6). Strains of
groups I and III are usually isolated from clinical samples,
with only group III strains (genuine M. abscessus) being
pathogenic [16].
Figure 2
MboI restriction patterns of amplified mycobacterial 16S
rRNA genes. Legend: M: marker (100 base pair ladder, Fer-
mentas, Vilnius, Lithuania)
Figure 3
RsaI restriction patterns of amplified mycobacterial 16S
rRNA genes. Legend: M: marker (100 base pair ladder, Fer-
mentas, Vilnius, Lithuania)
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M. tuberculosis was the most frequently cultured species
(40% of all culture positives), followed by M. gordonae
(27%) and M. xenopi (15%) The latter two species were
mostly isolated from non-pulmonar samples. 46% of the
samples culture positive for M. tuberculosis, were auramine
staining positive, and the average time of incubation until
a positive liquid culture of M. tuberculosis was 12.9 days
for the auramine positive samples and 20 days for au-
ramine negative samples. The range of time to positivity
for all M. tuberculosis positive samples was between 6 and
29 days. The average culture times for species other than
M. tuberculosis, as far as data were available, are presented
in Table 2.
Discussion
Restriction analysis of the amplified 16S rRNA gene, or
amplified rDNA restriction analysis (ARDRA) was intro-
duced into the Laboratory for Bacteriology of the Ghent
University Hospital for the identification of cultured my-
cobacteria in 1993 [12]. Since then, several comparable
approaches, based on restriction digestion of the ampli-
fied rRNA genes and spacer regions have been described
[18–21]. During that period, this approach has been up-
dated and refined. This was possible due to some techni-
cal changes, like increased quality control of gel
electrophoresis and pattern interpretation and the use of
primers specific for species of the order of the Actinomyc-
etales instead of universal bacterial primers. Refinement
was also possible because of the improvement of myco-
bacterial taxonomy and the possibility offered by PCR-
RFLP techniques, like ARDRA, to easily adapt to this new
information. Indeed, when new species are described,
there is no need to develop new probes or primers. In-
stead, new ARDRA profiles can be easily added to the ex-
isting library. Also, ARDRA profiles for newly described
species can be predicted by applying computer aided di-
gestion of the available GenBank sequences, given the
availability of sequences of sufficient quality [22].
ARDRA was found to be a useful tool for identification of
mycobacterial isolates in a clinical routine laboratory, be-
cause of its speed – compared to phenotypic identifica-
tion, its reliability, practical applicability, flexibility and
the possibility to identify most nontuberculous mycobac-
teria together with and at the same cost as M. tuberculosis,
Figure 4
HhaI (CfoI) restriction patterns of mycobacterial 16S rRNA
genes, theoretically calculated using RFLP (Applied Maths)
and published GenBank sequences. Graphical representation






















































Pattern CfoI restriction fragment lengths (bp)
1 408, 385, 312, 181, 168
1' 408, 388, 312, 187, 160
1" 408, 388, 312, 196, 157
2 408, 387, 347, 312
3 408, 385, 346, 300
4 408, 387, 225, 190, 155, 75
5 408, 387, 225, 187, 160, 75
7 408, 362, 225, 192, 152, 75
8 654, 408, 386
10 408, 389, 347, 225, 75
13 385, 346, 302, 300, 106
14 408, 360, 346, 312, 25
15 422, 408, 363, 225, 25
16 406, 364, 344, 225, 74, 25
Figure 5
MboI restriction patterns of mycobacterial 16S rRNA genes,
theoretically calculated using RFLP (Applied Maths) and pub-
lished GenBank sequences. Graphical representation and














































Pattern MboI restriction fragment lengths (bp)
1 710, 456, 121, 94, 51, 17
2 808, 508, 121, 17
3 702, 507, 120, 93, 17
4 808, 457, 121, 51, 17
6 718, 411, 121, 96, 94
7 1253, 120, 51, 17
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Table 1: Library of ARDRA profiles (combination of restriction patterns) obtained for mycobacterial species.
Species Genbank Number HhaI MboI RsaI BstUI Reference strains used
a
M. tuberculosis complex X52917 1 1 1 1 ITG 8021, IPB 92/0805
M. conspicuum X88922 1' 1 2 2
M. intracellulare X52927 1' 2 2 3 ITG 5913, ITG 5917
M. gastri X52919 1' 4 1 1
M. kansasii M29575 1' 4 1 1 ITG 8201
M. bohemicum AJ277283 1' 4 1 3
M. haemophilum U06638 1' 4 1 3 ITG 3065
M. malmoense AF152560 1' 4 1 3 ITG 940611
M. szulgai X52926 1' 4 2 1 ITG 4981
M. scrofulaceum X52924 1' 4 2 3 ITG 4988
M. xenopi X52929 1' 4 3 2 ITG 4986
M. heckeshornense AF174290 1' 4 3 4
M. marinum AF251565 2 1 1 1 ITG 1728
M. asiaticum M29556 2 1 2 5 ITG 8182
M. terrae X52925 2 1 4 2 ITG 4922
M. ulcerans Z13990 2 1 9 1 ITG 724, ITG 1837
M. avium AF306455 2 2 2 3 ITG 4991, ITG 2666
M. botniense AJ012756 2 4 3 2
M. terrae-like MCRO6b X93032 2 6 4 7
M. nonchromogenicum X52928 2 6 4 7 ITG 4980
M. phlei M29566 3 1 6 2'
M. elephantis AJ010747 3 1 8 3'
M. chelonae group IVc AJ416940 3 3 5 2' ITG 7701
M. abscessus group IIIc AJ419970 3 3 6 2' ITG 98-1296
M. chelonae group 1c AJ419969 3 3 6 2' ITG 95-0026
M. immunogenum AJ011771 3 3 6 2' ITG 98-1289
M. farcinogenes AF055333 4 1 6 7
M. fortuitum X52933 4 1 6 7 SLZ A046
M. senegalense M29567 4 1 6 7
M. septicum AF111809 4 1 6 7 ITG 4166
M. intermedium X67847 5 4 6 1'
M. interjectum AJ272088 5 4 6 2' ITG 96-116
M. heidelbergense X70960 5 4 8 2'
M. simiae X52931 5 7 6 2' ITG 4485
M. lentiflavum X80769 5 7 6 2'
M. peregrinumd X52921 7 1 6 9 ITG 99-2069, ATCC 14467
M. gordonae M29563 8 4 2 5 ITG 7838
M. wolinskyi Y12871 10 1 1 2'
M. speciesa AF028712 10 1 1 2'
M. goodii Y12872 10 1 2 2'
M. smegmatis AJ131761 10 1 2 2' ITG 4995
M. kubicae AF133902 10 1 6 1'
M. tusciae AF058299 10 1 6 2'
M. flavescens X52932 10 1 6 2' VUB A016
M. genavense X60070 10 7 6 2' ITG 97-102
M. triplex U57632 10 7 6 2'
M. chelonae group IIc AJ419968 13 3 6 6 ITG 96-0295
M. branderi X82234 14 1 1 9
M. celatume L08169 14 1 1 10
M. triviale X88924 15 1 10 10'
M. aurum X55595 16 1 6 8
a. ITG: Institute for Tropical Medicine, Antwerp, Belgium; IPB: Institute Pasteur du Brabant, Brussels, Belgium; SLZ: Streeklaboratorium Zeeland, 
Goes, the Netherlands; VUB: Free University of Brussels, Brussels, Belgium. b. Strains designated MCRO6 have been studied by Turenne et al.[22] 
and Torkko et al.[33]. c. Sequences determined in this study. Roman numbering according to Portaels et al.[16], who distinguished four groups 
within the M. abscessus/M. chelonae complex, based on the 16S–23S rRNA spacer region. d. The GenBank sequence (AF058712) of strain ATCC 
14467, submitted to GenBank as M. peregrinum, did not cluster within the M. fortuitum complex (Figure 8) and was highly similar to sequence 
Y12871 (M. wolinskyi). Moreover, the ARDRA profile calculated from sequence AF058712 (10-1-1-2') did not correspond with the profile we 
obtained for strain ATCC 14467 (4-1-6-7). The sequence obtained in this study from strain ATCC 14467 (submitted as AJ422046) was identical to 
the M. fortuitum sequence X52933. Sequence AF058712 is indicated as M. species in the table. e. Received as M. xenopi.
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at an affordable price. Of the 151 isolates during the last
three years, 148 could be identified without problems.
The other three isolates, respectively M. interjectum, M.
heckeshornense and an M. africanum-like strain, should be
identifiable when met again in the future, since they pre-
sented with specific ARDRA profiles.
Practical applicability of ARDRA
The theoretical turnaround time of ARDRA is 6 hours, and
the average identification time in practice during this
study was 36 hours. It should be emphasized that the
technique was not fully implemented in the routine labo-
ratory, but was carried out by the research laboratory tech-
nicians, which means that the practical turnaround time
should be far less than 36 hours in a routine diagnostic
laboratory. Technically, ARDRA is nondemanding, com-
prising only basic molecular biology techniques like sim-
ple DNA extraction, PCR, restriction digestion and
submarine agarose gel electrophoresis.
General considerations
We have addressed previously the several limitations of
molecular biology based detection in diagnostic bacteriol-
ogy [23]. Others agree that the expectations that DNA am-
plification technologies would supplant microscopy,
accurately predict culture results and provide an immedi-
ate definitive diagnosis were premature and that these
claims have to be replaced with a more realistic view of the
limitations and of the practical value of molecular diag-
nostics of tuberculosis [10,24,25]. Also the expectation
that susceptibility would be carried out solely by means of
DNA technology, had to be moderated [26]. Despite the
fact that during the last ten years a tremendous effort,
both in academic and commercial research, has been put
into the applicability of nucleotide amplification tech-
niques for the detection of mycobacteria directly from
clinical samples, the CDC approved application of these
techniques only for smear positive samples. This impli-
cates that for 52% of the culture positive samples with M.
tuberculosis encountered in this study, DNA technology
would not have accelerated detection, since microscopy
Figure 6
RsaI restriction patterns of mycobacterial 16S rRNA genes,
theoretically calculated using RFLP (Applied Maths) and pub-
lished GenBank sequences. Graphical representation and
















































Pattern RsaI restriction fragment lengths (bp)
1 616, 355, 167, 148, 99, 53, 16
2 556, 355, 167, 148, 99, 60, 53 ,16
3 788, 355, 148, 101, 53, 16
4 391, 355, 167, 167, 148, 99, 59, 55, 16
5 373, 237, 171, 167, 147, 117, 98, 59, 53, 16
6 373, 355, 171, 167, 148, 98, 60, 53, 16
8 433, 355, 171, 167, 148, 99, 53, 16
9 616, 502, 167, 102, 53, 16
10 604, 205, 167, 150, 148, 100, 53, 16
Figure 7
BstUI restriction patterns of mycobacterial 16S rRNA genes,
theoretically calculated using RFLP (Applied Maths) and pub-
lished GenBank sequences. Graphical representation and






















































Pattern BstUI restriction fragment lengths (bp)
1 378, 258, 227, 205, 166, 117, 68, 36
1’ 378, 258, 227, 204, 166, 105, 68, 36
2 521, 378, 203, 166, 117, 68
2’ 521, 378, 200, 166, 105, 68
3 485, 378, 202, 166, 117, 68, 35
3’ 485, 378, 205, 166, 117, 68, 36
4 487, 378, 166, 155, 117, 68, 54, 36
5 378, 294, 228, 196, 166, 117, 68
6 521, 448, 203, 166, 119
7 522, 378, 166, 153, 105, 68, 48
8 378, 362, 166, 160, 150, 105, 68, 50
9 378, 229, 205, 166, 160, 134, 117, 68
10 378, 360, 202, 166, 160, 117, 68
10’ 378, 363, 203, 166, 160, 105, 68
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was negative. Recently, AMTD2 (GenProbe) gained FDA
approval for testing smear negative sputa, but the cost of
the technique keeps limiting its use to only those smear
negative samples with strong clinical suspicion of tuber-
culosis. Moreover, since this kind of direct detection am-
plification technology is technically demanding or
requires specialized equipment and kits, many laborato-
ries carry out these tests only at well-set time intervals [e.g.
[11]], delaying diagnosis with several days on average,
and as such loosing some of the time gain offered by these
direct detection methods. As a final remark, one should
keep in mind that direct detection without direct antimi-
crobial susceptibility testing does not obviate the need for
culture after all.
ARDRA compared to other culture based genotypic identi-
fication techniques
ARDRA and other gene restriction techniques
[14,15,21,27,28] have been developed as a practical short
cut to full sequence determination. From this study and
others it is clear that the discriminatory power of these
RFLP approaches for identification of mycobacteria is al-
most as high as that of sequencing. The discriminatory
power and reliability of a commercially available rRNA-
spacer based hybridisation assay (INNO-LiPA Mycobacte-
ria) is high, but again this approach is somewhat more la-
borious and more expensive than in house PCR-RFLP-
based techniques. Restriction digestion of a 439 bp stretch
of the hsp65 gene for identification of mycobacteria was
described almost simultaneously with ARDRA and desig-
nated PCR-RFLP Analysis (PRA) [15]. Several laboratories
have published their experience using this technique [e.g.
[14,27,28]]. Possible drawbacks of hsp65 gene restriction
analysis are the smaller sized restriction fragments and the
higher intraspecific variability, which may make interpre-
tation more difficult. The small size differences have led to
the use of polyacrylamide gel electrophoresis [27], which
is less practical than agarose gel electrophoresis and the
interpretation difficulties in general have led to reconsid-
eration of the hsp65 gene restriction profiles used thus far
[28]. Comparable remarks can be made for PCR-RFLP
analysis of the rRNA spacer region [21].
Future developments
At present, in an effort to have the best of both worlds, we
are performing a double PCR, directly on smear positive,
decontaminated samples, extracting DNA with the com-
merially available QiaAmp Tissue kit (Qiagen, Hilden,
Germany). One PCR attempts to amplify the full length
16S rRNA gene (1500 bp), which can be used for ARDRA,
at an annealing at 55°C, and one PCR amplifies a 123 bp
region of the IS6110 at an optimal annealing of 68.6°C
[29]. Both PCRs are carried out simultaneously in a T-gra-
dient thermocycler (Biometra, Göttingen, Germany), pro-
grammed to have both annealing temperatures in the 96
well block. In case of the presence of the 123 bp fragment
on an agarose gel, the identification of M. tuberculosis is
completed, and can optionally be confirmed with AR-
DRA. Due to the higher sensitivity of the IS6110 PCR
compared to the rDNA PCR, we could amplify the IS6110
fragment of M. tuberculosis directly from all smear positive,
M. tuberculosis culture positive samples thus far. In case
only the 16S rDNA fragment of 1500 bp is present, the ab-
sence of M. tuberculosis can be confirmed by ARDRA which
Table 2: Distribution of the Mycobacterium species during 1998–2000 in the Ghent University Hospital, number of smear positives and 
time to positivity of culture.
Mycobacterium species Number of isolates (%) Number of samples positive on
direct smear a (% of culture positive)
Average time until positive culture in days
(smear positives; negatives)
M. tuberculosis complex 61 (40) 26 (46b) 16.7 (12.9; 20)
M. avium 12 2 6.5
M. heckeshornense 1 1 32.5
M. chelonae 4 0 18
M. fortuitum 2 0 35.5
M. gordonae 41 (27) 1 22.3
M. interjectum 1 0 30.5
M. intracellulare 1 0 11.6
M. kansasii/M. gastri 2 0 No data
M. malmoense 1 0 No data
M. szulgai 3 0 20.3
M. xenopi 22 (15) 0 38.1
Total 151 40 (26)
a: No data for 6 of the 61 samples. All six of these samples were M. tuberculosis culture positive. b. Calculated as 26 positives on a total of those 56 
culture positives for which data on smear positivity were available.
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also immediately provides with the identification of the
Mycobacterium species other than tuberculosis. Thus far,
this yielded in all cases an identification as a nontubercu-
lous strain, confirming the absence of M. tuberculosis. Also
in case both amplifications of the smear positive sample
remain negative, this can be interpreted as the absence of
M. tuberculosis. A positive culture is then awaited to iden-
tify the nontuberculous organism with ARDRA.
Taxonomical considerations
This study also confirmed the robustness of ARDRA based
identifications. For example, for the first study [12], we re-
ceived strains identified by reference laboratories as M.
avium and M. xenopi, using phenotypic methods. During
the first study already, some strains that had been sent as
M. avium could be shown by ARDRA (and subsequent
confirmation by another laboratory) to be M. scrofu-
laceum. For M. xenopi, ARDRA indicated the presence of
several groups. In the meantime mycobacterial taxonomy
has been refined and the groups we indicated as M. xenopi
A and M. xenopi B [12] appear to correspond to genuine
M. xenopi, resp. M. celatum (ITG 6147)[30], as becomes
apparent when applying the programme RFLP on the 16S
rRNA sequence data we obtained. Similarly, strains that
we classified as M. fortuitum A and B [12], appear to corre-




A collection of well characterized reference strains belong-
ing to different mycobacterial species was used to create
an ARDRA profile library. The strains used are listed in Ta-
ble 1. The 151 clinical strains used in this evaluation were
collected during the period between January 1998 and
December 2000 in the routine clinical laboratory of the
Ghent University Hospital.
Processing and culturing of the samples
Decontamination of the samples was done by mixing 1
ml of sample with 1 ml of decontamination buffer (3%
NaOH/N-acetyl L-cysteine (NALC)). After 15 min of incu-
bation at room temperature the mixture was neutralized
by adding 40 ml of 0.067 M phosphate buffer (pH 6.8),
followed by centrifugation at 11600 g during 15 min. The
supernatant was removed and part of the pellet was used
for auramine staining and microscopy. The remaining pel-
let was suspended in 1 ml of phosphate buffer and used
for inoculation of culture media. 100 µl was used for in-
oculation of a solid medium (Ogawa, Sanofi-Pasteur,
Marnes la Coquette, France) and 500 µl for the inocula-
tion of a liquid medium. During this study the automated
liquid culture system was changed from the Bactec system
(Becton Dickinson, Cockeysville, Md.) to the 3D BacT/
Alert system (Organon Teknika, Boxtel, The Netherlands).
DNA extraction
Starting from liquid culture, 500 µl of a positive culture
was transferred to a 1.5 ml screw cap Eppendorf tube. Af-
ter centrifugation at 13.000 rpm for 15 minutes, the su-
pernatant was removed and the resulting pellet was
resuspended in 50 µl TE buffer (100 mM Tris-HCl – 10
mM EDTA, pH 8.0). The mixture was heated for 30 min-
utes at 95°C, followed by a freezing step at -20°C for at
least 30 minutes. Starting from solid culture, a loopful of
a bacterial colony was suspended in 500 µl of TE buffer.
The mixture was heated at 95°C for 30 minutes, followed
by a freezing step at -20°C for at least 30 minutes. Prior to
PCR, DNA extracts were thawed at 4°C and centrifuged
shortly to pellet the debris.
ARDRA for mycobacteria consists of the amplification of
the 16S rRNA gene, followed by separate restriction diges-
tion with HhaI, MboI and RsaI The combination of the
three obtained fingerprints is designated an ARDRA pro-
file which can be compared with a library of ARDRA pro-
files, obtained from well-identified mycobacterial strains.
In some cases, more discriminatory identification is pos-
sible by additional restriction with BstUI.
Amplification of the 16S rRNA gene
The primers used to amplify the full length 16S rRNA gene
(approximately 1500 bp) were MBUZ1 (GAC GAA CGC
TGG CGG CGT GCT TAA C) and MBUZ2 (CGT CCC AAT
CGC CGA TC). These primers are designated to amplify
only the 16S rRNA gene for species of the order Actinomy-
cetales. The PCR mixture consisted of 25 µl Qiagen Mas-
termix (Qiagen, Hilden, Germany), 0.2 µM of each
primer, 5 µl of DNA extract, and was adjusted to 50 µl
with distilled water. Thermal cycling consisted of an ini-
tial denaturation of 5 min at 94°C, followed by three cy-
cles of 1 min at 94°C, 2 min at 55°C and 1 min at 72°C,
followed by 30 cycles of 20 sec at 94°C, 1 min at 55°C and
1 min 72°C, with a final extension of 7 min at 72°C, and
cooling at 10°C.
Amplification of 123 bp of the IS6110 region was carried
out as described [29] after DNA extraction from decon-
taminated sputum samples using the QiaAmp Tissue kit
(QiaGen, Hilden, Germany).
Restriction digestion
The restriction enzymes used were HhaI (isoschizomer of
CfoI)(Amersham Pharmacia Biotech Benelux, Roosend-
aal, the Netherlands), MboI (Fermentas, Vilnius, Lithua-
nia), RsaI (Amersham Pharmacia). When necessary for
further discrimination, digestion with BstUI (New Eng-
land Biolabs, Beverly, Ma.) was carried out. Each 16S
rDNA amplicon was divided in three separate tubes in al-
iquots of 10 µl, to which 10 U of the respective restriction
enzymes were added, with 2 µl of the corresponding en-
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Figure 8
Neighbour-joining similarity tree for 16S rRNA gene sequences of most mycobacterial species. Legend: N. asteroides ATCC
49872 (Genbank Z82229) was used as the outgroup. Table 1 lists the GenBank accession numbers of the sequences used to
construct this tree. ARDRA patterns for HhaI, MboI, RsaI and BstUI are listed after the species name. a: GenBank AF028712.
Erroneously listed in GenBank as M. peregrinum (see also legend of Table 1). b: M. gastri clusters below 100% with M. kansasii,
although it is generally agreed that the 16S rRNA gene sequences for M. kansasii and M. gastri are identical. This can be
explained by the fact that the only available GenBank M. gastri sequence (X52919) contained several ambiguities. c. M. lentifla-
vum, initially not included in the manuscript is not presented in this tree. It clusters close to the branch including M. heidelber-
gense, M. simiae, M. triplex and M. genavense.
Mycobacterium chelonae group II, 13-3-6-6
Mycobacterium chelonae group IV, 3-3-5-2’
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zyme buffer (10× concentrated, final concentration 2×)
and each restriction digestion mixture was adjusted to 20
µl with distilled water and incubated during 2 hours at
37°C in a heater.
Electrophoresis
The DNA restriction fragments were electrophoresed in a
2.5% agarose electrophoresis gel, containing 2% Meth-
aphor (FMC Bioproducts, Rockland, Me.) and 0.5% MP
agarose (Roche) in the presence of ethidium bromide (50
ng/ml). The gels were photographed and the fingerprints
were compared visually with the overview gels (Figures 1,
2 and 3).
16S rDNA sequencing and comparative analysis
A fragment of the 16S rRNA gene (corresponding to posi-
tions 10-1507 in the Escherichia coli numbering system)
was sequenced as described previously [31]. Sequencing
primers were MB UZ1 (GACGAACGCTGGCGGCGTGCT
TAAC, E. coli position 27-50), MB UZ2 (CGTC-
CCAATCGCCGATC, 1493 – 1476), MBP1 (CCG-
GCCAACTACGTGCCAGC, 502 – 522), MBP2
(CTGGAATTCCTGGTGTAGCGG, 673 – 693), MBP3R
(GCATGTCAAACCCAGGTAAGG, 1006 – 986) and
MBP4R (CCACCTTCCTCCGAGTTGACC, 1185 – 1165)
The 16S rDNA sequences obtained in this study are indi-
cated in Table 1. All steps of the comparative sequence
analysis were performed by using the GeneBase software
package (Applied Maths, St. Martens Latem, Belgium), as
described [32]. First, pairwise alignment using UPGMA
was carried out with a gap penalty of 100 %, a unit gap
cost of 20 % and an ambiguity cost of 50 % of the mis-
match cost. Subsequently, global alignment – with N. as-
teroides ATCC 49872 (Genbank Z82229) used as the
outgroup – was carried out on the region corresponding
to positions 67 through 1444 of the 16S rRNA gene of E.
coli, with costs as above. Finally, a similarity matrix of the
aligned sequences was constructed by global alignment
homology calculation and a gap penalty of 20 %. The
neighbour-joining method was used to construct the den-
drogram based on this similarity matrix. Bootstrap values
were calculated.
Theoretical calculation of restriction patterns was done by
means of RFLP (Applied Maths), which makes it possible
to obtain restriction patterns using sequences in EMBL
format, for every restriction enzyme. The programme Gel-
Compar (Applied Maths) was then used to display the ob-
tained fingerprints.
Acknowledgements
We thank Leen Rigouts for biochemical identification of some of the 
strains.
References
1. Wolinsky E: Mycobacterial diseases other than tuberculosis.
Clin Infect Dis 1992, 15:1-12
2. Espinal MA, Laserson K, Camacho M, Fusheng Z, Kim SJ, Tlali RE,
Smith I, Suarez P, Antunes ML, George AG, et al: Determinants of
drug-resistant tuberculosis: analysis of 11 countries. Int J Tu-
bere Lung Dis 2001, 5:887-93
3. Wayne LG, Sramek HA: Agents of newly recognized or infre-
quent encountered mycobacterial disease. Clin Microbiol Rev
1992, 5:1-25
4. Horsburg C, Metchok B, McGowen J, Thompson S: Clinical impli-
cations of recovery of M. avium complex from stool or respi-
ratory tract of HIV infected individuals. AIDS 1992, 6:512-514
5. Haas WH, Butler WR, Kirschner P, Plikaytis BB, Coyle MB, Amthor
B, Steigerwalt AG, Brenner DJ, Salfinger M, Crawford JT, et al: A new
agent of mycobacterial lymphadenitis in children: Mycobac-
terium heidelbergense sp. nov. J Clin Microbiol 1997, 35:3203-3209
Table 3: Overview of the theoretical ARDRA profiles of the species that were newly described since the start of the evaluation period 
(1998), as obtained after computer aided digestion of the published sequences (see also Figures 4,5,6,7).
Species Source of isolation Reference GenBank Accession Numbers Hhal Mbol Rsal BstUI
M. bohemicum [34] AJ277284, U84502 1' 4 1 3
M. botniense Water [35] AF012756 2 4 3 2
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M. septicum Catheter related bacteraemia [41] AF111809 4 1 6 7
M. tuberculosis subsp. caprae Goats in Spain [42] AJ131120 1 1 1 1
M. tusciae [43] AF058299 10 1 6 2'
M. wolinskyi Human wounds [37] Y12871, Y12873 10 1 1 2'
a. After resolving the ambiguity (N) present at E. coli position 95 in the Genbank sequence Y12872. An identical base (G) is found at this position in 
all mycobacteria.
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The discriminatory power, speed, and interlaboratory reproducibility of tRNA intergenic length polymor-
phism analysis (tDNA-PCR) combined with capillary electrophoresis was evaluated for the identiﬁcation of
streptococci. This method was carried out in three different laboratories under highly standardized conditions
for 54 strains belonging to 18 different species. It was concluded that interlaboratory reproducibility of tDNA
ﬁngerprints produced by means of capillary electrophoresis was sufﬁciently high to permit the exchange
between different laboratories and the construction of common libraries which can be consulted for comparison
with ﬁngerprints obtained independently in separate laboratories. In a second step, 17 other species were
included in the study and examined in one of the participating laboratories. All Streptococcus species studied,
except S. mitis, S. oralis, S. parasanguinis, S. pneumoniae, S. thermophilus, and S. vestibularis, showed distin-
guishable tDNA ﬁngerprints. A database of well-characterized strains was constructed to enable computer-
aided identiﬁcation of unknown streptococcal isolates.
Traditionally the clinically most important Streptococcus
species have been identiﬁed by Lanceﬁeld carbohydrate anti-
gen detection and the application of a few biochemical or
physiological tests. Difﬁculties arise when less-prevalent spe-
cies are to be dealt with. Lanceﬁeld groups are not species-
speciﬁc (5, 10), and certain species groups (2) are notoriously
difﬁcult to differentiate phenotypically (8).
A number of genotypic methods have been evaluated for the
identiﬁcation of streptococci: ampliﬁed ribosomal DNA re-
striction analysis (7, 9), ampliﬁcation of ddl genes (6), and
sequencing of the MnSOD gene (13). tRNA intergenic length
polymorphism analysis (tDNA-PCR) (15) has been used not
only for the differentiation of streptococcal species (3, 12) but
also for Acinetobacter (4, 16), staphylococci (11), Listeria (14),
and enterococci (1). Thus far the interlaboratory reproducibil-
ity of this kind of genotypic identiﬁcation technique has been
ill studied although it is crucial with regard to the ability to
compare ﬁngerprints generated in different laboratories and
with regard to the construction of publicly accessible DNA
ﬁngerprint data banks. Here we evaluated the interlaboratory
reproducibility of tDNA-PCR in combination with capillary
ﬂuorescent electrophoresis and its suitability for identiﬁcation
in routine diagnostics.
MATERIALS AND METHODS
Bacterial strains. Fifty-four BCCM-LMG culture collection strains (Univer-
sity of Ghent, K. L. Ledeganckstraat 35, B-9000 Ghent) belonging to 18 strep-
tococcal species were used to standardize the method of tDNA-PCR and to
evaluate its interlaboratory reproducibility (Table 1). The collection was ex-
tended with 47 strains of the BCCM-LMG culture collection belonging to 17
other streptococcal species (Table 2). Ten collection strains were subjected to
blind testing in all three laboratories.
DNA preparation. Bacterial cells were grown overnight on Columbia agar
(Gibco Life Technologies, Paisley, Scotland) with 5% ovine blood for 24 h at
37°C in a 5% CO2-enriched environment and checked for purity. A 1-l loopful
of cells was suspended in 20 l of lysis buffer (0.25% sodium dodecyl sulfate, 0.05
N NaOH) and heated at 95°C for 5 min. The cell lysate was spun down by brief
centrifugation at 16,000  g and neutralized by adding 180 l of distilled water.
The cell debris was removed by centrifugation at 16,000  g for 5 min. Super-
natants were used as the DNA in the PCR or were frozen at 20°C until further
use.
tDNA-intergenic PCR. PCR was carried out using outwardly directed tRNA
gene consensus primers T5A (5 AGTCCGGTGCTCTAACCAACTGAG) and
T3B (5 AGGTCGCGGGTTCGAATCC) as described by Welsh and McClel-
land (15). Reactions were carried out in a 10-l volume containing 9.1 l
(dilution, 1.1) of High Fidelity Mix (Gibco Life Technologies). Primers were
added to a ﬁnal concentration of 0.1 M. Primer T3B consisted of a mixture of
one-ﬁfth ﬂuorescent TET-labeled oligonucleotides and four-ﬁfths nonlabeled
oligonucleotides (PE Biosystems, Nieuwerkerk a/d IJssel, The Netherlands). A
volume of 0.7 l of sample DNA was added (dilution, 1/15). After 2 min at 94°C,
reaction mixtures were cycled 30 times in a Perkin-Elmer Cetus 9600 thermo-
cycler with the following conditions: 30 s at 94°C, 1 min at 50°C, and 1 min at
72°C, without a ﬁnal extension period. Reaction vials were then cooled to 10°C
and kept on ice until used in electrophoresis.
Capillary electrophoresis. Twelve microliters of deionized formamide was
mixed with 0.5 l of an internal size standard mixture containing 0.3 l of the
GS-400 high-density size standard and 0.2 l of the GS-500 size standard, which
both contain ROX-labeled fragments in the range of 50 to 500 bp. One microliter
of tDNA-PCR product was added. The mixtures were denatured by heating at
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95°C for 3 min and placed directly on ice for at least 15 min (according to the
recommendations of the manufacturer).
Capillary electrophoresis was carried out using an ABI-Prism 310 genetic
analyzer (Applied Biosystems) at 60°C, at a constant voltage of 1.5 kV, and at a
more or less constant current of approximately 10 mA. Capillaries with a length
of 47 cm and diameter of 50 m were ﬁlled with performance-optimized polymer
4. Electropherograms were normalized using Genescan Analysis software, ver-
sion 2.1 (Applied Biosystems).
Data analysis. tDNA-PCR ﬁngerprints were obtained as table ﬁles from the
Genescan Analysis software and used in a software program developed at our
laboratory (1). Using these sample ﬁles containing tDNA spacer fragment
lengths (peak values) in base pairs, this program enabled us to construct man-
ually a library which contains one entry for each species and whereby each entry
consists of a number of numeric values representing the peak values in base
pairs. The peak values in the library entries are the averages of the peak values
obtained after testing different strains of each species, which are listed in Tables
1 and 2. The peaks retained for each entry are user selected, which means that
the scientist takes the ﬁnal decision about which peaks appear to be character-
istic for each species. Negative values can be added to indicate that a certain peak
must not be present in the ﬁngerprint in order to be identiﬁed as a certain
species. The similarity between the unknown ﬁngerprint and a library entry is
calculated with a coefﬁcient, further referred to as dbp (differential base pairs):
the number of fragments in common between the unknown ﬁngerprint and the
species entry, divided by the total number of fragments of the species entry in the
library. A peak position tolerance of 0.7 bp was used.
A distance matrix was calculated with the in-house software. Clustering anal-
ysis was done with the Neighbor module of the Phylip software (http://evolution.
genetics.washington.edu/phylip.html), using the unweighted pair group method
using arithmetic averages (UPGMA) algorithm. Ten well-characterized strains
were tested blindly in all three laboratories and identiﬁed on the basis of their
tDNA-PCR ﬁngerprint by using this software.
Reproducibility testing. One S. agalactiae strain (LMG 14694T) was tested 135
times by tDNA-PCR in order to evaluate the variation caused by differences in
PCR mixture preparation, PCR cycling, and electrophoresis runs at and between
three different laboratories.
One 10-fold PCR mixture was made in each of the three laboratories and the
DNA template was added. This mixture was divided into 10 equal volumes of 10
l (samples 1 to 10). Samples 1 to 5 were cycled immediately, and samples 6 to
10 were kept at70°C. On each of the following 5 days, a 10-l PCR mixture was
freshly prepared (samples 11 to 15) and this tube was cycled together with one
of the samples 6 to 10. In total, this resulted for each laboratory in 15 tubes with
tDNA-PCR product obtained from the same strain. The content of all 45 prod-
ucts was then divided over three tubes, exchanged between labs, and run on the
ABI Prism 310 genetic analyzer at each laboratory. This resulted in 135 tDNA-
PCR ﬁngerprints of the same strain. For another S. agalactiae strain, LMG
14840, tDNA-PCR was performed on three other thermocyclers: the iCycler
TABLE 1. Strains used to standardize the tDNA-PCR method and to study the intra- and interlaboratory reproducibility
Streptococcus species Strain no.
S. agalactiae ........................................................................................................................................LMG14694T, LMG14840,a LMG15081
S. alactolyticus ....................................................................................................................................LMG14617,a LMG14872, LMG14808T
S. anginosus ........................................................................................................................................LMG14502T, LMG14696, LMG17666
S. bovis ................................................................................................................................................LMG15048,a LMG15055, LMG8518T
S. gallolyticus ......................................................................................................................................LMG14618,a LMG15049, LMG16802T, LMG16880
S. hyointestinalis .................................................................................................................................LMG14579T,a LMG14581, LMG14582
S. hyovaginalis ....................................................................................................................................LMG14710T, LMG14711, LMG14712
S. mitis.................................................................................................................................................LMG14553,a LMG14557T, LMG14552T
S. mutans ............................................................................................................................................LMG14558T,a LMG14560
S. oralis................................................................................................................................................LMG14532T, LMG14533,a LMG14534
S. parasanguinis ..................................................................................................................................LMG14537T,a LMG14538, LMG14539
S. pyogenes ..........................................................................................................................................LMG14237, LMG14238, LMG14700T
S. salivarius .........................................................................................................................................LMG13103, LMG13104, LMG11489T
S. sanguinis .........................................................................................................................................LMG14656, LMG14657, LMG14702T
S. suis ..................................................................................................................................................LMG14181T, LMG14182, LMG14643
S. thoraltensis ......................................................................................................................................LMG13593, LMG14173, LMG14174
S. uberis ...............................................................................................................................................LMG14375, LMG14892, LMG09465
S. pneumoniae ....................................................................................................................................LMG14545T, LMG15155a, LMG16738
a Strains used in this study for blind identiﬁcation of streptococci on the basis of their tDNA-PCR ﬁngerprint pattern.
TABLE 2. Strains used to expand our collection and the tDNA ﬁngerprint database
Streptococcus species Strain no.
S. acidominimus .................................................................................................................................LMG 17755T
S. canis ................................................................................................................................................LMG 14833, LMG 14834, LMG 15890T
S. constellatus......................................................................................................................................LMG 14503, LMG 14504, LMG 14507T
S. cricetus ............................................................................................................................................LMG 14508T, LMG 14511
S. crispatus ..........................................................................................................................................LMG 14512 LMG 16320T
S. downei .............................................................................................................................................LMG 14514T
S. dysgalactiae .....................................................................................................................................LMG 14602, LMG 14602, LMG 15832, LMG
15738, LMG 15747, LMG 16026T
S. equi subsp. zooepidemicus ............................................................................................................LMG 15760, LMG 15888, LMG 16030T
S. gordonii ...........................................................................................................................................LMG 14515, LMG 14517, LMG 14518T
S. iniae.................................................................................................................................................LMG 14520T, LMG 14521, LMG 15978
S. intermedius......................................................................................................................................LMG 14548, LMG 14549, LMG 17840T
S. phocae .............................................................................................................................................LMG 16735T, LMG 16736, LMG 16737
S. porcinus...........................................................................................................................................LMG 14615, LMG 14837, LMG 15980T
S. rattus................................................................................................................................................LMG 14559, LMG 14650T, LMG 14651
S. pluranimalium ................................................................................................................................LMG 13649, LMG 14177, LMG 14385, LMG 14827
S. thermophilus ...................................................................................................................................LMG 6896T, LMG 7952, LMG 13564
S. vestibularis.......................................................................................................................................LMG 13516T, LMG 14645, LMG 14646
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(Bio-Rad, Nazareth, Belgium), the PTC200 (MJ Research, Waltham, Mass.),
and the Mastercycler (Eppendorf, Hamburg, Germany).
Reproducibility was evaluated by (i) calculation of the standard deviation of
the peak values of the six predominantly present tDNA spacer fragment peaks
and (ii) calculation of the similarity between all ﬁngerprints by using the dbp
coefﬁcient and by clustering with the UPGMA algorithm, using the Phylip soft-
ware.
RESULTS
Standardization. In the three laboratories, different proto-
cols were tested in order to assess the best ﬁngerprint results.
This revealed that the PCR conditions which produced the
most reproducible and discriminatory tDNA ﬁngerprints in
each laboratory were obtained with the PCR mixture compo-
sition and the PCR cycling conditions as described in Materials
and Methods.
Reproducibility. Extensive testing of the reproducibility of
tDNA-PCR was done by repeated ampliﬁcation of one S. aga-
lactiae strain (LMG 14694T) in different laboratories using
different reaction mixtures, thermal cycling runs, and capillary
electrophoresis runs. One of the 45 PCR mixtures and 10 of
the 135 electrophoresis runs failed to produce a ﬁngerprint.
This resulted in 122 tDNA ﬁngerprints available for the repro-
ducibility studies.
In its tDNA-PCR ﬁngerprint, the S. agalactiae strain showed
six predominant peaks, of which the mean peak values, stan-
dard deviations, and percent standard deviations (SD/peak
value 100) for all 122 ﬁngerprints are shown in Table 3. Only
three samples (i.e., 2.5% of all cases), for all of which PCR was
performed in one of the labs, lacked a single peak (of 241 bp).
Each of the 44 obtained PCR products was electrophoresed
at the three different laboratories. For each PCR product, the
ranges between maximal and minimal peak values obtained for
the same DNA fragment were calculated. The lowest and high-
est ranges obtained for each of the six peaks are presented in
Table 4. For the largest peak of 252.70 bp, a maximal range of
1.56 bp was observed.
For all samples for which capillary electrophoresis was car-
ried out in the same laboratory, the mean peak values, stan-
dard deviations, and percent standard deviations were calcu-
lated for the six peaks and are summarized in Table 5. This
table also shows minimal and maximal peak positions ob-
tained. In laboratory A (41 samples), the maximal standard
deviation was 0.25 bp, for a mean peak value of 241.65 bp; in
laboratory B (39 samples), it was 0.22 bp for a mean peak value
of 252.56 bp; and in laboratory C (42 samples), it was 0.21 bp
for a mean peak value of 240.97 bp.
In addition to these standard deviation calculations, the sim-
ilarity values of the 122 capillary electrophoresis runs of the
same strain carried out in three laboratories with varying fac-
tors were also calculated, using the dbp coefﬁcient and clus-
tering with UPGMA. The lowest similarity obtained with all
122 ﬁngerprints was 87.8%.
It was observed that the addition of a ﬁnal extension period
of half an hour at 72°C increased the reproducibility of the
ﬁngerprints. Without ﬁnal extension, double peaks differing in
length by one bp frequently occurred. With a ﬁnal extension
period, the double peaks mostly disappeared to be replaced by
the larger of the two peaks only.
For 12 samples cycled on the iCycler, 6 samples on the
Mastercycler, and 6 on the PTC200, the standard deviations
were 0.18, 0.11, 0.22, 0.14, 0.20, and 0.16 bp for the six peaks.
All 35 streptococcal species tested gave a tDNA-PCR pat-
tern which consisted of three to seven large and reproducibly
present (i.e., present in 97.5 to 100% of all cases) peaks and
several small (i.e., less than 20% of the average peak height in
a ﬁngerprint) nonreproducibly present peaks, which were con-
sidered as noise. All 54 strains used in the reproducibility study
gave reproducible ﬁngerprints regardless of the laboratory in
which the assay was performed.
Discriminatory power. Most species were easily distinguish-
able using tDNA-PCR (Table 6). The closely related species S.
bovis, S. alactolyticus, and S. gallolyticus showed resembling but
distinctive tDNA ﬁngerprints. S. mutans and S. gordonii dif-
fered in one base pair of only one peak. The species S. angi-
nosus, S. constellatus, and S. intermedius could be differentiated
by the longer tRNA spacer fragments. S. canis and S. dysga-
lactiae ﬁngerprints differed slightly in two peak values (Table
6). S. oralis, S. mitis, S. parasanguinis, and S. pneumoniae were
not distinguishable on the basis of their tDNA pattern, nor
were S. vestibularis and S. thermophilus. Some species were
TABLE 3. Average values and standard deviations of six peak positions for all 122 ﬁngerprints of S. agalactiae strain LMG 14694T
Variable Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6
Mean (bp) 54.65 62.40 88.90 148.02 241.24 252.70
SD (bp) 0.27 0.20 0.15 0.21 0.37 0.33
% SD 0.49 0.31 0.17 0.14 0.16 0.13
Minimum (bp) 54.22 62.04 88.56 147.5 240.58 251.58
Maximum (bp) 55.29 62.73 89.19 148.56 242.04 253.38
TABLE 4. Mean values and minimal and maximal range of the peak values for a total of 35 triplets and 9 doublets obtained from three
different laboratories
Variable
Mean values and range of peak values (bp)
Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6
Peak avg 54.65 62.40 88.90 148.02 241.24 252.70
Minimal range 0.07 0.02 0.02 0.05 0.15 0.28
Maximal range 1.06 0.95 0.99 0.68 1.11 1.56
1438 BAELE ET AL. J. CLIN. MICROBIOL.
46
divided into two groups on the basis of different tDNA pat-
terns. This was the case for S. iniae and S. porcinus.
Use of the in-house software and a manually constructed
library, which contained only the reproducible peak values,
enabled straightforward differentiation between all of the spe-
cies tested except between strains belonging to the species S.
pneumoniae, S. mitis, S. oralis, and S. parasanguinis and be-
tween S. thermophilus and S. vestibularis strains. In three lab-
oratories, identiﬁcation of 10 well-characterized strains was
attempted using tDNA-PCR and our software, without former
knowledge of the species to which these strains belonged. All
10 strains were identiﬁed correctly in all laboratories.
A dendrogram obtained with the tDNA-PCR patterns is
shown in Fig. 1. All strains belonging to the same species
clustered together. The strains belonging to S. mitis, S. oralis, S.
parasanguinis, and S. pneumoniae were found in the same clus-
ter, as was the case for strains belonging to S. thermophilus and
S. vestibularis. Strains belonging to the species S. canis and S.
dysgalactiae, and to S. anginosus, S. constellatus, and S. inter-
medius, which show resembling but still different tDNA pat-
terns, clustered together.
DISCUSSION
tDNA-PCR and capillary electrophoresis of the ampliﬁed
DNA fragments already have been evaluated for the differen-
tiation of Listeria species (14) and enterococci (1). To enable
identiﬁcation of a large number of strains, a software program
which was described previously (1) has been developed at our
laboratory. In the present study, the interlaboratory reproduc-
ibility of tDNA-PCR was evaluated in order to develop a fully
exchangeable digital ﬁngerprint database which can be consec-
utively extended with new ﬁngerprints of species belonging to
a wide array of genera.
For S. agalactiae strains, tDNA-PCR resulted in a ﬁngerprint
with six reproducibly present peaks. The standard deviation of
the ampliﬁed tDNA spacer fragment lengths (peak values) was
calculated for each of the six peaks obtained in 122 ﬁngerprints
of strain LMG14694T. The standard deviation of all samples
ranged from 0.19 to 0.38 bp for peaks between 54 and 253 bp,
which indicates that reproducibility with regard to peak values
was extremely high.
The presence or absence of peaks must be caused by differ-
ent PCR mixtures and/or PCR cycling runs and not by elec-
trophoretic migration differences. The six DNA fragments
which are most strongly ampliﬁed are reproducibly present in
more than 97.5% of all cases. Therefore it can be concluded
that peak presence reproducibility, i.e., PCR reproducibility, is
high. Further, it becomes clear that the variation of peak values
around the mean value is caused by electrophoretic run-to-run
differences in and between laboratories (Table 4). The results
show that electrophoresis of the same PCR product on another
genetic analyzer can give peak position differences of more
than 1 bp (the highest range found was 1.56 bp), which means
that the difference is due to variation in migration and not to
the addition or loss of a nucleotide during PCR. Therefore we
conclude that the ﬁnal variability between the obtained ﬁnger-
prints was not caused by PCR mix preparation or by PCR
cycling runs either in one laboratory or in different laborato-
ries, but solely by differences in migration during capillary
electrophoresis, whereby the largest difference occurred be-
tween ABI Prism 310 genetic analyzers in different laborato-
ries. Nevertheless, the reproducibility was found to be very
high and a peak position tolerance of less than 0.8 bp can be
used to score corresponding fragments as identical.
In one laboratory, PCR mixtures were cycled on three other
PCR cyclers and electrophoresis was carried out on the same
genetic analyzer. The standard deviations for the six peaks
ranged from 0.11 to 0.22 bp. This means that this PCR assay
can be performed on the four PCR cyclers tested without the
need for adjustment of the cycling conditions.
The observation that prolonged extension resulted in the
disappearance of double peaks can be explained by the fact
that this enables the Taq polymerase to add an extra A to most
TABLE 5. Mean, standard deviation, and percent standard deviation of the six peaks in all ﬁngerprints obtained in each laboratory
CE results ina: Peak 1 Peak 2 Peak 3 Peak 4 Peak 5 Peak 6
Lab A (n  41)
Mean (bp) 54.39 62.48 88.72 148.22 241.65 253.05
SD (bp) 0.09 0.20 0.08 0.16 0.25 0.22
SD (%) 0.16 0.31 0.09 0.11 0.10 0.09
Minimal (bp) 54.22 62.04 88.56 148.00 240.82 252.08
Maximal (bp) 54.62 62.73 88.85 148.56 242.04 253.34
Lab B (n  39)
Mean (bp) 54.60 62.47 88.94 147.96 241.06 252.56
SD (bp) 0.13 0.17 0.07 0.14 0.16 0.22
% SD 0.23 0.27 0.08 0.09 0.07 0.09
Minimal (bp) 54.41 62.11 88.82 147.5 240.83 251.58
Maximal (bp) 54.88 62.68 89.06 148.29 241.74 253.38
Lab C (n  42)
Mean (bp) 54.95 62.26 89.04 147.86 240.97 252.46
SD (bp) 0.18 0.14 0.14 0.12 0.21 0.18
% SD 0.33 0.22 0.16 0.08 0.09 0.07
Minimal (bp) 54.20 61.53 88.80 147.64 240.58 252.06
Maximal (bp) 55.29 62.46 89.61 148.19 241.44 252.85
a CE, capillary electrophoresis. n, number of samples.
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of the PCR fragments, causing these to outnumber the peaks
without an additional A.
To be able to compare a large number of patterns, a soft-
ware program was developed in our laboratory. It takes into
account only peak values, not peak intensities. Importantly,
extra peaks which are caused by electrophoretic impurities or
other unknown factors are ignored by the approach used here
and therefore cannot inﬂuence the identiﬁcation results. Vari-
ability in peak positions due to electrophoretic differences can
be compensated by enlarging the position tolerance in the
software. Still, visual checking of the patterns to conﬁrm the
results is advised.
tDNA-PCR seems to be suited for the identiﬁcation of most
streptococcal species. However, S. mitis, S. oralis, S. parasan-
guinis, and S. pneumoniae, belonging to the clinically important
viridans streptococci and to one phylogenetically closely re-
lated S. mitis species group (2), showed highly resembling
patterns (see Table 6) and were not distinguishable. Recently,
Degheldre et al. (3) have evaluated the discriminatory power
of tDNA-PCR for the differentiation of viridans streptococci
with separation of fragments on an ALFexpress DNA se-
quencer. Apparently, the patterns they found are not similar to
those obtained in our study, because of the presence of more
large fragments and fewer small ones. In their study, the large
fragments enabled discrimination within the S. mitis group.
The cause of this disagreement is not clear.
tDNA-PCR is very rapid and relatively easy to perform. In a
PE 9600 thermocycler, 96 samples can be run at once. Starting
from a single colony, DNA extraction takes about 3 h for 96
strains. The preparation of the tDNA-PCR mixtures in sepa-
rate tubes and addition of the sample DNA takes about 1 h and
the PCR run itself takes 2 h. During this run, the genetic
analyzer ABI Prism 310 capillary electrophoresis apparatus
can be prepared. Denaturation and preparation of the PCR
products takes about 30 min. The electrophoresis run takes
about half an hour per sample, but with the use of different
dyes for labeling primers, three samples can be run at the same
time. Quality control of the obtained proﬁles by means of
GeneScan analysis and comparison of the tDNA-PCR proﬁles
of the unknown strains with the database takes another hour.
Summarized results for all 96 strains can be available within
25 h if the three-dye technology is used. Obviously, taking
fewer samples at once will reduce the manipulation time,
which makes it possible to have the ﬁrst electrophoresis results
within 8 h after colony picking.
The cost, including culture, DNA extraction, PCR, and cap-
illary electrophoresis, was calculated as $2.50 per strain. Given
the possibility for automation, the broad applicability of
TABLE 6. tDNA-PCR library constructed manually and containing numeric values that represent lengths of ampliﬁed tDNA spacers that
ought to be present or absent in the ﬁngerprint of an unknown strain in order to be identiﬁed as a certain species
Streptococcus species entry Length of fragments considered (bp)a
S. acidominimus .......................................................................................................................................................65.1, 75, 90.3, 103.9, 165.5, 261.5
S. agalactiae ..............................................................................................................................................................54.8, 62.5, 89, 148, 241, 252.5
S. alactolyticus ..........................................................................................................................................................55.8, 63.5, 154, 155, 253.8
S. anginosus ..............................................................................................................................................................77, 88, 155.3
S. bovis ......................................................................................................................................................................55.8, 63.5, 154, 155, 241, 255
S. canis ......................................................................................................................................................................92, 164, 264.5
S. constellatus ...........................................................................................................................................................88, 155.3
S. cricetus ..................................................................................................................................................................72.6, 81, 165.5, 260.5
S. crispatus ................................................................................................................................................................56.3, 79.7, 90, 152, 251
S. downei...................................................................................................................................................................71.8, 166.5, 261.3
S. dysgalactiae...........................................................................................................................................................92, 163.4, 263.5
S. equi subsp. zooepidemicus ..................................................................................................................................56.4, 63.5, 84.7, 92.8, 171.8, 234.6, 272.3
S. gallolyticus ............................................................................................................................................................55.8, 63.5, 155, 241, 255
S. gordonii .................................................................................................................................................................77, 88, 159.7
S. hyointestinalis .......................................................................................................................................................61.2, 69, 88.6, 159.6, 255.1
S. hyovaginalis ..........................................................................................................................................................69, 88.6, 147.8, 160.2, 255.6
S. iniae 1 ...................................................................................................................................................................130.5, 150, 167.5, 265.3
S. iniae 2 ...................................................................................................................................................................130.5, 150, 169.5, 267.4
S. intermedius ...........................................................................................................................................................77, 88, 155.3, 253.7
S. mitis/oralis/parasanguinis/pneumoniae ...............................................................................................................63.5, 84.5, 150
S. mutans ..................................................................................................................................................................77, 88, 158.2
S. parauberis .............................................................................................................................................................66, 115.7, 165.5, 260.7, 290.5
S. phocae...................................................................................................................................................................56.3, 98.4, 165.3
S. pluranimalium ......................................................................................................................................................74.1, 99.5, 141, 162, 263
S. porcinus 1 .............................................................................................................................................................148.3, 171.5, 242, 266.5, 318.1
S. porcinus 2 .............................................................................................................................................................151.6, 168, 245, 263.3, 322.5
S. pyogenes ................................................................................................................................................................80.6, 92, 166.5, 266.5
S. rattus .....................................................................................................................................................................56.3, 67.5, 261.6, 266.7
S. sanguinis ...............................................................................................................................................................65.3, 92.7, 161.5, 258.6
S. salivarius ...............................................................................................................................................................78.3, 148.3
S. suis ........................................................................................................................................................................57.5, 65.5, 75.3, 92.8, 106.6, 162.2, 259.6
S. thermophilus/vestibularis......................................................................................................................................70.5, 79.5, 148.2, 247.5
S. thoraltensis............................................................................................................................................................74, 83.2, 166.5, 258, 271.9
S. uberis.....................................................................................................................................................................117.5, 133.5, 168.5, 263
a Negative values indicate the length of tDNA spacers that should be absent in the ﬁngerprint.
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tDNA-PCR for species identiﬁcation, and the interlaboratory
exchange of data due to its high reproducibility, tDNA-PCR
could be developed as a routinely applicable genotypic identi-
ﬁcation technique.
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Abstract
Background: The number of patients with yeast infection has increased during the last years. Also
the variety of species of clinical importance has increased. Correct species identification is often
important for efficient therapy, but is currently mostly based on phenotypic features and is
sometimes time-consuming and depends largely on the expertise of technicians. Therefore, we
evaluated the feasibility of PCR-based amplification of the internally transcribed spacer region 2
(ITS2), followed by fragment size analysis on the ABI Prism 310 for the identification of clinically
important yeasts.
Results: A rapid DNA-extraction method, based on simple boiling-freezing was introduced. Of the
26 species tested, 22 could be identified unambiguously by scoring the length of the ITS2-region.
No distinction could be made between the species Trichosporon asteroides and T. inkin or between
T. mucoides and T. ovoides. The two varieties of Cryptococcus neoformans (var. neoformans and var.
gattii) could be differentiated from each other due to a one bp length difference of the ITS2
fragment. The three Cryptococcus laurentii isolates were split into two groups according to their
ITS2-fragment lengths, in correspondence with the phylogenetic groups described previously. Since
the obtained fragment lengths compare well to those described previously and could be exchanged
between two laboratories, an internationally usable library of ITS2 fragment lengths can be
constructed.
Conclusions: The existing ITS2 size based library enables identification of most of the clinically
important yeast species within 6 hours starting from a single colony and can be easily updated when
new species are described. Data can be exchanged between laboratories.
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Background
Rapid and correct identification of the different clinically
relevant yeast species has become more important be-
cause of several reasons. During the last decade, the im-
pact and frequency of yeast infections has gained
importance mainly due to an increased number of immu-
nocompromised patients [1]. Furthermore, an increasing
number of non-C. albicans yeast species are considered as
potential agents of clinical infections [2]. Finally, the dif-
ferences in susceptibility towards antifungal agents be-
tween the different species make that rapid yeast
identification can be used as a first indication for efficient
treatment.
Phenotypic identification relies on cell and colony mor-
phology and on biochemical characteristics, but this ap-
proach is not always fully discriminative, may be time-
consuming and requires specific expertise of the techni-
cians [3]. Therefore several groups have explored the pos-
sibilities of PCR-based techniques for the differentiation
between different yeast species. The use of species specific
probes [4,5] or molecular beacons [6] resulted in very sen-
sitive and very specific techniques but remains restricted
to the species for which the probes are designed for. A
more broadly applicable approach is based on PCR with
universal fungal primers (directed towards conserved re-
gions in the ribosomal region) and followed by either re-
striction analysis [7], sequencing [8] or size determination
of the amplified fragment(s) [9,10].
Here we report an evaluation and extension of the tech-
nique published by Turenne et al.[9], whereby the rRNA
Internally Transcribed Spacer Region 2 (ITS2), i.e. the re-
gion in between the fungal 5.8S and 28S rRNA genes, is
amplified and its length is determined by fragment analy-
sis on an ABI Prism 310 capillary electrophoresis system.
Turenne et al.[9] showed that the length of the ITS2-spacer
region was characteristic for most species and that it was
identical for all strains within a species, although only a
limited number of strains was used per species. By using
one fluorescently labeled primer, the size of the amplicon
can be determined by electrophoresis on an ABI Prism
310 capillary apparatus, which provides with the one base
pair resolution that is needed to differentiate between
ITS2-fragment lengths of closely related species. In this
study, we also evaluated a simpler and more rapid DNA-
extraction method and we applied ITS2-PCR on ABI Prism
310 on more strains and species than in the original pub-
lication.
Results
Using DNA-extraction based on boiling/freezing of the
yeast colonies, the ITS2-PCR fragment could be amplified
easily from all yeast strains. An initial ITS2 size based li-
brary was constructed using a panel of reference strains,
belonging to most of the clinically important species (Ta-
ble 1).
When amplifying the ITS2-PCR fragment, care was taken
to label the same primer as used by Turenne et al.[9] and
to use the same HEX-label, in order not to introduce arte-
factual length differences. Still, when the obtained frag-
ment lengths were compared with those of Turenne et
al.[9], differences were observed (Table 2). These could be
explained by our use of dTTP, compared to the use of
dUTP in the original publication [9]. Unpublished frag-
ment lengths obtained at the laboratory of Turenne when
using dTTP were in agreement with our findings (Turenne,
pers. comm.).






Candida albicans IHEM 3242, IHEM 3731, IHEM 3740, IHEM 
6440
C. dubliniensis IHEM 14280
C. glabrata IHEM 4210, IHEM 4566, IHEM 5573, IHEM 
9556
C. guilliermondii IHEM 1067, IHEM 1879, IHEM 3283
C. humicola AZB 98-043
C. kefyr IHEM 4211, IHEM 4593, IHEM 5556
C. krusei IHEM 4562, IHEM 5579, IHEM 6387
C. lipolytica HHR A101315
C. lusitaniae IHEM 4593, IHEM 10293, IHEM 14663
C. norvegensis HHR A211294
C. parapsilosis IHEM 1001, IHEM 2052, IHEM 2305, IHEM 
3270
C. tropicalis IHEM 4222, IHEM 4666, IHEM 5609, IHEM 
12085
Cryptococcus albidus IHEM 3267, IHEM 4786, IHEM 6895
C. laurentii IHEM 895, IHEM 5515
C. neoformans var. gattii IHEM 4170
C. neoformans var. 
neoformans
IHEM 4165, IHEM 4171
Geotrichum candidum IHEM 6284
Malassezia furfur IHEM 3697
Saccharomyces 
cerevisiae
IHEM 3962, IHEM 14402, IHEM 14542, 
IHEM 17539
Trichosporon asahii IHEM 9334, IHEM 17910
T. asteroides IHEM 10214
T. inkin IHEM 5824
T. mucoides IHEM 13920
T. ovoides IHEM 17913
*: IHEM: strains from the BCCM/IHEM Culture Collection, Mycology 
Section, Scientific Insitute of Public Health, Brussels, Belgium; HHR: 
Heilig Hart Ziekenhuis, Roeselare, Belgium, AZB: St. Jan Akademisch 
Ziekenhuis, Bruges, Belgium.
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Table 2: Overview of the different ITS2-fragment lengths observed and of the number of strains identified by means of ITS2-PCR.
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average 
length)




















1 250.7 248 251 AF455443
Candida albicans 116 (19) 281.6 281.0 – 282.6 0.37 279 284 AF217609
C. dubliniensis 1 286.3 289 AF218993
C. glabrata 94 (12) 362.6 362.4 – 362.8 0.15 360 365 AF218994
C. guilliermondii 8 323.2 322.7 – 324.2 0.46 321 325 AF218996
C. humicola 1 295.8
C. kefyr 7 375.5 375.4 – 375.8 0.17 372 378 AF218997
C. krusei 10 (2) 285.3 285.2 – 285.4 0.13 282 294 L47113
C. lipolytica 3 (2) 180.6 179.9 – 181.1 0.62 190 AF218983
C. lusitaniae 9 (4) 200.3 200.2 – 200.4 0.10 199 204 AF218970
C. norvegensis 3 (2) 267.1 266.6 – 267.1 0.62 318 AF333096
C. parapsilosis 36 (12) 254.1 253.5 – 255.4 0.60 251 259 U10989
C. rugosa 1 215.0 214.8 – 215.1 0.10 223 AF218971





3 353.3 352.4 – 354.7 1.26 350 353 AF218972
C. laurentii (envi-
ronmental)
2 272.1 271.9 – 272.3 0.26 275 AF218974
C. laurentii (clini-
cal)
1 307.9 306 310 AJ421006
C. neoformans 
var. neoformans
8 (4) 318.3 318.0 – 318.6 0.29 315 320 AF218975
C. neoformans 
var. gattii
1 320.0 321 AF196312
Dekkera bruxel-
lensis
1 261.8 263 AF043502
Geotrichum can-
didum
3 (1) 193.4 192 195 AF157596
Malassezia furfur 1 494.4 500 AF246896
Saccharomyces 
cerevisiae





2 301.0 300.8–301.4 0.50 304 AB018014
T. asteroides 1 298.6 304 AF444416
T. inkin 1 298.7 304 AF444420
T. mucoides 1 297.2 297 AF444423
T. ovoides 1 297.5 303 AF444439
*: Values obtained by using dUTP instead of dTTP for the PCR-based amplification reaction [9].
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The reproducibility of ITS2-PCR is apparent from Table 2.
For example, for 19 C. albicans strains tested, the observed
fragment sizes ranged between 281.0 bp and 282.6 bp
(with an average value of 281.6 bp and a SD of 0.4 bp).
Table 2 presents the ITS2-lengths observed for the differ-
ent species and reference strains tested.
In one laboratory, we observed in a reproducible manner
a smaller sized peak with lower intensity for half of the
strains and for more than half of the species. An example
is shown in Figure 1 for C. glabrata. However, using the
same DNA-extracts, primer batch, commercially prepared
PCR mixture and thermal cycling protocol, this additional
fragment could not be observed in a second laboratory.
When the primers of the second laboratory were used in
the first laboratory, the additional fragments were ob-
served again. The only technical difference noticed be-
tween both laboratories were the thermal cyclers.
Of the 26 species, 22 could be identified unambiguously
by scoring the length of the ITS2-region. In the genus Tri-
chosporon however, no distinction could be made between
the species T. asteroides and T. inkin, since the ITS2-frag-
ment length is approximately 298.6 bp for both species,
and between the species T. mucoides and T. ovoides, which
both have an ITS2-fragment of approximately 297.5 bp.
Also the two varieties of Cryptococcus neoformans (var. neo-
formans and var. gattii) could be differentiated from each
other due to a one bp length difference of the ITS2 frag-
ment, although these findings should be further con-
firmed by inclusion of more strains.
Figure 1
The ITS2-PCR fragment lengths observed for 10 Candida species (GeneScan Analysis screen, ABI Prism 310,
Applied Biosystems).
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The three C. laurentii isolates were split into two groups
according to the ITS2-fragment length. The clinical isolate
(IHEM, 1296, human mouth) had a fragment of 307.9
bp, while the two environmental isolates (from filter
board of humidifier system (IHEM 0895) and from in-
door air (IHEM 5515)), had an ITS2 length of 272.1 bp.
The ATCC 18803 type strain, an isolate from palm wine,
was found to yield a fragment of 306 base pairs, using
dUTPs [9]. Sequencing of the ITS2 of the three strains
identified them all as C. laurentii. Cluster analysis with
Genbank sequences, published recently [11], revealed
that the clinical isolate (IHEM 1296, Genbank AJ421004)
clustered most closely to the type strain in Sugita's phylo-
genetic group I [11], in correspondence with the ITS2-PCR
results, whereas the environmental strains (IHEM 0895:
Genbank AJ421005 and IHEM 5515: Genbank
AJ421006) clustered in phylogenetic group II, which con-
tained mostly environmental strains and one isolate from
the bronchi of a lung patient (Figure 1).
After construction of the library, a large collection of clin-
ical isolates was identified both with ITS2-PCR and by
phenotypic means, using Albicans ID plate (BioMérieux,
Marcy-l'Etoile, France) and/or Auxacolor (Sanofi-Pasteur,
Marnes-la-Coquette, France) and/or cellular and colony
morphology. The number of additional strains tested for
each species is listed in Table 2. Two isolates could initial-
ly not be identified by ITS2-PCR, because the observed
ITS2-fragment lengths were not present in the library. Ac-
cording to biochemical and ITS2-sequencing data, the first
isolate belonged to the species Candida rugosa, a species
initially lacking in the library. The ITS2 fragment length
value of 215.0 bp for C. rugosa was added to the database.
Another isolate from a hematology patient and from syr-
up present in his room, had a previously not observed ITS-
length of 261.8 bp and sequencing revealed an identity as
Dekkera (Brettanomyces) bruxellensis, a species that had not
been included in the library initially. The ITS2 fragment
lengths obtained for 25 S. cerevisiae strains ranged be-
tween 365.1 and 368.5 bp (average 366.7 bp., SD 0.89
bp.), but no misidentifications occurred.
Clear differences could be observed between the length of
the ITS2-region as derived from published sequences (the-
oretical length) and as calculated after capillary electro-
phoresis (estimated length) (Table 2). Although the
estimated length is highly reproducible, it is consistently
shorter than the theoretical length (except for Blastoschizo-
myces capitatum, C. albidus, T. mucoides and S. cerevisiae,
where it is identical). A maximal difference of 9 bp was
observed for C. krusei. For S. cerevisiae, the range of 3 bp
observed for the estimated ITS2 lengths was also present
in the theoretical lengths derived from the Genbank se-
quences.
Discussion
ITS2-PCR followed by size determination of the fragment
length by capillary electrophoresis has been described as a
possible tool for the identification of yeasts by Turenne et
al. [9] and by Chen et al. [10]. The latter authors amplified
a 50 bp longer stretch of the ITS2 region than did the
former. Since ITS2-PCR fragments of different species may
differ by only one bp, highly reproducible high resolution
electrophoresis as provided by capillary electrophoresis
on ABI Prism 310 is necessary.
In order to increase the speed of this approach we used a
simple and rapid boiling/freezing based DNA extraction
protocol, which proved to be highly efficient. Together,
DNA-extraction, PCR and capillary electrophoresis took
3.5 hours. Thus, the total time to identification is 3.5
hours for the first sample, added with 45 minutes for each
following sample, when using a single capillary apparatus
like the ABI Prism 310. When a 16 capillary apparatus is
used (ABI Prism 3100), the first 16 strains can be identi-
fied within 3.5 hrs. Besides speed and high discriminatory
power, another advantage of this approach is that newly
recognized species or species not yet present in the data-
base can be added after appropriate initial identification,
whereafter their identification by means of ITS2-PCR is
straightforward. Given the identical values we obtained
with unpublished ones by Turenne et al. [pers. comm.], it
can be assumed that the data are exchangeable between
laboratories, as also has been shown for other DNA-fin-
gerprints obtained on ABI Prism 310 machines [12,13].
The lengths obtained for the amplified ITS2 fragments in
two different laboratories during this study were indeed
perfectly comparable. The only difference was an appar-
ently artefactual additional peak of lower size and lower
intensity in one laboratory, never observed in the other
laboratory.
The variety of species that can be identified can be expand-
ed and this can be achieved in a joint effort between lab-
oratories. Moreover, laboratories not having constructed
such a database their selves, can compare the data of their
unknowns to a publicly available database, like the one
published here. Care should be taken to use the same
primer labeled in the same manner and to use the same
size markers and size standard files (available upon re-
quest) to normalize the capillary electrophoresis runs,
since minor differences between these can introduce mi-
gration and normalization differences.
The differences between the theoretical length (as ob-
tained after counting the bases of the available ITS2 se-
quences) and the calculated length (as obtained after
capillary electrophoresis) can be explained by the fact that
electrophoretic migration is also partially sequence de-
pendent, such that the calculated length will not always
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match exactly the theoretical length. However, as long as
the calculated length is reproducible from run to run and
between laboratories, this observation poses no problem
for the purpose of identification. Only for one species (C.
norvegensis) the obtained length in this study was com-
pletely different from the one derived from the published
GenBank sequence (Table 2).
Using ITS2-PCR, identification to species level is very effi-
cient for the genera Candida and Cryptococcus, while four
species of the five tested for the genus Trichosporon could
be split into two groups only. However, the current taxon-
omy of Trichosporon needs further refinement, and our
findings should be corroborated on additional, taxonom-
ically well characterized strains.
The two different ITS2 lengths found for the C. laurentii
strains in this study appear to correspond with a recently
described phylogenetic subdivision within this species,
that was based on the sequences of the 28S rRNA and of
the ITS1 and ITS2 regions [11]. Thus, it appears that both
groups can be differentiated simply by determination of
the ITS2 length and that a distinction between environ-
mental and clinical isolates might be possible. Although
the ITS2-fragment lengths range between 365.1 and 368.5
basepairs for S. cerevisiae strains, identification remains
possible since these fragment lengths are not encountered
in other clinically important yeast species studied thus far.
When methods are used that are suitable for DNA-extrac-
tion directly from clinical specimens, it should be possible
to detect and identify at once the different species that
may be simultaneously present, since the fingerprint will
consist of ITS2 fragments of different lengths, correspond-
ing to the different ITS2-lengths for each species. Howev-
er, when applied for direct detection, the minor peaks, as
observed in one of the laboratories, could lead to prob-
lems in assessing the number and nature of the species
present.
When ITS2-primers are labeled differently from e.g. tRNA-
PCR primers [12–14], electrophoresis of bacterial tRNA-




A collection of 53 culture collection strains (Table 1) and
90 phenotypically well-identified strains, representing 24
species, was used to evaluate the technique and to set up
an initial database. The technique and database were eval-
uated by identification of 242 clinical isolates from four
Belgian hospitals (Ghent University Hospital, Heilig Hart
Ziekenhuis Roeselare, Akademisch Ziekenshuis VUB Jette
and Akademisch Ziekenhuis St. Jan Bruges). In total, 385
strains belonging to 26 species (Table 2) were included.
DNA extraction
A boiling-freezing protocol was used for DNA-extraction.
A 1 µl loopful of growth on Sabouraud agar (Becton Dick-
inson, Maryland, Ca.) was suspended in 500 µl distilled
water and heated for 15 minutes at 95°C, immediately fol-
lowed by freezing at -70°C for at least 15 minutes. Before
adding the DNA-extract to the PCR mix, the samples were
thawed at room temperature, and shortly centrifuged to
pellet the cell debris still present in the extract.
ITS2-PCR
The ITS2-region was amplified with the following prim-
ers: ITS86 (GTG AAT CAT CGA ATC TTT GAA C-HEX)
(fluorescently labeled) and ITS4 (TCC TCC GCT TAT TGA
TAT GC) [9]. The ITS86 primer was used as a mixture of
10% fluorescently labeled and 90% non-fluorescently la-
beled primer in order to avoid out of range peak heights.
The PCR reaction mix contained 12.5 µl Qiagen Master-
mix (Qiagen, Hilden, Germany), 0.5 µM of each primer,
2.5 µl of the DNA extract and 9 µl of sterile distilled water
in a final volume of 25 µl. The thermal cycling was carried
out according to the following protocol: 5 min at 94°C, 30
cycli of 1 min at 94°C, 1 min at 55°C and 1 min at 72°C
and a final extension of 7 min at 72°C, followed by cool-
ing at 4°C.
Capillary electrophoresis
The capillary electrophoresis apparatus used was the ABI
Prism 310 Genetic Analyser (Applied Biosystems, Foster
City, Ca.). Electrophoresis was done in a single capillary,
filled with liquid polymer (POP-4: Performance Opti-
mized Polymer, Applied Biosystems), which was auto-
matically replaced after every electrophoresis run.
Preparation of the sample before electrophoresis consist-
ed of adding 1 µl of ITS2-PCR product to 12.5 µl of elec-
trophoresis mixture (0.1 µl HD 400 marker, 0.3 µl of
ROX-500 marker and 12.1 µl of deionized formamide, all
from Applied Biosystems). The double stranded ITS2-PCR
fragments were denatured by heating this mixture for 2
minutes at 95°C, followed by immediate cooling on ice.
Electrophoresis of each sample was carried out at 60°C
and at 15 kV, during 35 min. The Gene Scan analysis soft-
ware (Applied Biosystems) was used to derive the frag-
ment length of the HEX-labeled DNA-fragments using the
known fragment lengths of the ROX-labeled marker
peaks. The results were presented in a table indicating
length and intensity of the observed fragments. BaseHop-
per software, described previously [12,13] and freely
available upon request was used to quickly compare the
obtained ITS2-fragment lengths with those of the ITS2-da-
tabase.
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Sequencing of the ITS2 region
After amplification of the ITS2 region, the amplicon was
purified using the Qiaquick PCR purification kit, accord-
ing to the manufacturer's instructions. Cycle sequencing
was performed using the Ready-reaction mix (ABI Prism
Bigdye Terminator Cycle Sequencing kit, Applied Biosys-
tems) according to the manufacturer's instructions. Anal-
ysis of the sequencing products was done on the ABI
Prism 310 capillary (Applied Biosystems). Assembly of se-
quence fragments and editing was done with GeneBase
(Applied Maths, St. Martens Latem, Belgium). The ob-
tained ITS2 sequences were compared to all known se-
quences in the Genbank by use of Blast 2.0 (National
Center for Biotechnology Information, Bethesda, Md.  [ht-
tp://www.ncbi.nlm.nih.gov/BLAST/]).
Cluster analysis and dendrogram construction of ITS2 se-
quences
Comparative sequence analysis was performed by using
the GeneBase software package (Applied Maths, St. Mar-
tens Latem, Belgium), as described previously [15]. First,
pair wise alignment using UPGMA was carried out with a
gap penalty of 100 %, a unit gap cost of 20 % and an am-
biguity cost of 50 % of the mismatch cost. Subsequently,
global alignment – with C. neoformans ATCC 90113 (Gen-
bank AB034643) used as the outgroup – was carried out
on the region between 26 and 205 bp of the ITS2 region
of C. neoformans, with costs as above. Finally, a similarity
matrix of the aligned sequences was constructed by global
alignment homology calculation and a gap penalty of 20
%. The neighbour-joining method was used to construct
the dendrogram based on this similarity matrix. Bootstrap
(n=100) values were calculated.
Figure 2
Dendrogram of ITS2 sequences of Cryptococcus laurentii, C. albidus and C. neoformans. Numbers on branches indi-
cate bootstrap value. Species name, phylogenetic group according to Sugita et al.[11], strain number, GenBank accession
number (and ITS2-length in bp) are indicated.
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V. Application of PCR-based identification techniques for classification and description 
of newly or infrequently encountered species. 
V.1. Introduction: Bacterial systematics.
Systematics is the scientific study of organism diversity. It is a fundamental discipline that 
encompasses classification, nomenclature and identification. Classification is the ordering of 
organisms into groups (taxa). Nomenclature is the means by which organisms are allocated 
internationally recognised scientific names. Identification is the means by which unknown 
organisms are placed into previously described taxa, derived from classification (Priest and 
Austin, 1993). 
There are three good reasons to classify organisms: (i) classification is an efficient means of 
summarising and cataloguing information about an organism; (ii) databases of grouped 
organisms allow new isolates to be catalogued and ordered into their appropriate taxa, thereby 
facilitating identification and (iii) insight can be gained into the origins and evolutionary 
history of organisms.
Using structural and phenotypical properties of organisms, all liFe on Earth has for a long 
time been classified into five Kingdoms: Plantae, Animalia, Protista, Procaryota and Fungi.
However, currently only three Domains are being recognized: Bacteria, Archae and Eukarya 
(Woese et al., 1990) (Figure 5). 
The most useful molecules for phylogenetic measurement are those that are essential to basic 
functioning and are therefore likely to span the full evolutionary spectrum. One such family of
molecules are the ribosomal RNA genes. Ribosomal RNAs are essential elements in protein 
synthesis, and are therefore conserved in all living organisms. They have changed very little 
over time and therefore even the most taxonomically distinct organisms will share a degree of 
rRNA homology and therefore relatedness can be assessed. Certain regions of the rRNA gene 
evolve more rapidly than others and sequence variation occurs between closely related 
bacteria, allowing comparisons to be made at the species level.
The amount of homology between rRNA sequences of organisms will reflect phylogenetic
relatedness. High homology implies recent divergence from a common ancestor and low 
homology implies early divergence from a primitive ancestor (Priest and Austin, 1993; 
Woese, 1987).
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This knowledge leads towards the classification based on the small subunit rRNA (16S or 18S 
rRNA gene), which revealed that cellular life on Earth has evolved along three major
lineages. Two of them had remained exclusively microbial and are composed only of 
prokaryotic cells and are called Bacteria and Archaea. The third line consists of the eucaryotic
lineage, called Eukarya to which the Fungi belong (Figure 5). 
Figure 5: Phylogenetic tree of life, based on the small subunit rRNA homologies
The introduction of the small ribosomal subunit sequence as basis for phylogeny and 
classification enabled the use 16S rRNA gene sequencing for identification of unknown 
isolates and for classification of newly encountered species in relation to the already known 
species. Sequencing of 16S rRNA genes resulted in a characteristic that could be compared
and classified and expressed as a percentage of similarity. It has been proposed that a 
prokaryote whose 16S rRNA sequence differs by more than 3% from that of all other 
organisms, should be considered as a new species (Stackebrandt & Goebel 1994).
There are, however, some important drawbacks in the use of 16S rRNA gene sequencing for 
phylogeny.
(i) The homology rate between members of certain genera (e.g. Staphylococcus, Bacillus,
Aeromonas, Enterococcus) is too high, such that the 3% rule is not applicable. For example, it 
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was found that on the basis of 16S rRNA sequence data, all Bacillus species should be 
considered as a single species, having 99.5% sequence identity (Fox et al., 1992). Previously 
published DNA-DNA relatedness data contradicted this result;
(ii) The presence of mosaic rRNA genes, which indicates the occurrence of horizontal transfer 
and recombination of (parts of) rRNA cistrons between strains and species (Sneath, 1993; 
Gürtler,1999);
(iii) Heterogeneity among the different alleles of the 16S rRNA genes (one to ten copies)
(Gürtler and Stanisch, 1996; Rainey et al., 1994), which can sometimes be very high, up to 
5% in certain strains (Vaneechoutte and Heyndricks, 2000). 
Due to those several limitations 16S rRNA gene sequencing can not be used as the sole 
classification method. In practice, the identification commonly implies a polyphasic approach 
using several characteristics, and classification is based on a polyphasic taxonomy
(Vandamme et al., 1996). 
An ad hoc committee on reconciliation of approaches to bacterial systematics in 1987 stated 
that the reference standard by which phylogeny is determined is complete DNA sequence
data; and that phylogeny should also determine taxonomy. The committee members stated 
that the species is the only taxonomic unit that can be defined in taxonomic terms and they 
proposed a polyphasic approach to its definition, in which a DNA reassociation value of about 
70% plays a dominant role (Wayne et al, 1987; Stackebrandt and Goebel, 1994). An update of 
the recommendations on species definition is currently published (Stackebrandt et al., 2002). 
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V.2. Overview of the taxonomy of the genera studied.
Identification of clinical isolates, making use of the molecular identification techniques
presented in chapter IV, can reveal unsuspected pathogens amongst the majority of clinical 
suspected with known clinical importance or strains difficult to place on the exact 
taxonomical positions. These isolates are the basis for further taxonomical research leading to 
the description of new species, or case reports. 
During this doctoral work, taxonomical studies were carried out on Acinetobacter and 
Mycobacterium using ARDRA and additional techniques like biochemistry, 16S rRNA gene 
sequencing and DNA-DNA hybridizations. This has resulted in the description of two new 
species in the genus Acinetobacter and the review of the clinical importance of M. interjectum
after such an isolate was seen in our hospital. Other genera of interest were Ralstonia, leading 
to the description of R. mannitolilytica and the publication of two case reports with R. gilardii
and R. manitolilytica isolates. Finally the genus Moraxella was studied because of the two 
case reports of clinical isolations of M. atlantae and M. canis.
These publications are included and are introduced by a taxonomical overview of the genera 
of interest. 
V.2.1. Taxonomy of the genus Acinetobacter.
Bacteria of the genus Acinetobacter (Brisou and Prévot, 1954) are widespread in nature, and 
can be recovered from water, soil and living organisms. They are non-motile, non-
fermentative, coccobacillary, strictly aerobic and Gram-negative. They can use a wide variety 
of different carbon sources for growth, and can be cultured on simple media. They are 
oxidase-negative and catalase-positive. Their mol% G+C of the DNA is 38-47. The genus is 
placed within the gamma-subclass of the Proteobacteria (Railey et al., 1994). 
The type species of the genus is Acinetobacter calcoaceticus.
The first classification was presented by Bouvet & Grimont (1986) who distinguished 12 
different groups using DNA-DNA hybridization. Seven of these received a validated species 
name. Three years later (Tjernberg and Ursing, 1989) three additional DNA groups were 
described, coded 13 through 15 TU. In the same year another group (Bouvet and Jeanjean, 
1989) described five additional proteolytic Acinetobacter species, numbered 13 through 17. 
The DNA group 13 BJ appeared to correspond to 14 TU (Vaneechoutte et al., 1995), while 
for the other groups no correlation is apparent. Apart from the known genomic species, 
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additional strains were found, some of which are closely related to already known groups, like 
the DNA group CTTU 13: “close to Tjernberg-Ursing DNA group 13”, 1-3L: “ genospecies 1 
or 3-like”, and genospecies “between 1 and 13”. (Gerner-Smidt and Tjernberg, 1998). 
A. baumannii, and the unnamed groups 3 and 13 TU are recovered predominantly from 
clinical specimens, with A. baumannii being known for its capacity to colonize and infect
severely ill, hospitalised patients. Strains of this genomic species can persist in hospitals and 
give rise to outbreaks. They are usually highly resistant to antibiotics, which makes them
difficult to eradicate. The other species are more known as environmental isolates, and only 
rarely encountered as clinical isolates. 
Using ARDRA, it could be shown that the well known industrially important, emulsan-
producing strain RAG-1, isolated from tar on a beach in Israel (Rosenberg et al., 1979), an 
isolate designated ‘A. venetianus’, found in the lagoon of Venice, capable of oil-degradation 
(Di Cello et al., 1997), and a n-tetradecane-degrading marine strain (T4) (Yamamoto and 
Harayama, 1996) belonged to the same species (Vaneechoutte et al., 1999). 
By sequencing the 16S rRNA genes, in addition to ARDRA and phenotypic data, it was 
possible to contribute to the description of two new species, A. ursingii and A. schindleri, of 
which several strains have clinical importance (Nemec et al., 2001). 
Currently, the genus Acinetobacter comprises at least 23 genomic species (DNA-DNA 
hybridisation groups, DNA groups), 10 of which have been given species names. Table 3 
represents an overview of all the species and DNA-groups. 
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Table 3: Overview of the Acinetobacter DNA-groups and corresponding nomenspecies.
DNA-Group Species Reference
1 A. calcoaceticus Bouvet and Grimont, 1986 
2 A. baumannii Bouvet and Grimont, 1986 
3 Bouvet and Grimont, 1986 
4 A. haemolyticus Bouvet and Grimont, 1986 
5 A. junii Bouvet and Grimont, 1986 
6 Bouvet and Grimont, 1986 
7 A. johnsonii Bouvet and Grimont, 1986 
8/9* A. lwoffii Bouvet and Grimont, 1986 
10 Bouvet and Grimont, 1986 
11 Bouvet and Grimont, 1986 
12 A. radioresistens Nishimura et al.,1988
13TU Tjernberg and Ursing, 1989 
13 BJ / 14 TU Bouvet and Jeanjean, 1989 
Tjernberg and Ursing, 1989 
14 BJ Bouvet and Jeanjean, 1989 
15 BJ Bouvet and Jeanjean, 1989 
15 TU Tjernberg and Ursing, 1989 
16 BJ Bouvet and Jeanjean, 1989 
17 BJ Bouvet and Jeanjean, 1989 
A. venetianus Di Cello et al., 1997, 
Vaneechoutte et al., 1999 
A. schindleri Nemec et al., 2001 
A. ursingii Nemec et al., 2001 
* DNA groups 8 and 9 were later shown to be synonymous (Tjernberg and Ursing, 1989). 
Figure 6 represents a similarity tree based on 16S rRNA gene sequences of most of the
ARDRA groups and phenological groups currently known, besides the 23 DNA-groups. 
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Figure 6: Similarity tree based on 16S rRNA gene sequence similarities
Legend: Neighbour-Joining phylogenetic tree, based on 16S rRNA gene sequences comparison, calculating the
global alignment similarities on a region corresponding to E. coli positions 67-1444. Global alignment was
carried out with a gap penalty of 100%, a unit gap penalty of 20% and an ambiguity cost of 50%. Boot strap
values (n=100) are indicated at the nodes, and the scale bar is 1% sequence dissimilarity (one substitution on 100
nucleotides).
Bacteria can be identified to the genus Acinetobacter by a list of the phenotypic criteria. 
However, a simple test is based on the finding that DNA of organisms belonging to the genus 
can be used to transform an auxotrophic Acinetobacter strain (BD413) to prototrophy (Juni,
1972). According to the 16S rRNA gene sequence of this strain, as obtained during this 
doctoral work, strain BD413 belong to a separate species, indicated as ‘A. ornstonii’ (Figure
6). During this work groups of clinical encountered species were identified as belonging to 
Acinetobacter species not yet published, further research is in progress towards the 
description of these species. One species of particular clinical importance, but overlooked 
until now, is phenon 4, for which description as A. parvus is in progress. The isolates are 
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biochemically inert and form very small nonhemolytic colonies, atypical for Acinetobacter 
(Nemec et al., in progress). 
Biochemical and phenotypical discrimination between the different species is difficult and 
needs a wide variety of different tests (Gerner Smith et al., 1991; Kämpfer et al., 1993). 
Commercial systems like API and Biolog have only a moderate performance for the 
identification of Acinetobacter species (Bernards et al., 1995; Bernards et al., 1996). 
Genotypical identification offers more possibilities. Different systems have been applied:
Ribotyping (Gerner-Smith, 1992), AFLP (Janssen et al., 1997), ARDRA (Vaneechoutte et al.,
1995; Dijkshoorn et al., 1998), 16S rRNA gene sequencing (Ibrahim et al., 1997), tRNA 
fingerprinting (Ehrenstein and Schön, 1996) and ribosomal spacer amplification (Nowak et


















































































































































































































































































































































































































































































V.2.2. Taxonomy of the genus Moraxella.
The genus Moraxella, is classified in the family of the Moraxellaceae (Rossau et al., 1991), 
together with Acinetobacter and Psychrobacter. They were formerly known as ‘false 
neisseriae’.
The Moraxella are Gram-negative, non-motile aerobic species. Some of them have the ability 
for ‘twitching motility’ and spread on the culture plate. No flagella are observed and only
occasionally some fimbriae. They are oxidase-positive, usually catalase-positive and no acid 
is produced from carbohydrates. The mol% G+C of the DNA ranges from 40 to 47,5. 
A subdivision is sometimes made based on morphology whereby the rod-shaped species are 
classified in Moraxella (subgen. Moraxella) and the cocci in Moraxella (subgen. 
Branhamella) (Bvre, 1984).
The genus currently consists of 15 validated species, which are summarized in Table 5. 
Table 5: overview of the Moraxella species.
Species Reference
M. atlantae Bøvre et al., 1976 
M. boevrei Kodjo et al., 1997. 
M. bovis Bøvre et al., 1984 
M. catarrhalis* Bøvre et al., 1984 
M. caviae* Henriksen and Bøvre, 1968 
M. ovis* Bøvre et al., 1984 
M. canis* Jannes et al., 1993 
M. caprae* Kodjo et al., 1997. 
M. cuniculi* Bøvre and Hagen, 1984 
M. equi Hughes and Pugh, 1970 
M. lacunata Lwoff, 1939 
M. lincolnii Vandamme et al., 1993 
M. nonliquefasciens Bøvre et al., 1984 
M. osloensis Bøvre et al., 1984 
M. saccharolytica Flamm, 1956 
* Species with coccal cell morphology (sometimes classified in the subgenus Branhamella
(Bøvre et al., 1984)
Two species, previously known as Moraxella, were placed in other genera during the last 
years: M. urethralis was changed to Oligella urethralis (Rossau et al., 1987) and M. 
phenylpyruvica to Psychrobacter phenylpyruvica (Bowman et al., 1996). 
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Suggestions for a separate classification of M. osloensis, M. atlantae and M. lincolnii were 
made based on 16S rRNA gene similarities (Petterson et al., 1998; De Baere et al., 2002); 
DNA-DNA hybridisation (Tønjum et al., 1989) and DNA-transformation (Bøvre et al., 1976). 
The clinically most important species is Moraxella catarrhalis, a human pathogen mainly
known for causing upper airway infections. Some of the other species are known as 
pathogenic for animals, for example M. bovis (Chandler et al., 1980). 
During this doctoral work we described the first known human infection with M. canis
(Vaneechoutte et al., 2001) and an infection with another rare pathogen, M. atlantae (De
Baere et al., 2002).
69
V.2.3. Taxonomy of the genus Mycobacterium.
The genus Mycobacterium is one of the oldest defined (1896) and the generic name
Mycobacterium initially designated a group of organisms that grew as mould-like pellicules 
on liquid media (Lehman, 1896). 
During the 1900s the characteristics used to define mycobacteria were the absence of motility, 
morphology of the bacilli (slightly curved and rod-shaped) and the characteristic resistance to 
acid-alcohol following coloration with phenicated fuchsin (Ziehl-Neelsen stain), called acid-
fastness.
Taxonomically Mycobacterium is the only genus in the family Mycobacteriaceae, which is 
part of the order of the Actinomycetales. Related taxa are Corynebacterium, Nocardia,
Rhodococcus, Gordona and Tsukamurella.
Mycobacterium species and the members of the mentioned related genera are the only 
microbial organisms that are able to synthesize mycolic acids (Goodfellow and Wayne, 1982). 
Discrimination between those organisms can be done by Ziehl-Neelsen staining, the
G + C base ratio, and the mycolic acid content (Vincent, 1994). 
At present, the mycobacteria are defined as aerobic, acid-alcohol fast, rod-shaped
actinomycetes with occasional branching: aerial hyphae are normally absent, and the bacteria 
are non-motile, non-sporulating organisms that contain arabinose, galactose, and meso-
diaminopimelic in the cell wall. The GC base ratio ranges from 62 to 70 % (except for M.
leprae: 58%). Mycolic acids of high molecular weight (sixty to ninety carbon atoms) are 
present, lacking components with more than two points of unsaturation in the molecule
(Goodfellow and Wayne, 1982). 
The most important member of the genus is the species Mycobacterium tuberculosis.  This
omnipresent organism is one of the most important and oldest known pathogens of the world, 
causing tuberculosis. Tuberculosis is known to have been present since antiquity (Rastoghi et
al., 2001) and it is suspected as the cause of death of some of the Egytian mummies 3000 
years ago, and has been proved as the cause of death, by evidence of pulmonary tuberculosis 
and the presence of acid-fast organisms, of a mummy of Peru, dated 700 AD. 
From the 19
th
 century, onward it was known as the ‘White Plague’ being the leading cause of 
death in Europe and the United States of America (4/1000 in the USA in 1830). Due to 
improvements in social and sanitary conditions the tuberculosis rate was dropped to 2/1000 in 
1900. During the twentieth century major advances were seen in the struggle against 
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tuberculosis. At first there was the development of chemotherapy, based on streptomycine
(1944), para-amino salicylic acid (1949), isoniazide (1952) and rifampicin (1967). On the 
other hand there was the vaccination program with the BCG strain (Bacillus Calmette-
Guérin), used for the first time in 1921. This and the availability of good laboratory methods
and still improving living conditions have lead to a steady decline of the tuberculosis 
incidence in the industrial countries (less than 1/10.000 in 1980 (Kalkut, 2000)).
But the struggle has not (yet?) come to an end, because two major threats are the cause of a 
re-emergence of the deathly pathogen: co-infection with HIV (Pozniak, 2002) and the 
existence of multi-drug resistant strains (Espinal et al., 2001). 
The mycobacterial species are for practical reasons mostly divided in two groups: M.
tuberculosis complex {M. tuberculosis, M. bovis, M. africanum, M. microti and the recently 
described species M. canetii (Pfyffer et al., 1998)} and ‘mycobacteria other than the M.
tuberculosis complex’ or MOTT, sometimes called atypical mycobacteria. 
MOTTs have been subdivided in four different groups. (Runyon, 1959) 
Group I: the photochromogenic species, whereby the colonies acquire pigmentation in 
the presence of light only (M. kansasii, M. marinum, ..).
Group II: the scotochromogenic species whereby the colonies acquire pigmentation in 
the presence or abscence of light. (M. gordonae, M. scrofulaceum, …) 
Group III: non-chromogenic species which have non-pigmented colonies (M. avium,
M. intracellulare,…)
Group IV: rapid growers (M. fortuitum, M. chelonae).
Slow growers (Groups I to III) have a mean division time of 12 to 24 hours, and a fully-grown 
culture requires approximately fifthteen till twenty-eight days. The average division time for 
fast growers is 2 to 6 hours, with a culture available within two to seven days. 
The taxonomy of Mycobacterium has become very complex, with almost 100 species 
described, 19 of them reported during the last 5 years. An overview of the species, containing 
amongst others, the clinical important species; but restricted to those that have 16S rRNA 
gene sequences available in Genbank, is presented in Figure 7. 
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Figure 7: A phylogenetic tree of representants of the genus Mycobacterium.
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Legend: Neighbour-Joining phylogenetic tree of the 16S rRNA genes of the clinically 
important Mycobacterium species, with the addition of their ARDRA pattern. (De Baere et
al., 2002). 
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A wide variety of different technologies are used for the differentiation of Mycobacterium
species. Some well-known techniques were evaluated recently in literature: HPLC analysis of 
mycolic acids (Butler and Guthertz, 2001); hsp65 fingerprinting PCR (Brunello et al., 2001), 
16S rRNA gene sequencing (Turenne et al., 2001) and a commercial probe test Inno-Lipa 
Mycobacteria (Suffys et al., 2001).
During this doctoral thesis the PCR-based DNA-fingerprinting technique ARDRA was
updated and evaluated for the identification of Mycobacterium species (De Baere et al.,
2002).
Using ARDRA, an isolate from a lymph node of a child with cervical lymphadenitis was 
identified as M. interjectum. Analysis of this case and previously published cases indicated 
the importance of M. interjectum as a causative agent of cervical lymphadenitis in young
children (De Baere et al., 2001). 
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V.2.4. Taxonomy of the genus Ralstonia.
The genus Ralstonia (Yabuuchi et al., 1995) has been created for a group of organisms from
ecologically diverse niches to accommodate bacteria that were formerly classified as members
of Burkholderia (Yabuuchi et al., 1992) and Alcaligenes. The type species of the genus is 
Ralstonia pickettii (Ralston et al., 1973).
They are Gram-negative rod-shaped cells, which are either motile with a single flagellum
(polar or peritrichous) or non-motile without flagella. Monosaccharides, disaccharides and 
polyalcohols are oxidized and assimilated as a sole source of carbon and energy. The GC 
content is around 65 mol%, with Burkholderia as the closest genus. Ralstonia species, in 
contrast to Burkholderia species, are negative for assimilation of galactose, mannitol and
sorbitol. The description of R. mannitolilytica (De Baere et al. 2001) showed however that 
mannitol assimilation is not a discriminating factor anymore, because this formerly known 
subspecies of R. picketti assimilates mannitol.
The type species R. pickettii was originally regarded as the only representative of clinical 
importance (Gardner and Shulman, 1984; Lacey and Want, 1991; Raveh et al., 1993; 
Verschraegen et al., 1985). The other members in the first description were Ralstonia
solanacearum, one of the most important bacterial phytopathogenic species, causing bacterial 
wilt on a wide range of crops (Palleroni and Doudoroff, 1971) and R. eutropha, an 
environmentally encountered bacterium (Davis, 1969) (Figure 6a). 
Only recently, the taxonomy of this genus has begun to be elucidated with the description of 
several new species. In 1998 the first new member was R. basilensis (Steinle et al., 1998), a 
species isolated from a fresh water pond and able to degradate 2,6 dichloro-phenol. The 
following years the species R. gilardii (Coenye et al., 1999) and R. paucula (Vandamme et
al., 1999) were added. These species are environmental and sporadic cases of infection with 
clinical evidence have been described (Anderson et al., 1997; Wauters et al., 2001). 
During this doctoral work we described the formerly known third biovar of R. picketii as the
separate species R. mannitolilytica (De Baere et al., 2001) and reported two clinical cases 
(Vaneechoutte et al., 2001).  Two metal-resistant bacteria, R. campinensis and R.
metallidurans (Goris et al., 2001) and a plant pathogen R. taiwanensis (Chen et al., 2001) 
were also added (Figure 6b). 
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Most of the new findings were based on 16S rRNA sequence data, corroborated by 
phenotypic testing (Prof. Em. Dr. G. Wauters). tRNA-PCR did not appear to be suited for 
Ralstonia species identification, since most species gave no or only few amplification 
fragments.
16S rRNA gene sequencing and phenotypic testing led to the description of R. mannitolilytica
and to a proposal to split the genus Ralstonia into Ralstonia sensu stricto and Wautersia gen.
nov. (Vaneechoutte et al., in preparation). Indeed the newly obtained sequence data in this 
doctoral study, together with those available from the Genbank showed a clear bifurcation 
within the genus (Fig 6c). This division corresponded with clear morphological and 
biochemical differences between both groups, as observed by Prof. Em. Dr. G. Wauters, with 
the flagellation as the most important discriminating factor. 
Figure 8: The changing taxonomy of the genus Ralstonia during history,
based on 16S rRNA gene sequence similarity.
Figure 8a. Situation in 1995 (Yabuuchi et al., 1995)
Figure 8b. Current situation (Chen et al., 2001) 
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Figure 8c: The proposed taxonomy for the near future (Vaneechoutte et al., in preparation)
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V.3. Studies
The described DNA-based fingerprinting techniques (IV.3) could be used for precise 
identification of different kinds of organisms. Their application on large series of isolates 
revealed species not yet described before (V.3.1. and V.3.5) and species infrequently 
encountered in the clinical setting (V.3.2.; V.3.3; V.3.4; V.3.6; V.3.7.). 
V.3.1. Description of Acinetobacter ursingii and A. schindleri.
Nemec, A., T. De Baere, I. Tjernberg, M. Vaneechoutte, T.J.K. van der Reijden,
and L. Dijkshoorn. 2001. Acinetobacter ursingii sp. nov. and Acinetobacter
schindleri sp. nov., isolated from human clinical specimens. Int. J. Syst. Evol.
Microbiol. 51:1891-1899.
V.3.2. Ulcerated lymph node containing Moraxella canis.
Vaneechoutte, M., G. Claeys, S. Steyaert, T. De Baere, R. Peleman, and G. 
Verschraegen. 2000. Moraxella canis isolation from an ulcerated metastatic lymph
node. J. Clin. Microbiol. 38:3870-3871.
V.3.3. Bacteremia with Moraxella atlantae.
De Baere, T., A. Muylaert, E. Everaert, G. Wauters, G. Claeys, G. Verschraegen, 
and M. Vaneechoutte. 2002. Bacteremia with Moraxella atlantae in a cancer
patient. J. Clin. Microbiol. 40: 2693-2695.
V.3.4. Mycobacterium interjectum as a causative agent of lymphadenitis.
De Baere, T., M. Moerman, L. Rigouts, C. Dhooge, H. Vermeersch, G. 
Verschraegen, and M. Vaneechoutte. 2001. Mycobacterium interjectum as
causative agent of cervical lymphadenitis. J. Clin. Microbiol. 39:725-727.
V.3.5. Description of Ralstonia mannitolilytica
De Baere, T., S. Steyaert, G. Wauters, P. De Vos, J. Goris, T. Coenye, T. .Suyama,
G. Verschraegen, and M. Vaneechoutte. 2001. Classification of Ralstonia pickettii
biovar 3/‘thomasii’ strains (Pickett 1994) and of new isolates related to 
nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int. J. Syst.
Evol. Microbiol. 51:547–558
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V.3.6. Two separate case reports of Ralstonia mannitolilytica
Vaneechoutte, M., T. De Baere, G. Wauters, S. Steyaert, G. Claeys, D. Vogelaers, 
and G. Verschraegen. 2001. One case each of recurrent meningitis and 
hemoperitoneum infection with Ralstonia mannitolilytica. J. Clin. Microbiol.
39:4588-4590.
V.3.7. Catheter sepsis with Ralstonia gilardii
Wauters, G., G. Claeys, G. Verschraegen, T. De Baere, E. Vandecruys, L. Van 
Simaey, C. De Ganck, and M. Vaneechoutte. 2001. Case of catheter sepsis with
Ralstonia gilardii in a child with acute lymphoblastic leukemia. J. Clin. Microbiol.
39:4583-4584.
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The taxonomic status of two recently described phenetically distinctive groups
within the genus Acinetobacter, designated phenon 1 and phenon 2, was
investigated further. The study collection included 51 strains, mainly of clinical
origin, from different European countries with properties of either phenon 1
(29 strains) or phenon 2 (22 strains). DNA–DNA hybridization studies and DNA
polymorphism analysis by AFLP revealed that these phenons represented two
new genomic species. Furthermore, 16S rRNA gene sequence analysis of three
representatives of each phenon showed that they formed two distinct lineages
within the genus Acinetobacter. The two phenons could be distinguished from
each other and from all hitherto-described Acinetobacter (genomic) species by
speciﬁc phenotypic features and ampliﬁed rDNA restriction analysis patterns.
The names Acinetobacter ursingii sp. nov. (type strain LUH 3792TNIPH 137T
LMG 19575TCNCTC 6735T) and Acinetobacter schindleri sp. nov. (type strain
LUH 5832TNIPH 1034TLMG 19576TCNCTC 6736T) are proposed for phenon
1 and phenon 2, respectively. Clinical and epidemiological data indicate that A.
ursingii has the capacity to cause bloodstream infections in hospitalized
patients.
Keywords : Acinetobacter ursingii sp. nov., Acinetobacter schindleri sp. nov.,
polyphasic taxonomy
INTRODUCTION
Over the last 15 years, considerable progress has been
made in resolving the taxonomy of the genus Acineto-
bacter. The basis for the present classiﬁcation was
established by Bouvet & Grimont (1986), with the
description of 12 DNA–DNA hybridization groups
(genomic species) within the genus. This scheme was
subsequently extended to include 10 additional
genomic species (Tjernberg & Ursing, 1989; Bouvet &
Jeanjean, 1989; Gerner-Smidt & Tjernberg, 1993).
Seven genomic species have names (Acinetobacter
calcoaceticus, Acinetobacter baumannii, Acinetobacter
haemolyticus, Acinetobacter junii, Acinetobacter john-
.................................................................................................................................................
Abbreviations: ARDRA, ampliﬁed rDNA restriction analysis.
The EMBL accession numbers for the 16S rRNA gene sequences of strains
LUH 3299, LUH 3792T, LUH 4763, LUH 4591, LUH 4760 and LUH 5832T are
respectively AJ275037–AJ275041 and AJ278311.
sonii, Acinetobacter lwoﬃi and Acinetobacter radio-
resistens), while the others are designated by numbers
(reviewed by Janssen et al., 1997). Another genomic
species (‘Acinetobacter venetianus ’) comprisingmarine
oil-degrading organisms was delineated recently (Di
Cello et al., 1997; Vaneechoutte et al., 1999). Never-
theless, the DNA–DNA hybridization studies of
Bouvet & Grimont (1986), Tjernberg & Ursing (1989)
and Bouvet & Jeanjean (1989) left several strains
unclassiﬁed, which indicates that the diversity of the
genus extends beyond the described groups.
In a recent study, 45 additional unidentiﬁable isolates
were found among 700 clinical isolates from the Czech
Republic (Nemec et al., 2000). Two groups of isolates
(designated phenon 1 and phenon 2) were delineated
among the unidentiﬁable isolates, each of which
showed distinctive phenotypic features and ampliﬁed
rDNA restriction analysis (ARDRA) patterns. The
aim of the present study was to deﬁne the taxonomic
01914 2001 IUMS 1891
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Table 1. Strains of phenon 1 (Acinetobacter ursingii sp. nov.) and phenon 2 (Acinetobacter schindleri sp. nov.)
.................................................................................................................................................................................................................................................................................................................
All strains were from human specimens. CNCTC, Czech National Collection of Type Cultures, Prague, Czech Republic ; LMG,
Bacteria Collection, Laboratorium voor Microbiologie Gent, Gent, Belgium; LUH and RUH, Collection L. Dijkshoorn, Leiden
University Medical Centre, Leiden, The Netherlands; NIPH, Collection A. Nemec, National Institute of Public Health, Prague,
Czech Republic. Abbreviations: CZ, Czech Republic ; NL, The Netherlands; NO, Norway; SE, Sweden.
Strain Other strain designation(s) Reference/received from Specimen* Location and year of isolation
Phenon 1 (A. ursingii sp. nov.)
LUH 3792T NIPH 137T†LMG 19575T
CNCTC 6735T
Nemec et al. (2000) Blood (in) Praha, CZ, 1993
LUH 4582 NIPH 177† Nemec et al. (2000) Intravenous line (in) Praha, CZ, 1993
LUH 4592 NIPH 280† Nemec et al. (2000) Blood (in) Sedlc any, CZ, 1994
LUH 3793 NIPH 371† Nemec et al. (2000) Blood (in) Pr ıbram, CZ, 1995
LUH 4613 NIPH 375† Nemec et al. (2000) Pus (in) Pr ıbram, CZ, 1995
LUH 4614 NIPH 376† Nemec et al. (2000) Pus (in) Pr ıbram, CZ, 1995
LUH 4618 NIPH 398† Nemec et al. (2000) Ulcer (out) Pr ıbram, CZ, 1996
LUH 4622 NIPH 439† Nemec et al. (2000) Eye (out) Sedlc any, CZ, 1996
LUH 5767 NIPH 706† Nemec et al. (2000) Blood (in) Pr ıbram, CZ, 1997
LUH 5829 NIPH 950† Nemec et al. (2000) Blood (in) Ta bor, CZ, 1998
LUH 5830 NIPH 993† Nemec et al. (2000) Cervix (out) Pr ıbram, CZ, 1998
LUH 5831 NIPH 1025† Nemec et al. (2000) Eye (out) Pr ıbram, CZ, 1998
LUH 5833 NIPH 1048† Nemec et al. (2000) Blood (in) Liberec, CZ, 1998
LUH 5834 NIPH 1118† Nemec et al. (2000) Wound (out) Sedlc any, CZ, 1999
LUH 5835 NIPH 1120† Nemec et al. (2000) Urine (out) Pr ıbram, CZ, 1999
LUH 4761 72a† Tjernberg & Ursing (1989) Urine (out) Malmo , SE, 1980
LUH 4762 93† Tjernberg & Ursing (1989) Blood (in) Malmo , SE, 1980
LUH 4763 119† Tjernberg & Ursing (1989) Urine (out) Malmo , SE, 1980
LUH 4766 166† Tjernberg & Ursing (1989) Wound (in) Malmo , SE, 1981
LUH 4768 175† Tjernberg & Ursing (1989) Wound (in) Malmo , SE, 1981
RUH 1501 Hairy skin (in) Rotterdam, NL, 1985
RUH 3329 Patient K† Horrevorts et al. (1995) Blood (in) Nijmegen, NL, 1990
LUH 3292† Bernards et al. (1997) Blood (in) Leiden, NL, 1995
LUH 3299† Bernards et al. (1997) Blood (in) Leiden, NL, 1995
LUH 3140 A. T. Bernards Toes (in) Enschede, NL, 1995
LUH 3059 A. T. Bernards Blood (in) Enschede, NL, 1995
LUH 3324 6101994‡ J. G. M. Koeleman Blood Amsterdam, NL, 1994
LUH 4739 84† Bouvet & Grimont (1986) Blood Unknown
LUH 4828 161496‡ D. A. Caugant Abscess (out) Kristiansand, NO, 1996
Phenon 2 (A. schindleri sp. nov.)
LUH 5832T NIPH 1034T†LMG 19576T
CNCTC 6736T
Nemec et al. (2000) Urine (out) Pr ıbram, CZ, 1998
LUH 4590 NIPH 228† Nemec et al. (2000) Vagina (out) Praha, CZ, 1994
LUH 4591 NIPH 257† Nemec et al. (2000) Urine (out) Hluboka nad Vltavou,
CZ, 1993
LUH 4594 NIPH 285† Nemec et al. (2000) Throat (out) Pr ıbram, CZ, 1994
LUH 4595 NIPH 286† Nemec et al. (2000) Ear (out) Pr ıbram, CZ, 1994
LUH 4597 NIPH 291† Nemec et al. (2000) Nasal swab (out) Pr ıbram, CZ, 1994
LUH 4598 NIPH 293† Nemec et al. (2000) Cervix (out) Sedlc any, CZ, 1994
LUH 4599 NIPH 296† Nemec et al. (2000) Cervix (out) Sedlc any, CZ, 1994
LUH 4612 NIPH 369† Nemec et al. (2000) Cervix (out) Sedlc any, CZ, 1994
LUH 4615 NIPH 383† Nemec et al. (2000) Nasal swab (out) Milın, CZ, 1996
LUH 5825 NIPH 883† Nemec et al. (2000) Urine (out) Pr ıbram, CZ, 1998
LUH 5826 NIPH 900† Nemec et al. (2000) Conjunctiva (out) Sedlc any, CZ, 1998
LUH 5827 NIPH 904† Nemec et al. (2000) Urine (out) Pr ıbram, CZ, 1998
LUH 5939 NIPH 907† Nemec et al. (2000) Nasal swab (out) Pr ıbram, CZ, 1998
LUH 5828 NIPH 933† Nemec et al. (2000) Vagina (out) Pr ıbram, CZ, 1998
LUH 4760 60† Tjernberg & Ursing (1989) Urine (in) Malmo , SE, 1980
LUH 4764 120† Tjernberg & Ursing (1989) Pleural eﬀusion (in) Malmo , SE, 1980
LUH 4765 129† Tjernberg & Ursing (1989) Urine Malmo , SE, 1980
RUH 203† Dijkshoorn et al. (1998) Liquor (out) Rotterdam, NL, 1983
LUH 4742 594‡ P. J. M. Bouvet Skin Unknown
LUH 4743 585‡ P. J. M. Bouvet Skin Unknown
LUH 4744 586‡ P. J. M. Bouvet Skin Unknown
* If known, specimens from outpatients (out) or inpatients (in) are indicated.
†Strain designation used in a previous publication.
‡Strain designation as received.
status of these groups by a polyphasic analysis. For
this purpose, the collection of Czech strains was
enlarged with strains from other European countries
that showed characters similar to those of the two
phenons.
METHODS
Strains. The 29 strains of phenon 1 and 22 strains of phenon
2 investigated in this study are listed in Table 1. The Czech
strains (n 30) were those from the previous study (Nemec
et al., 2000). Additionally, 21 strains were selected from a set
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Table 2. Biochemical characteristics of phenon 1 (A. ursingii sp. nov.) and phenon 2 (A. schindleri sp. nov.)
.................................................................................................................................................................................................................................................................................................................
Data are from this study and from Nemec et al. (2000). Growth on carbon sources was evaluated after 2 and 6 d of incubation.
, Positive for all strains ;, negative for all strains ; numbers are percentages of strains giving a positive reaction. All strains
utilized -lactate and acetate. None of the strains grew at 44 C, hydrolysed gelatin, produced haemolysis on sheep-blood agar,
acidiﬁed Hugh & Leifson’s medium with -glucose or utilized -4-aminobutyrate, β-alanine, -histidine, malonate, histamine, -
phenylalanine, phenylacetate, laevulinate, citraconate or -leucine.
Characteristic Phenon 1 (A. ursingii sp. nov.) (n 29) Phenon 2 (A. schindleri sp. nov.) (n 22)
Growth at 41 C  *
Growth at 37 C * 
Utilization of:









*Weak growth of some strains.
of about 100 Acinetobacter strains isolated by diﬀerent
laboratories that could not be identiﬁed as any of the
described genomic species. The 21 strains were selected from
this set on the basis of phenotypic properties and ARDRA
patterns similar to those of the phenon 1 or phenon 2 strains
(Nemec et al., 2000). All 51 strains had the properties of the
genus Acinetobacter (Juni, 1984) ; i.e. they were Gram-
negative, strictly aerobic, oxidase-negative, non-motile
coccobacilli and positive in the transformation assay of Juni
(1972).
Phenotypic characterization.The tests described byNemec et
al. (2000) were used, with the following modiﬁcations.
Carbon-source utilization tests were supplemented with
those for laevulinate, citraconate, 4-hydroxybenzoate, -
tartrate, -leucine, 2,3-butanediol, ethanol and acetate. The
test for trans-aconitate utilization was omitted since it may
give irreproducible results with some phenon 1 strains.
Production of pigments was tested on glycerol-containing
media A and B as described by King et al. (1954). All tests
were performed at 30 C unless indicated otherwise.
ARDRA. Ampliﬁed 16S rDNA was obtained by PCR and
analysed by restriction digestion with six restriction endo-
nucleases (CfoI, AluI, MboI, RsaI, MspI and BfaI) as
described previously (Nemec et al., 2000). Interpretation of
ARDRA patterns was based on the positions of the
fragments of molecular size  100 bp. The patterns were
numbered according to the scheme of Dijkshoorn et al.
(1998), supplemented by Seifert et al. (1997) andNemec et al.
(2000).
AFLP ﬁngerprinting. AFLP was performed according to
Koeleman et al. (1998), with some modiﬁcations. DNA was
puriﬁed as described by Boom et al. (1990) and adapters
were as described by Vos et al. (1995). Restriction and
ligation were performed simultaneously at 37 C for 3 h in a
10 µl volume with 10–50 ng template DNA, 1 U EcoRI
(Amersham Pharmacia Biotech), 1 U MseI (New England
BioLabs), 4 U T4 DNA ligase (Amersham Pharmacia
Biotech), 1 T4 DNA ligase buﬀer, 500 ng BSA, 50 mM
NaCl, 2 pmol EcoRI adapters and 20 pmol MseI adapters.
After incubation, the mixture was diluted with 10 mM
TrisHCl, 01 mM EDTA (pH 80) to a ﬁnal volume of
200 µl. Five microlitres diluted mixture was added to a ﬁnal
volume of 10 µl reaction mixture containing 20 ng Cy5-
labelled EcoRIA primer (Cy5-GACTGCGTACCAA-
TTCa-3 ; where a is a selective A base), 60 ng MseIC
primer (5-GATGAGTCCTGAGTAAc-3 ; where c is a
selectiveC base), 1Taq polymerase buﬀer, 15 mMMgCl

,
02 mM (each) dNTP and 1 U Goldstar Taq DNA poly-
merase (Eurogentec). Ampliﬁcation with a Progene thermo-
cycler (Techne) was as follows: 2 min at 72 C and 2 min at
94 C; one cycle of 30 s at 94 C, 30 s at 65 C and 60 s at
72 C; 12 cycles of 30 s at 94 C, 30 s at a temperature of
07 C lower than the previous cycle, starting at 643 C,
followed by 60 s at 72 C; 23 cycles of 30 s at 94 C, 30 s at
56 C and 60 s at 72 C; and a ﬁnal cycle of 10 min at 72 C.
PCR products were mixed with 3 µl formamide containing
05% dextran blue, heated for 5 min at 95 C and cooled on
ice. Samples of 3 µl were loaded on a denaturing poly-
acrylamide gel (ReproGel High Resolution; Amersham
Pharmacia Biotech) with 200 mm standard thermoplates.
Fragment separation was performed using the ALFexpress
II DNA analysis system (Amersham Pharmacia Biotech) for
500 min at 55 C and 30 Wconstant power with 2 s sampling
intervals. The peak patterns generated were converted to
TIF ﬁles, which were analysed by the BN 2.0
software package (Applied Maths). Fragments in the range
50–500 bp were used for cluster analysis. Pearson’s product-
moment coeﬃcient (r) was used as a measure of similarity
and grouping was obtained by the unweighted pair group
average linked method (UPGMA).
DNA–DNA hybridization. The two-step elution procedure
was used to determineDNA–DNA relatedness (Tjernberg et
al., 1989). By this method, I-labelled DNA probes from
strains LUH 3792T (phenon 1) and LUH 5832T (phenon 2)
were hybridized on a ﬁlter with unlabelled DNAs of the
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Table 3. ARDRA patterns of phenon 1 and phenon 2 strains
.................................................................................................................................................................................................................................................................................................................
Data were from this study and from Nemec et al. (2000). Pattern designation according to Dijkshoorn et al. (1998) and Nemec et
al. (2000). , Not determined; New, novel patterns.
Strain(s) Restriction pattern with :
CfoI AluI MboI RsaI MspI BfaI
Phenon 1 (A. ursingii sp. nov.)
LUH 3792T, LUH 3292, LUH 3299,
LUH 4592, LUH 4614, LUH 4622,
LUH 4762, LUH 4763, LUH 4766,
LUH 4828, LUH 5829, LUH 5830,
LUH 5834, RUH 1501, RUH 3329
1 4 3 5 3 
LUH 3059, LUH 3793, LUH 4582, LUH 4768 1 4nw* 3 4 3 
LUH 3140, LUH 5767, LUH 5835 1 4nw* 3 45 3 
LUH 3324, LUH 4761 1 4nw* 13 45 3 
LUH 4739 1 4 13 5 3 
LUH 4618 1 4 3 45 3 
LUH 5833 1 4 13 45 3 
LUH 5831 1 4 3 25 3 
LUH 4613 1 4† 13 25 3 
Phenon 2 (A. schindleri sp. nov.)
LUH 5832T, LUH 4591, LUH 4595,
LUH 4597, LUH 4598, LUH 4599,
LUH 4615, LUH 4742, LUH 4760,
LUH 4764, LUH 5825, LUH 5827,
LUH 5828, LUH 5939, RUH 203
15 24‡ 1 2 2 10
LUH 4590, LUH 4594, LUH 4612,
LUH 4743, LUH 4744, LUH 5826
15 2 1 2 2 10
LUH 4765 5 New 1 2 2 New
*A combined AluI pattern, tentatively interpreted as the mixture of pattern 4 and a new pattern (Nemec et al., 2000; Fig. 1).
†Pattern 4 containing an additional, weak band of approximately 223 bp; this pattern is highly similar to combinedAluI pattern 24
(Nemec et al., 2000).
‡The band (220 bp) speciﬁc for AluI pattern 2 was diﬀuse in all strains (Nemec et al., 2000; Fig. 1).
phenon 1 and phenon 2 strains and reference strains of all
described Acinetobacter genomic species. The amount of
DNA released from the ﬁlter was measured at two tempera-
tures, at 7 C below the thermal melting midpoint of the
homologous duplex and at 100 C. The amount of DNA
released in the ﬁrst step expressed as a percentage of the total
amount of eluted DNA at 100 C (%DR7) was the criterion
for inclusion of strains in a species, with the intraspecies and
interspecies values for %DR7 being 	 26 and  37,
respectively (Tjernberg et al., 1989). Each %DR7 value
was calculated as a mean of at least two hybridization
experiments.
16S rDNA sequencing and comparative analysis. A fragment
of the 16S rRNA gene (corresponding to positions 10–1507
in the Escherichia coli numbering system) of three phenon 1
strains (LUH 3792T, LUH 3299, LUH 4763) and three
phenon 2 strains (LUH 5832T, LUH 4591, LUH 4760) was
sequenced as described by Vaneechoutte et al. (2000). The
16S rDNA sequences obtained for phenon 1 and phenon 2
strains were compared with the sequences representing all
described Acinetobacter genomic species, i.e. 21 sequences
determined by Ibrahim et al. (1997) (EMBL accession
numbers Z93434–Z93454) and the sequence of ‘A.
venetianus ’ strain RAG-1 (AJ295007), and the sequences of
Moraxella lacunataATCC 17967T (AF005160) andPsychro-
bacter immobilis ATCC 43116T (U39399). All steps of the
comparative sequence analysis were performed by using the
GB software package (Applied Maths). Firstly, pair-
wise alignment using UPGMA was carried out with a gap
penalty of 100%, a unit gap cost of 20% and an ambiguity
cost of 50% of the mismatch cost. Subsequently, global
alignment with P. immobilis as the outgroup was carried out
on the region corresponding to positions 67–1444 of the 16S
rRNA gene of E. coli, with costs as above. Finally, a
similarity matrix of the aligned sequences was constructed
by global alignment homology calculation and a gap penalty
of 20%. The neighbour-joining method was used to con-
struct the dendrogram based on this similarity matrix.
RESULTS AND DISCUSSION
Phenotypic characteristics
Colonies of all strains grown on nutrient agar after
24 hwere circular, convex, smooth and slightly opaque
with entire margins. The colonies of phenon 1 strains
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Fig. 1. Overview of the ARDRA patterns found in phenon 1 (A. ursingii sp. nov.) and phenon 2 (A. schindleri sp. nov.)
strains. Strains are indicated by upper-case letters above the lanes: A, LUH 3792T (phenon 1); B, LUH 4594 (phenon 2); C,
LUH 4765 (phenon 2); D, LUH 5832T (phenon 2); E, LUH 3793 (phenon 1); F, LUH 4761 (phenon 1); G, LUH 4613 (phenon
1); H, LUH 4618 (phenon 1). Lanes M, molecular size markers (100-bp ladder). Pattern designations for the various
enzymes are given below the lanes.
were respectively 1–15 mm and 15–3 mm in diameter
after 24 h and 48 h of incubation. The colonies of
phenon 2 strains were respectively 15–25 and
2–45 mm in diameter after 24 h and 48 h of incu-
bation. Some phenon 2 strains (e.g. LUH 5832T, LUH
4615 and LUH4764) produced diﬀuse, light yellowish-
brown pigment on King’s medium A and were sur-
rounded by dark greenish zones on sheep-blood agar.
Biochemical test results are given in Table 2. The
strains of phenon 1 were, with few exceptions, bio-
chemically uniform, while those of phenon 2 varied in
the utilization of citrate (Simmons), azelate, 4-
hydroxybenzoate, -tartrate and 2,3-butanediol.
Growth of some strains of both phenons on -malate
and of some phenon 1 strains on -aspartate was weak
after 6 d and became more apparent after prolonged
incubation (up to 10 d).
ARDRA
ARDRA patterns of the phenon 1 and phenon 2
strains are summarized in Table 3 and Fig. 1. Most
phenon 1 strains shared the recently described RsaI
pattern 5 (Nemec et al., 2000), which diﬀers slightly
from pattern 4 in migration of a fragment of about
300 bp (Fig. 1). Based on the analysis of the 16S rDNA
sequences in the present study, this diﬀerence can be
explained by the presence of an additional RsaI
restriction site responsible for a 22 bp truncation of the
fragment in RsaI pattern 5. Accordingly, the pre-
viously publishedRsaI patterns 4 of strains LUH3292,
LUH 3299 and LUH 3329 (Bernards et al., 1997;
Dijkshoorn et al., 1998) were reinterpreted as RsaI
patterns 5. Some of the ARDRA patterns appeared to
be mixtures of two known single patterns. Of these,
AluI 24 and CfoI 15 patterns were found in most
phenon 2 strains. However, the band speciﬁc for AluI
pattern 4 (162 kb) was very weak in some of these
strains (e.g. RUH 203 and LUH 4760) and could only
be seen clearly when the gel was overloaded with
DNA. Similarly, RUH 203 and LUH 4590 yielded
very faint bands of 160 and 479 kb speciﬁc for CfoI
pattern 5. This observation may explain the diﬀerence
between the published CfoI pattern 1 and AluI pattern
2 of strain RUH 203 (Dijkshoorn et al., 1998) and
those of the present study.
AFLP ﬁngerprinting
Reproducibility of AFLP as determined by testing
several control strains was always higher than 90%
(data not shown). Cluster analysis of the phenon 1 and
2 strains was performed together with a total of 200
strains from all described Acinetobacter genomic
species (identiﬁed by DNA–DNA hybridization). The
strains of each of the described genomic species formed
a separate cluster at a cut-oﬀ level of about 50% (data
not shown). Clustering of all phenon 1 and phenon 2
strains and one representative strain of each described
Acinetobacter genomic species is shown in Fig. 2. The
strains of phenon 1 and phenon 2 grouped in two
clusters at levels of 67 and 63% and were clearly
separated from each other, and from all other strains
at 33 and 20%, respectively.
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Fig. 2. UPGMA/product-moment cluster analysis of the AFLP
ﬁngerprints of 29 strains of phenon 1 (A. ursingii sp. nov.), 22
strains of phenon 2 (A. schindleri sp. nov.) and 22 strains
representing all hitherto-described (genomic) species of the
genus Acinetobacter. The latter strains are designated by either
the ATCC numbers or the numbers used in previous DNA–DNA
hybridization studies (Tjernberg & Ursing, 1989; Bouvet &
Jeanjean, 1989; Gerner-Smidt & Tjernberg, 1993). Levels of
correlation are expressed as percentages of similarity for
convenience.
DNA–DNA hybridization
The %DR7 values obtained with radiolabelled DNA
from strains LUH 3792T and LUH 5832T are sum-
marized in Table 4. The intraphenon range of the
%DR7 values corresponded to the intraspecies varia-
bility of %DR7 values found previously (Tjernberg et
al., 1989), the only exception being LUH4590 (phenon
2), with %DR7 30. However, although the latter
value was relatively high, it was signiﬁcantly lower
than the values found for hybridization with both the
reference strains of the described genomic species and
phenon 1 strains. Thus, the %DR7 values support the
conclusion that the strains of phenon 1 and phenon 2
represent novel, distinctive genomic groups.
16S rDNA sequence analysis
The 16S rDNA sequences of phenon 1 strains LUH
3792T, LUH 3299 and LUH 4763 were identical, and
the sequences of phenon 2 strains LUH 5832T, LUH
4591 and LUH 4760 were nearly identical (994%
similarity). A dendrogram based on the comparison of
these sequences with those representing known
Acinetobacter genomic species and the closest genera is
shown in Fig. 3. Both phenon 1 and phenon 2 strains
clustered with the other members of the genusAcineto-
bacter and were well separated from their neighbours.
The similarity values between the 16S rDNA sequence
of the phenon 1 strains and those of the other members
of the genus Acinetobacter were in the range 954–
973%; the similarity between the sequences of the
phenon 2 strains and those of the other members of the
genus ranged from 954 to 980%. The lowest intra-
generic 16S rDNA sequence similarity (954%) was
observed between phenon 1 and phenon 2 strain LUH
4760.
Taxonomic status of phenon 1 and phenon 2
The results of DNA–DNA hybridization and AFLP
conﬁrmed that phenon 1 and phenon 2 represent two
distinctive genomic species, diﬀerent from all hitherto-
described Acinetobacter genomic species. Further-
more, comparative analysis of 16S rDNA sequences
indicated that phenon 1 and phenon 2 formed two
distinct lineages within the genus Acinetobacter. Both
phenons could be diﬀerentiated from the other
genomic species of the genus and from each other by
ARDRA patterns and biochemical characters (see
below). On the basis of these ﬁndings, phenon 1 and
phenon 2 described by Nemec et al. (2000) represent
two novel species of the genusAcinetobacter, for which
the respective names Acinetobacter ursingii sp. nov.
and Acinetobacter schindleri sp. nov. are proposed.
Differentiation and identiﬁcation
The array of 19 biochemical tests suggested by Bouvet
&Grimont (1987) allowed unambiguous identiﬁcation
of almost all strains of A. ursingii and A. schindleri.
Comparison of our results with those of previous
studies (Bouvet &Grimont, 1987; Gerner-Smidt et al.,
1991; Vaneechoutte et al., 1999) showed that both
novel species could be diﬀerentiated from most other
genomic species of the genus Acinetobacter by their
inability to grow at 44 C, to oxidize -glucose, to
hydrolyse gelatin and to utilize -4-aminobutyrate, β-
alanine, -histidine, malonate, histamine, -phenyl-
alanine and phenylacetate. Growth at 41 and 37 C
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Table 4. Results of DNA–DNA hybridization using the %DR7 coefﬁcient
.................................................................................................................................................................................................................................................................................................................
The reference strains were those used in the studies of Tjernberg & Ursing (1989) and Bouvet & Jeanjean (1989), strains 10095
and 10090 (Gerner-Smidt & Tjernberg, 1993) and ‘A. venetianus ’ strains C3 and RAG-1 (Di Cello et al., 1997; Vaneechoutte et
al., 1999). Values are means
SD, with the range in parentheses.
Source of unlabelled DNA Labelled DNA from LUH 3792T
(phenon 1, A. ursingii sp. nov.)
Labelled DNA from LUH 5832T
(phenon 2, A. schindleri sp. nov.)
Phenon 1 strains (n 29) 12
4 (7–25) –
Reference strains of the known genomic
species (n 22) and phenon 2 strains
LUH 4590 and LUH 4765
46
5 (37–54) –
Phenon 2 strains (n 22) – 22
4 (14–30)
Reference strains of the known genomic
species (n 22) and phenon 1 strains




Fig. 3. Rooted 16S rDNA sequence-based tree showing the relationship of phenon 1 (A. ursingii sp. nov.), phenon 2 (A.
schindleri sp. nov.), the other members of the genus Acinetobacter, Moraxella lacunata and Psychrobacter immobilis (the
outgroup). The tree was constructed using the neighbour-joining method. The numbers at the branching points are the
proportions of 100 bootstrap resamplings that support the tree topology (only values above 90% are shown). EMBL
accession numbers are given in parentheses. Bar, 1% estimated sequence divergence.
and utilization of glutarate and -aspartate were the
most useful tests for diﬀerentiating A. ursingii and A.
schindleri from each other and from A. junii, A.
johnsonii, A. lwoﬃi and genomic species 15TU
(Table 5). Only two strains could not be identiﬁed
unambiguously; A. ursingii LUH 4614 failed to grow
on -aspartate and therefore could not be diﬀer-
entiated from A. schindleri, while A. schindleri LUH
5939 did not utilize glutarate and consequently could
not be distinguished from genomic species 15TU and
A. lwoﬃi. However, LUH 5939 could be diﬀerentiated
from A. lwoﬃi by its ability to utilize 4-hydroxy-
benzoate, which is not included in the identiﬁcation
scheme of Bouvet & Grimont (1987).
None of the ARDRA proﬁles of the A. ursingii and A.
schindleri strains have been observed previously in any
of the known genomic species (Dijkshoorn et al., 1998;
Seifert et al., 1997; Vaneechoutte et al., 1999). All but
one of the A. schindleri strains yielded BfaI pattern 10,
whichmay be particularly useful in their diﬀerentiation
from A. johnsonii strains that have highly similar
pattern combinations with the other enzymes used in
ARDRA (Seifert et al., 1997). A total of nine diﬀerent
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Table 5. Phenotypic characters useful for discrimination of A. ursingii and A. schindleri and for their differentiation
from phenotypically similar (genomic) species
.................................................................................................................................................................................................................................................................................................................
Data for A. junii, A. johnsonii, A. lwoﬃi and genomic species 15TU were taken from Gerner-Smidt et al. (1991)., Positive for
90–100% of strains ;, positive for 0–10% of strains ; , positive for 11–89% of strains.
Characteristic A. ursingii A. schindleri A. junii A. johnsonii A. lwoﬃi Genomic species 15TU
Growth at 41 C      
Growth at 37 C      
Utilization of:
Glutarate      
-Aspartate      
ARDRA proﬁles were encountered among the A.
ursingii strains. In spite of this variability, several
pattern combinations may be useful for the identi-
ﬁcation of A. ursingii, e.g. the combination of CfoI 1,
MboI 3 or MboI 13 and MspI 3 or the combination
of RsaI 4 or RsaI 5 or RsaI 45 or RsaI 25 and
MspI 3.
Clinical importance
The available clinical and epidemiological data suggest
that A. ursingii and A. schindleri diﬀer in their
distribution in patients. While the majority of the A.
schindleri strains were isolated from non-sterile body
sites of outpatients, A. ursingii comprised mainly
clinically signiﬁcant isolates from seriously ill hospital-
ized patients. Almost half of theA. ursingii strains were
isolated from blood cultures and at least some of them
were recovered from patients with diagnosed bac-
teraemia or septicaemia (Bernards et al., 1997; Horre-
vorts et al., 1995; Nemec et al., 2000). Moreover, the
identity of typing characters that was found in two
epidemiologically related isolates (Nemec et al., 2000)
indicates that A. ursingii strains have the potential to
spread among patients.
Description of Acinetobacter ursingii sp. nov.
Acinetobacter ursingii (ur.singi.i. N.L. gen. masc. n.
ursingii in honour of Jan Ursing, the recently deceased
Swedish bacteriologist and taxonomist).
Characteristics correspond to those of the genus (Juni,
1984). Colonies on nutrient agar after 24 h incubation
at 30 C are approximately 10–15 mm in diameter,
circular, convex, smooth and slightly opaque with
entire margins. Growth occurs at 37 C but not at
41 C. Acid is not produced from -glucose, sheep
blood is not haemolysed and gelatin is not hydrolysed.
-Lactate, citrate (Simmons), azelate, -malate, etha-
nol and acetate are utilized as sole sources of carbon
and energy. Glutarate, -aspartate and 4-hydroxy-
benzoate are utilized by most strains. -4-Amino-
butyrate, β-alanine, -histidine, malonate, histamine,
-phenylalanine, phenylacetate, laevulinate, citracon-
ate, -tartrate, -leucine and 2,3-butanediol are not
utilized.
The type strain is LUH 3792T (NIPH 137TLMG
19575TCNCTC 6735T), isolated from blood of a
hospitalized patient with endocarditis. This strain
utilizes glutarate, -aspartate and 4-hydroxybenzoate.
The restriction patterns of ampliﬁed 16S rDNA of the
type strain are CfoI 1, AluI 4, MboI 3, RsaI 5, MspI 3.
The EMBL accession number for its 16S rDNA
sequence is AJ275038.
Description of Acinetobacter schindleri sp. nov.
Acinetobacter schindleri (schindle.ri. N.L. gen. masc.
n. schindleri in honour of Jir ı Schindler, Czech micro-
biologist and taxonomist).
Characteristics correspond to those of the genus (Juni,
1984). Colonies on nutrient agar after 24 h incubation
at 30 C are approximately 15–25 mm in diameter,
circular, convex, smooth and slightly opaque with
entire margins. Growth occurs at 41 C but not at
44 C. Acid is not produced from -glucose, sheep
blood is not haemolysed and gelatin is not hydrolysed.
-Lactate and acetate are utilized as sole sources of
carbon and energy. Glutarate, -malate and ethanol
are utilized bymost strains. Various numbers of strains
utilize citrate (Simmons), azelate, 4-hydroxybenzoate,
-tartrate and 2,3-butanediol. -4-Aminobutyrate, -
aspartate, β-alanine, -histidine, malonate, histamine,
-phenylalanine, phenylacetate, laevulinate, citracon-
ate and -leucine are not utilized.
The type strain is LUH 5832T (NIPH 1034T
LMG 19576TCNCTC 6736T), isolated from urine
of a male outpatient with cystitis. This strain utilizes
citrate (Simmons), glutarate, -malate, 4-hydroxy-
benzoate and ethanol but not azelate, -tartrate or 2,4-
butanediol. The restriction patterns of the ampliﬁed
16S rDNA of the type strain are CfoI 15, AluI 24,
MboI 1,RsaI 2,MspI 2, BfaI 10. The EMBL accession
number for its 16S rDNA sequence is AJ278311.
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Moraxella canis was isolated in large numbers from an ulcerated supraclavicular lymph node of a terminal
patient, who died a few days later. Although the patient presented with septic symptoms and with a heavy
growth of gram-negative diplococci in the lymph node, blood cultures remained negative. M. canis is an
upper-airway commensal from dogs and cats and is considered nonpathogenic for humans, although this is the
third reported human isolate of this species.
Case report. A 51-year-old patient who was a 55-pack-per-
year smoker and who had a long history of serious, chronic
obstructive pulmonary disease was sent to the hospital in Oc-
tober 1998 because of dyspnea. A primary bronchial carcinoma
was diagnosed. Biopsy of the left supraclavicular lymph node
revealed a moderately differentiated adenocarcinoma. Pallia-
tive radiotherapy was started but was stopped in December
1998, and the patient was sent home during the ﬁrst week of
January.
The patient was in a cachectic, immunodepressed condition,
presented with fever and chills, and had a large ulcer at the left
supraclavicular lymph node. A differential diagnosis of sepsis
and tumor was made. Computed tomography of the thorax
showed a large necrotic nodus at the left supraclavicular lymph
node and a tumor at the right lower lobe in association with
pleural ﬂuid effusion and a diffuse metastasized bronchial car-
cinoma. Staphylococcus aureus in small numbers and Moraxella
canis in large numbers were isolated from the ulcer wound.
Blood cultures remained negative. The patient was discharged
2 days later and died shortly thereafter at home.
The oxidase-positive gram-negative diplococci were given a
preliminary identiﬁcation as M. canis after observation of
brown pigmentation of the Mueller-Hinton II agar (MHAII;
BBL Becton Dickinson, Cockeysville, Md.), used routinely for
disk diffusion susceptibility testing. This characteristic was
present in 15 of the 16 previously described isolates of M. canis,
while absent in all other Moraxella species (2). Further differ-
entiation from other Moraxella species was possible on the
basis of a positive DNase reaction, acetate assimilation posi-
tivity, and a positive gamma glutamyl aminopeptidase reaction
(2).
The isolate (LBV436) was resistant to ampicillin and sus-
ceptible to co-trimoxazole, doxycycline, fucidic acid, vancomy-
cin, rifampin, gentamicin, and quinolones. Production of -lac-
tamase has been demonstrated in some strains of M. canis (2),
and this strain was also -lactamase positive.
M. canis, together with Moraxella catarrhalis, Moraxella cu-
niculi, Moraxella caviae, Moraxella ovis, and Moraxella sp. in-
certae sedis strain NCTC 4103 belong to the coccal moraxellae,
which, in contrast to the bacillary moraxellae, all exhibit DNase
activity. M. canis and strain NCTC 4103 differ from all other
coccoid moraxellae by the production of gamma glutamyl ami-
nopeptidase and the ability to grow on MHAII at room tem-
perature. Moreover, M. canis and, to a weaker extent, strain
NCTC 4103 produce a brownish pigment on this growth me-
dium, which is a feature not shown by any other moraxellae.
To our knowledge, this is the third isolation of M. canis from
humans. The ﬁrst isolate (N7T, CCUG 8415AT) was from a
dog bite wound in a Swedish female in 1979, for which no
further clinical data are available (2). Wu¨st et al. (7) described
a blood culture isolate (U33, BLU8387) obtained in 1988 from
a 61-year-old alcoholic Swiss male with bleeding esophageal
varices who was hospitalized for symptoms suggesting pneu-
monia. The cachectic immunodepressed condition of our pa-
tient is comparable to that of the Swiss patient (7). All other
known isolates of this species are commensals isolated from
dog saliva (P37, Paris) (2) or swabs from dog muzzles (one was
from a cat muzzle) (2), from which M. canis could be cultured
only after suppression of other commensal bacteria with a
selective medium (4).
Sequence determination of the ﬁrst 450 to 700 bp of the
PCR-ampliﬁed 16S rRNA gene was carried out for isolate
LBV436, for four of the previously collected M. canis strains
(O18, P37, U33, and W4), for strain NCTC 4103, for an un-
identiﬁed gram-negative diplococcus isolated from a dog bite
(MOR32), and for a Moraxella strain producing yellowish pig-
ment on MHAII (LBV438). The complete sequence was de-
termined for the M. canis type strain N7. Ampliﬁcation was
done by PCR with the primers 5-AGT TTG ATC CTG GCT
CAG and 5-TAC CTT GTT ACG ACT TCG TCC CA. The
reactions were performed in a ﬁnal reaction mixture of 50 l
containing 25 l of Master Mix (Qiagen, Hilden, Germany), a
0.2-M concentration of each primer, and 5 l of a DNA
suspension obtained by alkaline lysis. Alkaline lysis was done
by suspending one colony in 20 l of 0.25% sodium dodecyl
sulfate–0.05 N NaOH and heating at 95°C for 15 min, followed
by a ﬁnal dilution with 180 l of distilled water. The ampliﬁ-
cation reactions were performed in a GeneAmp PCR System
9600 (Applied Biosystems, Foster City, Calif.) with the follow-
ing cycling parameters: 94°C for 5 min, followed by 3 cycles of
45 s at 94°C, 2 min at 50°C, 1 min at 72°C, and 30 cycles of 20 s
at 94°C, 1 min at 50°C, 1 min at 72°C, with a ﬁnal extension at
72°C for 7 min. The presence of ampliﬁcation products was
checked by electrophoresis on 2% agarose gels stained with
ethidium bromide. The ampliﬁcation products were then pu-
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riﬁed with the Concert PCR puriﬁcation kit (Gibco BRL Life
Technologies, Merelbeke, Belgium), used according to the
manufacturer’s instructions. Sequencing was done using the
ABI Big Dye cycle sequencing reaction kit with AmpliTaq FS
DNA polymerase (Applied Biosystems) with the following
primers: 5 AGT TTG ATC CTG GCT CAG (Escherichia coli
16S rRNA gene sequence position 8 to 27), 5CTCCTACGG
GAGGCAGCAGT (339 to 358 bp), 5CAGCAGCCGCGG
TAATAC (519 to 536), 5AACTCAAAGGAATTGACGG
(908 to 926), 5AGTCCCGCAACGAGCGCAAC (1093 to
1112), and 5GCTACACACGTGCTACAATG (1222 to 1241)
(1). Electrophoresis was performed on an ABI 310 analyzer.
Analysis of the sequences and clustering was done by Gene-
Compar, version 2.0 (Applied Maths, Kortrijk, Belgium).
The clinical isolate reported here revealed 100% 16S rDNA
sequence identity with U33 (the clinical isolate described by
Wu¨st et al. [7]) and above 99% identity with the other four M.
canis strains sequenced and with strain NCTC 4103. Less than
96% identity was observed with the 16S rDNA sequences of
other Moraxella species (3). The dog bite isolate MOR32 was
identiﬁed as Neisseria weaveri, and the Moraxella isolate which
produced yellow pigmentation on MHAII (LBV438) was iden-
tiﬁed as M. osloensis (Fig. 1).
M. canis can also be differentiated from all other Moraxella
species by ampliﬁcation of the tRNA intergenic spacers (6) and
determination of the tRNA intergenic-spacer lengths by means
of capillary electrophoresis (5). M. canis and M. catarrhalis had
tRNA spacer fragments with lengths of 66, 81, and 215 bp in
common, which were absent in M. caviae, M. cuniculi, Morax-
ella lacunata, Moraxella nonliquefaciens, M. osloensis, and M.
ovis and could be differentiated from each other by the pres-
ence of a fragment of 193 bp in M. canis tDNA PCR ﬁnger-
prints and the presence of fragments of 167 and 179 bp in M.
catarrhalis ﬁngerprints.
Despite the fact that M. canis was isolated in large numbers
from the clinical site, the organism has to be considered an
opportunistic pathogen, since this strain was isolated from a
heavily debilitated patient, as was the case for the Swiss patient
(7). Whether our patient lived in close contact with dogs or cats
could not be investigated.
In conclusion, gram-negative oxidase-positive diplococci
which produce brownish pigment on MHAII are most proba-
bly M. canis, a Moraxella species that is a commensal of dogs
and cats and that exceptionally can be isolated from clinical
samples in humans.
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A gram-negative alkaline phosphatase- and pyrrolidone peptidase-positive rod-shaped bacterium (CCUG
45702) was isolated from two aerobic blood cultures from a female cancer patient. No identiﬁcation could be
reached using phenotypic techniques. Ampliﬁcation of the tRNA intergenic spacers revealed fragments with
lengths of 116, 133, and 270 bp, but no such pattern was present in our reference library. Sequencing of the 16S
rRNA gene revealed its identity as Moraxella atlantae, a species isolated only rarely and published only once as
causing infection. In retrospect, the phenotypic characteristics ﬁt the identiﬁcation as M. atlantae (formerly
known as CDC group M-3). Comparative 16S rRNA sequence analysis indicates that M. atlantae, M. lincolnii,
and M. osloensis might constitute three separate genera within the Moraxellaceae. After treatment with amoxi-
cillin-clavulanic acid for 2 days, fever subsided and the patient was dismissed.
CASE REPORT
In April 2001 a 31-year-old female patient was admitted to
the oncology department with a history of intermittent fever
for more than 1 week and with complaints of right hypochon-
drial pain and rectal cramps. The patient had a rectal adeno-
carcinoma that was diagnosed 1 year previously, with recent
massive liver metastasis which had been treated with an ante-
rior resection and with palliative chemotherapy (irinotecan
and 5-ﬂuorouracil) for 10 months. Clinical examination re-
vealed a relapse of the rectal cancer at the anastomosis and a
hepatomegaly of 8 cm. X-ray examination of the thorax re-
vealed no inﬁltrates. Three pairs of blood cultures and a urine
culture were carried out, with the latter being negative. Strep-
tococci of the viridans group were isolated from one aerobi-
cally incubated culture bottle. A gram-negative rod, suscepti-
ble to all antibiotics tested and later identiﬁed as Moraxella
atlantae (CCUG 45702), was isolated from the two other aer-
obic bottles. The anaerobic cultures remained negative. The
patient was treated with amoxicillin-clavulanic acid (875 mg)
two times a day, resulting in the disappearance of the fever
after 2 days, whereafter the patient was dismissed. A computed
tomography of the abdomen 7 days later showed an abscess
around the rectum, which was drained with evacuation of 100
ml of serous ﬂuid. Culture of this ﬂuid remained negative. The
patient died 4 months later as a result of her underlying
disease.
The blood culture bottles (FA aerobic and SN anaerobic
bottles; Organon Teknika, Boxtel, The Netherlands) were in-
oculated with 10 ml of blood and incubated in the Bact/Alert
3D system (Organon Teknika). Gram staining showed short,
plump, rod-shaped to coccoid gram-negative rods. On tryptic
soy agar plus 5% sheep blood (Becton Dickinson, Erembode-
gem, Belgium), colonies were small and grayish, with twitching
motility and corroding activity. The isolate grew well on Mac-
Conkey agar, in contrast to most other Moraxella sp. It was
nonmotile. Catalase and oxidase were positive. No sugars were
acidiﬁed, either fermentatively or oxidatively. No growth was
observed on triple sugar iron agar. Nitrate reduction and pro-
duction of indol, urease, phenylalanine deaminase, lysine and
ornithine decarboxylases, and arginine dihydrolase were neg-
ative. Using Rosco Diatabs (Taastrup, Denmark), tributyrin
and proline aminopeptidase were negative, but alkaline phos-
phatase was positive and pyrrolidone peptidase was strongly
positive. The code obtained by API 20 NE (BioMe´rieux, Marcy
L’Etoile, France) strips was 0000004, corresponding to Morax-
ella sp. (82.3%). No identiﬁcation was obtained when the ID 32
GN (BioMe´rieux) strips were used. This phenotypic proﬁle did
not initially lead to an identiﬁcation, but in retrospect it was
found to be consistent with the genotypic identiﬁcation as M.
atlantae.
Susceptibility was tested with the disk diffusion technique.
No criteria are available for interpretation of the results, but
because of the large inhibition zones, the strain was considered
to be susceptible to all tested antibiotics, namely ampicillin,
cotrimoxazole, cefuroxime, gentamicin, colimycin, temocillin,
and ciproﬂoxacin.
Since no initial phenotypic identiﬁcation could be obtained,
the isolate was subjected to genotypic identiﬁcation. Initially,
identiﬁcation with tRNA-PCR (13) in combination with cap-
illary electrophoresis (1, 12) failed because no entries for M.
atlantae were present in our tRNA-ﬁngerprint library. How-
ever, since this M. atlantae isolate had tRNA spacer fragments
with lengths of 116, 133, and 270 bp, a pattern which is differ-
ent from all other members of the genus Moraxella and from
those obtained for all bacterial species tested thus far, addition
of this ﬁngerprint to the library should enable future identiﬁ-
cation by means of tRNA-intergenic spacer-length polymor-
phism analysis. Two M. atlantae culture collection strains
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(CCUG 10707 and CCUG 31324) were shown to have tRNA
spacer fragments with identical lengths.
16S rRNA gene ampliﬁcation and sequencing was carried
out as published before (11). Brieﬂy, the complete 16S rRNA
gene was ampliﬁed, followed by sequencing reactions using the
Big Dye Terminator Sequencing kit (Applied Biosystems, Fos-
ter City, Calif.) and analysis of the obtained fragments on the
ABI 310 capillary electrophoresis apparatus (Applied Biosys-
tems). Total gene assembling of the obtained fragments, align-
ment, and clustering were done with GeneBase (Applied
Maths, Kortrijk, Belgium). The obtained sequence (1,354 bp)
was compared to all known sequences in the GenBank by Blast
(National Center for Biotechnology Information, Bethesda,
Md.; http://www.ncbi.nlm.nih.gov/blast/index.html). The Blast
search resulted in a similarity of almost 99% with the only M.
atlantae sequence present (GenBank number AF005191).
However, the sequences obtained for the M. atlantae strain
of this study and for the GenBank M. atlantae strain contained
two regions with substantial differences. Therefore, two M.
atlantae culture collection strains (CCUG 10707 and CCUG
31324) were sequenced. This revealed other differences in the
same regions. Those differences appeared to be nonrandom.
For region 1 (Escherichia coli position 201 to 218), sequences
a (TTTWGGGTTC) and b (GCGAGAGCTTT) were ob-
served. Sequence a was present in strain CCUG 10707 and the
strain of this case report, and sequence b was observed for the
GenBank entry AF005191. Strain CCUG 31324 apparently
carried different alleles from either one or both sequences,
since the ambiguities in the sequence obtained for this strain
corresponded to a mixture of both sequences found in the
other strains (Fig. 1). For region 2 (E. coli position 455 to 478),
two possible sequences were seen, with strain CCUG 10707
and the GenBank entry AF005191 having one possible se-
quence and CCUG 31324 and our clinical isolate having the
other. Other points of difference were found at E. coli position

































































































































FIG. 1. Alignment of two variable regions of the 16S rRNA gene
sequences of four M. atlantae strains. IUB codes: S, C or G; Y, C or G;
K, G or T; W, A or T; R, A or G. Sequences: 1, M. atlantae CCUG
10707 (GenBank no. AJ417491); 2, M. atlantae CCUG 31324 (Gen-
Bank no. AJ417492); 3, M. atlantae CDCA1922 (GenBank no.
AF005191); 4, M. atlantae CCUG 45702, the clinical strain of this study
(GenBank no. AJ313278); 5, E. coli ATCC 11775T (GenBank no.
X80725).
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position 848 (either C or T), and E. coli position 1136 (either
A or G).
In fact, all four strains have highly identical 16S ribosomal
DNA sequences which at some regions are different mixtures
of a few basic themes, probably reﬂecting past recombination
events (5, 9). Furthermore, strain CCUG 31324 appears to
have alleles with different sequences in a region between E. coli
positions 201 and 218 whereby one or more cistrons have
sequence a while one or more others have sequence b.
The 16S rRNA sequences of two M. atlantae isolates were
compared with those of other moraxellae (including a more
complete sequence of Moraxella lincolnii obtained in this
study), Psychrobacter immobilis and Psychrobacter phenylpyru-
vicus, and the Acinetobacter calcoaceticus type strain (Fig. 2).
Psychrobacter and Acinetobacter are genera which belong to the
Moraxellaceae as well. A dendrogram of 16S rRNA gene se-
quences was constructed using the GeneBase software pack-
age. First, pairwise alignment using the unweighted pair group
method with arithmetic mean was carried out with a gap pen-
alty of 100%, a unit gap cost of 20%, and an ambiguity cost of
50% of the mismatch cost. Subsequently, global alignment with
A. calcoaceticus as the outgroup was carried out on the region
corresponding to positions 60 through 1334 of the 16S rRNA
gene of E. coli, with costs as described above. Finally, a simi-
larity matrix of the aligned sequences was constructed by
global alignment homology calculation and a gap penalty of
20%. The neighbor-joining method was used to construct the
dendrogram based on this similarity matrix (7).
This revealed that in fact the species Moraxella osloensis, M.
lincolnii, and M. atlantae could be classiﬁed as separate genera,
based on a less than 95% sequence relatedness to each other,
to the other moraxellae, and to Psychrobacter. The similarity
percentages were 91 for M. atlantae versus M. lincolnii, 92 for
M. atlantae versus M. osloensis, 89 for M. atlantae versus the
other moraxellae, 93 for M. lincolnii versus M. osloensis, and 89
for M. atlantae versus P. immobilis and P. phenylpyruvicus. The
sequence differences between the two Psychrobacter species
amounted to 5.7% as well. The suggestion that these species
could be classiﬁed as separate genera is in correspondence to
earlier reports based on 16S rRNA gene sequencing (8), DNA-
DNA hybridization (10), and DNA transformation (2).
M. atlantae is an unusual and only rarely isolated bacterium,
formerly known as CDC group M-3. Bøvre et al. (2) described
ﬁve strains isolated from blood cultures, all with the tendency
to spread on blood agar plates, but without mentioning the
clinical importance. The strain of the only case report thus far
(3) was isolated from a blood culture of a 25-year-old patient
suffering from systemic lupus erythematosis and had the same
biochemical and phenotypic characteristics as the strain from
the present case report.
M. atlantae is a rare opportunistic pathogen that is appar-
ently susceptible to most common antibiotics. This—together
with the difﬁculties encountered in most laboratories in the
identiﬁcation of gram-negative nonfermenters—may cause
possible underestimation of its occurrence. For example, the
Culture Collection of the University of Go¨teborg (CCUG)
harbors 12 M. atlantae strains, of which 10 were isolated since
1981. Ten are from blood, one from pleural ﬂuid, and one from
a dog bite wound. Unambiguous identiﬁcation of this organism
is possible by means of 16S rRNA gene sequencing, tRNA-
PCR, and phenotypic characteristics. Short, nonmotile, gram-
negative rods forming small colonies, possessing twitching mo-
tility and corroding activity on blood agar, capable of growing
on MacConkey agar, oxidase and catalase positive, not acidi-
fying sugars, negative for nitrate reduction, urease, acetate
assimilation, and tributyrin hydrolysis, and positive for pyrro-
lidone peptidase can be considered M. atlantae.
Nucleotide sequence accession numbers. The sequences of
the 16S rRNA genes from M. atlantae and M. lincolnii obtained
in this study were deposited under GenBank numbers
AJ313278 and AJ417490, respectively.
We thank Leen Van Simaey and Catharine De Ganck for excellent
technical assistance and Enevold Falsen for supplying us with M. at-
lantae strains CCUG 10707 and CCUG 31324.
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A mycobacterial strain isolated from a lymph node of a 3-year-old female with cervical lymphadenitis was
identiﬁed as Mycobacterium interjectum by means of sequencing of the 16S rRNA gene. Analysis of this case and
previously published cases demonstrates the importance of M. interjectum as a causative agent of cervical
lymphadenitis in young children.
Molecular techniques have made it possible to recognize
previously overlooked mycobacterial species. A mycobacterial
isolate from a lymph node of a child with lymphadenitis could
not be identiﬁed with ampliﬁed ribosomal DNA restriction
analysis (ARDRA), the molecular technique routinely used at
our laboratory for identiﬁcation of mycobacteria. Determina-
tion of the sequence of the 16S rRNA gene led to a ﬁnal
identiﬁcation as Mycobacterium interjectum and prompted us to
review previously described cases of infection due to this or-
ganism.
Case report. A 3-year-old female was admitted to Ghent
University Hospital with cervical lymphadenitis lasting for a
period of 8 weeks. In the left submandibular and left parotid
areas, a ﬁrm nodular mass of 3 by 4 cm was palpable and the
overlying skin was blue-red. There was discrete local pain but
no systemic illness. A chest X-ray and routine hematological
examination were normal. An intradermal skin test using pu-
riﬁed protein derivative (PPD) (ﬁve tuberculin units) of both
tuberculous and nontuberculous mycobacteria was applied,
and an induration with a diameter of more than 10 mm was
seen for M. avium complex. Because antibiotic treatment with
azithromycin given for 3 weeks resulted in no response, com-
plete surgical excision was performed.
During surgery, the affected skin was resected, including a
left parotidectomy and resection of the submandibular gland
with associated lymph nodes in the superior jugular area. Sam-
ples of the lymph nodes were preserved for laboratory inves-
tigation and culturing. Diffuse tuberculoid granulomatous
lymphadenitis and caseous necrosis were seen throughout the
specimen. M. interjectum was isolated from all resected lymph
nodes. Drug susceptibility testing was performed by the pro-
portion method with Lowenstein-Jensen (LJ) medium or
Middlebrook 7H11 agar (7H11) and a single concentration of
each drug as recommended before (1, 7). The isolate was
found to be resistant to rifampin (40 g/ml of LJ), isoniazid
(0.2 g/ml of LJ), ethambutol (2 g/ml of LJ), para-aminosal-
icylic acid (0.5 g/ml of LJ), streptomycin (4 g/ml of LJ),
kanamycin (6 g/ml of 7H11), and capreomycin (10 g/ml of
7H11) and susceptible to cycloserine (60 g/ml of 7H11), ethi-
onamide (10 g/ml of 7H11), clarithromycin (1 g/ml of LJ),
rifabutin (40 g/ml of LJ), and oﬂoxacin (4 g/ml of 7H11).
After surgery, the patient recovered completely and no re-
lapse was seen.
Preparation of the specimens for mycobacterial culturing
started with N-acetyl-L-cysteine-NaOH-based decontamina-
tion, followed by auramine staining and inoculation of a liquid
medium (MB BacT; Organon Teknika, Boxtel, The Nether-
lands) and a solid medium (Ogawa; Sanoﬁ-Pasteur, Marnes-la-
Coquette, France). The auramine staining (auramine obtained
from Merck, Darmstadt, Germany) was negative, no growth
was observed on the solid medium, but the liquid culture be-
came positive after 30 days.
At our laboratory, identiﬁcation of cultured mycobacteria is
done by ARDRA (14), which consists of restriction digestion
of the ampliﬁed 16S rRNA gene. For the isolate obtained here,
the combination of CfoI restriction pattern 5, MboI pattern 4,
and RsaI pattern 4 was observed; this proﬁle did not corre-
spond to any of the proﬁles of the mycobacterial species in-
cluded in our reference panel (14; http://allserv.rug.ac.be
/mvaneech/ARDRA/Mycobacterium.html). Therefore, se-
quencing of the 16S rRNA gene was necessary to obtain ﬁnal
identiﬁcation. Sequencing was carried out as described previ-
ously (6). The obtained sequence was compared with all known
sequences of GenBank by use of Blast 2.0 (National Center for
Biotechnology Information, Bethesda, Md. [http://www3.ncbi
.nlm.nih.gov/BLAST/]) and showed 99.8% similarity with M.
interjectum. Identiﬁcation as M. interjectum was conﬁrmed by
cluster analysis performed by use of Genecompar (Applied
Maths, Kortrijk, Belgium). The sequences of the following
strains were used in the UPGMA (unweighted pair-group
method using arithmetic averages) clustering: Ghent Univer-
sity Hospital clinical strain (GenBank accession no.
AJ272088), four previously sequenced M. interjectum strains
(GenBank accession no. AF014935, AF014936, AF014937, and
X70961), an M. simiae strain (GenBank accession no. X52931),
an M. heidelbergense strain (GenBank accession no. AJ000684)
(in the latter two species, the 16S rRNA gene sequence clusters
* Corresponding author. Mailing address: Laboratory Bacteriology
& Virology, Ghent University Hospital, De Pintelaan 185, B-9000




very closely with that of M. interjectum), and an M. tuberculosis
strain (GenBank accession no. X52917) (Fig. 1).
Further conﬁrmation of the sequencing results was done by
biochemical testing as described before (15). The strain was
found to be a scotochromogenic, slowly growing mycobacte-
rium, susceptible on LJ medium to NaCl (5%) and isoniazid
(10 g/ml) but resistant to carboxylic acid hydrazide (2 g/ml),
hydroxylamine (250 g/ml), and para-nitrobenzoic acid (500
g/ml).
The strain was found to be negative for semiquantitative
catalase (i.e., less than 45-mm foam production) nitrate reduc-
tion, acid phosphatase, and niacin production but positive for
Tween hydrolysis and urease. Thin-layer chromatography of
the fatty acids revealed alpha-, methoxy-, and keto-mycolic
acids. All of these biochemical characteristics ﬁt with the iden-
tiﬁcation as M. interjectum (10). The negative catalase reaction,
the positive Tween hydrolysis, and the susceptibility to 10 g of
isoniazid per ml, as well as the mycolic acid pattern, differen-
tiate this species from the phenotypically very similar species
M. scrofulaceum (15).
M. interjectum, for which the species name refers to the
intermediate phylogenetic position between rapidly and slowly
growing mycobacteria, was ﬁrst described in 1993 (9). Table 1
summarizes the clinical features of all published cases in which
M. interjectum was isolated.
M. interjectum was described as the causative agent in ﬁve
pediatric cases of cervical lymphadenitis. Four cases in adults
have been described, but in only one case (Table 1, case 7) was
M. interjectum considered clinically important. The four pa-
tients (three pediatric) treated with antibiotics alone and/or
undergoing partial resection were not cured. Cure was ob-
tained only after total resection of the infected region.
Nontuberculous mycobacterial lymphadenitis was tradition-
ally associated with M. scrofulaceum (5). During the 1980s, the
M. avium complex was predominant (16). More recently, how-
ever, a wide variety of mycobacterial species causing lymphad-
FIG. 1. UPGMA clustering of the 16S rRNA gene sequence of the clinical isolate reported in this study with sequences obtained from
GenBank. Lengths are shown in base pairs.






subsequent) Outcome (initial; subsequent)
1 (this
study)
3 yr/female Cervical swelling in the left
submandibular region
Azithromycin; total resection No response; no relapse
2 (9) 18 mo/male Enlarged lymph node in the right
submandibular region
Partial resection  isoniazid, rifampin,
and pyrazinamide; Total resection 
clarithromycin, isoniazid, and
protionamid
Further enlargement of the lymph
node, including a ﬁstula; no
relapse
3 (12) 2 yr/female Right laterocervical swelling Clarithromycin; total resection No response; no relapse
4 (6) 2 yr/female Enlarged lymph node in the left
anterior triangle
Total resection No relapse
5 (6) 3 yr/female Cervical swelling in the left
anterior triangle and mildly
enlarged node in the right
neck
Total resection No relapse
6 (6) Elderly/female Widespread interstitial lung
opacities
No treatment (considered not clinically
signiﬁcant)
7 (2) 52 yr/female Chronic destructive lung disease,
with multiple positive cultures
Amikacin No response
8 (11) 71 yr/female No speciﬁc symptoms; a single
isolate from a urine sample
No treatment (considered not clinically
signiﬁcant)
9 (10) 36 yr/male No speciﬁc symptoms; a single
isolate from sputum of an
AIDS patient
No treatment (considered not clinically
signiﬁcant)
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enitis in young children have been reported, including some
previously unrecognized mycobacteria (3, 4, 9, 12, 13). At
present, it is difﬁcult to establish whether this observation
reﬂects real changes in the prevalence of different mycobacte-
rial species or is due to increased diagnostic capabilities and to
reﬁned mycobacterial taxonomy.
Full identiﬁcation of the nontuberculous agents causing cer-
vical lymphadenitis in young children is warranted to reveal the
role of different mycobacterial species and may indicate an
underestimation of the pathogenic role of species such as M.
interjectum. Also, correct identiﬁcation may be important to
guide therapy, since present experience seems to indicate that
total resection is the only cure for lymphadenitis caused by
species such as M. interjectum. Identiﬁcation of M. interjectum
by phenotypic methods is slow and not always straightforward,
since the species has been reported to have quite a few variable
reactions (6). Also, with high-pressure liquid chromatography
analysis of mycolic acids, differences among the patterns ob-
tained for different M. interjectum strains have been reported
(6, 10). Accurate identiﬁcation of M. interjectum is possible by
means of 16S rRNA gene sequencing and by means of
ARDRA, which results in CfoI restriction pattern 5, MboI
pattern 4, and RsaI pattern 4, a proﬁle thus far observed only
for M. interjectum.
We thank Leen Van Simaey for excellent technical assistance.
REFERENCES
1. Canetti, G., W. Fox, A. Khomenko, H. T. Mahler, M. K. Menon, D. A.
Mitchison, N. Rist, and N. A. Smelev. 1969. Advances in techniques of
testing mycobacterial drug sensitivity, and the use of sensitivity tests in
tuberculosis control programmes. Bull. W.H. O. 41:21–43.
2. Elmer, S., T. Rochat, P. Rohner, C. Perrot, R. Auckenthaler, L. Perrin, and
B. Hirschel. 1994. Chronic destructive lung disease associated with a novel
Mycobacterium. Am. J. Respir. Crit. Care Med. 150:261–265.
3. Haas, W. H., W. R. Butler, P. Kirschner, B. P. Plikaytis, M. B. Coyle, B.
Amthor, A. G. Steigerwalt, D. J. Brenner, M. Salﬁnger, J. T. Crawford, B. C.
Bo¨ttger, and H. J. Bremer. 1997. A new agent of mycobacterial lymphade-
nitis in children: Mycobacterium heidelbergense sp. nov. J. Clin. Microbiol.
35:3203–3209.
4. Haase, G., H. Kentrup, H. Skopnik, B. Springer, and E. C. Bo¨ttger. 1997.
Mycobacterium lentiﬂavum: an etiologic agent of cervical lymphadenitis. Clin.
Infect. Dis. 25:1245–1246.
5. Lincoln, E. M., and L. A. Gilbert. 1972. Disease in children due to myco-
bacteria other than Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 105:
683.
6. Lumb, R., A. Goodwin, R. Ratcliff, R. Stapledon, A. Holland, and I. Bastian.
1997. Phenotypic and molecular characterization of three clinical isolates of
Mycobacterium interjectum. J. Clin. Microbiol. 35:2782–2785.
7. Rastogi, N., K. S. Goh, and H. L. David. 1989. Drug susceptibility testing in
tuberculosis: a comparison of the proportion methods using Lo¨wenstein-
Jensen, Middlebrook 7H10 and 7H11 agar media and a radiometric method.
Res. Microbiol. 140:405–417.
8. Rogall, T., J. Wolters, T. Flohr, and E. C. Bo¨ttger. 1990. Towards a phylog-
eny and deﬁnition of species at the molecular level within the genus Myco-
bacterium. Int. J. Syst. Bacteriol. 40:323–330.
9. Springer, B., P. Kirschner, G. Rost-Meyer, K. H. Schro¨der, R. M. Kropper-
stedt, and E. C. Bo¨ttger. 1993. Mycobacterium interjectum, a new species
isolated from a patient with chronic lymphadenitis. J. Clin. Microbiol. 31:
3083–3089.
10. Tortoli, E., P. Kirschner, A. Bartoloni, C. Burrini, B. Manfrin, A. Mantella,
M. Scagnelli, C. Scarparo, M. T. Simonetti, and E. C. Bo¨ttger. 1996. Isola-
tion of an unusual Mycobacterium from an AIDS patient. J. Clin. Microbiol.
34:2316–2319.
11. Tortoli, E., A. Bartoloni, C. Burrini, D. Colombrita, A. Mantella, G. Pinsi,
M. T. Simonetti, G. Swierczynski, and E. C. Bottger. 1996. Characterization
of an isolate of the newly described species Mycobacterium interjectum. Zen-
tralbl. Bakteriol. 283:286–294.
12. Tortoli, E., P. Kirschner, B. Springer, A. Bartoloni, C. Burrini, A. Mantella,
M. Scagnelli, C. Scarparo, M. T. Simonetti, and E. C. Bottger. 1997. Cervical
lymphadenitis due to an unusual Mycobacterium. Eur. J. Clin. Microbiol.
Infect. Dis. 16:308–311.
13. Tortoli, E., A. Bartoloni, V. Manfrin, A. Mantella, C. Scarparo, and E. C.
Bo¨ttger. 2000. Cervical lymphadenitis due to Mycobacterium bohemicum.
Clin. Infect. Dis. 30:210–211.
14. Vaneechoutte, M., H. De Beenhouwer, G. Claeys, G. Verschraegen, A. De
Rouck, N. De Paepe, A. Elaichouni, and F. Portaels. 1993. Identiﬁcation of
Mycobacterium species by using ampliﬁed ribosomal DNA restriction anal-
ysis. J. Clin. Microbiol. 31:2061–2065.
15. Vincent Le´vy-Fre´abault, V., and F. Portaels. 1992. Proposed minimal stan-
dards for the genus Mycobacterium and for the description of new slowly
growing Mycobacterium species. Int. J. Syst. Bacteriol. 42:315–353.
16. Wolinsky, E. 1995. Mycobacterial lymphadenitis in children: a prospective
study of 105 nontuberculous cases with long-term follow-up. Clin. Infect. Dis.
20:954–963.
VOL. 39, 2001 NOTES 727
95
International Journal of Systematic and Evolutionary Microbiology (2001), 51, 547–558 Printed in Great Britain
Classiﬁcation of Ralstonia pickettii biovar
3/‘thomasii ’ strains (Pickett 1994) and of new
isolates related to nosocomial recurrent
meningitis as Ralstonia mannitolytica sp. nov.
Thierry De Baere,1 Sophia Steyaert,1 Georges Wauters,2 Paul De Vos,3
Johan Goris,3 Tom Coenye,3 Tetsushi Suyama,4 Gerda Verschraegen1
and Mario Vaneechoutte1
Author for correspondence: Mario Vaneechoutte. Tel :32 9 240 36 92. Fax:32 9 240 36 59.
e-mail : Mario.Vaneechoutterug.ac.be




De Pintelaan 185, B-9000
Ghent, Belgium








35, B-9000 Ghent, Belgium
4 Applied Microbiology
Division, National Institute




Strains isolated independently from two patients could be recognized as
Ralstonia pickettii biovar 3/‘thomasii ’. The 16S rDNA sequences of these strains
and two other strains of R. pickettii biovar 3/‘thomasii ’ clustered at less than
98% similarity versus all other described Ralstonia species and at less than
97% versus the two other R. pickettii biovars. The separate species status of R.
pickettii biovar 3/‘thomasii ’ was conﬁrmed by DNA–DNA hybridization,
indicating less than 60% DNA homology with the R. pickettii biovars Va-1 and
Va-2 and with two as-yet unclassiﬁed but biochemically similar Ralstonia
strains. Phenotypically, this Ralstonia species can be distinguished from all
described Ralstonia species by its acidiﬁcation of D-arabitol and mannitol and
by its lack of nitrate reduction and of alkalinization of tartrate and from two
as-yet unclassiﬁed Ralstonia strains only by its lack of nitrate reduction. The
name Ralstonia mannitolytica sp. nov. is proposed, reﬂecting the characteristic
acidiﬁcation of mannitol. Resistance to desferrioxamine is another difference
from R. pickettii and Ralstonia solanacearum. Although several nosocomial
outbreaks have been associated with R. mannitolytica, life-threatening
infections have not yet been reported, possibly due to misidentiﬁcation as
Pseudomonas fluorescens or Burkholderia cepacia. In at least one of the two
cases reported here, the R. mannitolytica isolate was found to be clinically
relevant, causing recurrent nosocomial meningitis, with an infected implanted
catheter as the source. The type strain of R. mannitolytica is NCIMB 10805T
(LMG 6866T), which was isolated during the ﬁrst described outbreak as
‘Pseudomonas thomasii ’ at St Thomas’ Hospital, London, UK, in 1971.
Keywords : Ralstonia pickettii biovar 3‘ thomasii ’, Ralstonia mannitolytica sp. nov.,
infection
INTRODUCTION
The genus Ralstonia (Yabuuchi et al., 1995) has been
created for a group of organisms from ecologically
diverse niches to accommodate bacteria that were
formerly classiﬁed as members of Burkholderia
.................................................................................................................................................
Abbreviation: TSA, tryptic soy agar.
The GenBank/EMBL/DDBJ accession numbers for the 16S rDNA sequences
reported in this paper are AJ270252–AJ270266 and AJ271437.
(Yabuuchi et al., 1992) and Alcaligenes. The type
species of the genus, Ralstonia pickettii, was originally
regarded as the only representative of clinical im-
portance (Dimech et al., 1993; Fass & Barnishan,
1976; Fujita et al., 1981; Gardner & Shulman, 1984;
Kahan et al., 1983; Lacey & Want, 1991; Raveh et al.,
1993; Roberts et al., 1990; Verschraegen et al., 1985).
Only recently, the taxonomy of this genus has begun to
be elucidated with the description of several new
species, Ralstonia paucula, Ralstonia gilardii and
Ralstonia basilensis, some of which are of moderate
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clinical importance (Coenye et al., 1999; Vandamme
et al., 1999; Moissenet et al., 1999; Osterhout et al.,
1998; Steinle et al., 1998).
Historically, R. pickettii was created for a group of
clinical isolates (Ralston et al., 1973) and also turned
out to include strains of CDC group Va-2 (Tatum et
al., 1974; Riley & Weaver, 1975) and possibly other
strains. The CDC groups Va-2 andVa-1 were regarded
as two diﬀerent biovars and hence Pickett & Green-
wood (1980) decided that CDC groups Va-1 and Va-2
represented two diﬀerent biovars of R. (‘Pseudo-
monas ’) pickettii. Shortly before this, King et al. (1979)
had concluded that R. (‘Pseudomonas ’) pickettii con-
tained several biovars, including the strains originally
isolated from clinical samples in St Thomas’ Hospital,
London, UK (Phillips & Eykyn, 1972; Phillips et al.,
1972), and which had been designated ‘Pseudomonas
thomasii ’. Although this name was never validated, it
has been used several times (Baird et al., 1976; King
et al., 1979; Costas et al., 1990). According to Pickett
(1994), the present taxonomic situation of R. pickettii
should be reduced to the recognition of three biovars,
with biovar 1 equal to CDC groupVa-1, biovar 2 equal
to CDC group Va-2 and biovar 3 mostly consistent
with the invalid ‘Pseudomonas thomasii ’ (Pickett,
1994).
Here, we report a case of recurrent nosocomial
meningitis caused by a colistin-resistant, Gram-nega-
tive rod that was identiﬁed by means of API 20NE as
Pseudomonas ﬂuorescens. Because of its colistin
resistance, this strain was studied in more detail,
which lead to its identiﬁcation as R. pickettii biovar
3‘ thomasii ’. The further data gathered, by means of
sequence determination of the 16S rDNA, determi-
nation of the cellular fatty acid composition, DNA
hybridization, SDS-PAGE and extensive charac-
terization of biochemical reactivity, indicate that this
biovar can be considered as a separate species within
the genusRalstonia, namedRalstonia mannitolytica sp.
nov. after its characteristic acidiﬁcation of mannitol,
distinct from all other described Ralstonia species.
Retrospectively, a strain stored previously as P.
ﬂuorescens and isolated repeatedly from an abdominal
haematoma of a patient with cholangiocarcinoma and
a strain from an outbreak due to contaminated water
in the neonatal intensive care department of the Ghent
University Hospital, Belgium (GUH), in 1990 could
also be identiﬁed as R. mannitolytica. Several noso-
comial outbreaks withR. pickettii biovar 3‘ thomasii ’,
mostly due to contaminated ﬂuids, have been described
(Costas et al., 1990; Pan et al., 1992; Phillips et al.,
1972), but no life-threatening infections have been
reported yet to our knowledge.
METHODS
Bacterial strains.The strains studied are listed in Table 1. The
clinical strains LMG 19090, LMG 19091 and LMG 19092
were isolated at the GUH. Strain LMG 19090 (LBV407
UCL310) was isolated repeatedly from a patient with
recurrent meningitis (patient 1), strain LMG 19091
(LBV371RAL13) was isolated repeatedly from an ab-
dominal haematoma of a patient with cholangiocarcinoma
(patient 2) and strain LMG 19092 (PSE061) was one of
several strains isolated during an outbreak due to con-
taminated water at the GUH neonatal intensive care
department in 1990. Strains LMG 19083 (RAL05ML7),
LMG 19087 (RAL07YL13), LMG 19088 (RAL06ML10)
and LMG 19089 (RAL04MC5) are environmental soil
isolates described by Suyama et al. (1998) and were included
because some of these strains showed the highest 16S rDNA
sequence similarity to the clinical strains of all the sequences
available from the GenBankEMBL database. All other
strains studied here, including the R. mannitolytica type
strain (LMG 6866T), were supplied by the BCCMLMG
Bacteria Collection (Ghent, Belgium) or were isolated at the
GUH. [Pseudomonas] syzygii strains, which are so closely
related to Ralstonia solanacearum (Brim et al., 1998; this
study) that they can be regarded as members of this genus,
were included to exclude synonymy with the R. pickettii
biovar 3‘ thomasii ’ strains studied here.
Biochemical characterization. Growth at 30 and 37 C was
evaluated on tryptic soy agar (TSA) (Sanoﬁ Diagnostics
Pasteur). Growth at 42 Cwas tested by adding two drops of
a McFarland suspension 3 in water, prepared from a 24 h
culture on TSA, to 5 ml of tryptic soy broth and subsequent
incubation in a water bath at 42 C and reading after 48 h.
Conventional tests were carried out as described elsewhere
(Gilligan, 1995). Commercial tests (API ZYM, API 20NE,
API 50CH and ID 32GN; bioMe rieux) were carried out
according to the instructions of the manufacturer. As-
similation testing was carried out using the AUX medium
(bioMe rieux). To test for assimilation and alkalinization of
organic substrates, Simmons’ citrate agarwas used, whereby
citrate was replaced by organic substrates at a concentration
of 02% (wv). Desferrioxamine susceptibility was tested
according to a method adapted from Lindsay & Riley
(1991), by loading 6 mm diameter paper discs with 250 µg
desferal on Mu ller Hinton II agar (MHA) (BBL Becton
Dickinson). Alkaline phosphatase, pyrrolidonyl aryl-
amidase and benzyl arginine arylamidase (trypsin) were
tested using Rosco tablets (Taastrup, Denmark) and read
after 4 h. Colistin susceptibility was tested using 10 µg
colistin paper disks (BBL) onMHA and susceptibility to the
vibriostatic agent O:129 was tested with Sanoﬁ Diagnostics
Pasteur paper discs on MHA. Acidiﬁcation of ethylene
glycol was tested as described previously (Wauters et al.,
1998). Staining of ﬂagella was done as described previously
(Kodaka et al., 1982).
16S rDNA sequence determination. Ampliﬁcation was done
by PCR with primers named αβNOT (5-AGTTTGATC-
CTGGCTCAG-3) and ωMB (5-TACCTTGTTACGAC-
TTCGTCCCA-3). The reactions were performed in a ﬁnal
reaction mixture of 50 µl containing 25 µl Master Mix
(Qiagen), 02 µM of each primer and 5 µl of a DNA
suspension obtained by alkaline lysis. The ampliﬁcation
reactions were performed in a GeneAmp PCR System 9600
(Perkin-Elmer Applied Biosystems) with the following cyc-
ling parameters : 94 C for 5 min, followed by three cycles of
45 s at 94 C, 2 min at 50 C and 1 min at 72 C and 30 cycles
of 20 s at 94 C, 1 min at 50 C and 1 min at 72 C, with a
ﬁnal extension at 72 C for 7 min. The ampliﬁcation
products were checked by 2% agarose gel electrophoresis
and staining with ethidium bromide. The ampliﬁcation
products were puriﬁed with a PCR puriﬁcation kit (Qiagen)
according to the manufacturer ’s instructions. Sequencing
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Table 1 List of strains studied
.................................................................................................................................................................................................................................................................................................................
Names of taxa in brackets indicate that the organisms were misnamed at the corresponding taxonomic level. Abbreviations:
ATCC, American Type Culture Collection, Manassas, VA, USA; CDC, Centers for Disease Control, Atlanta, GA, USA; CIP,
Collection Institut Pasteur, Paris, France; DSM, Deutsche Sammlung von Mikroorganismen, Braunschweig, Germany; GUH,
Ghent University Hospital, Belgium; LMG, BCCMLMG Bacteria Collection, Laboratorium voor Microbiologie, Universiteit
Gent, Belgium; NCIB, National Collection of Industrial Bacteria, Aberdeen, UK; NCPPB, National Collection of Plant-
pathogenic bacteria, Harpenden Laboratory, Herts, UK; UCL, Universite Catholique de Louvain, Belgium.
Strain Other strain designation(s) Origin
[P.] syzygii
LMG 6969 RAL08, Eden-Green S593
LMG 6970 RAL09, Eden-Green S594
LMG 10661T RAL10T, Eden-Green R001T, Jones W1330T, NCPPB 3446T West Sumatra (‘Syzygium aromaticum ’)
LMG 10662 RAL11, Eden-Green R002, NCPPB 3445 West Java
R. basilensis
LMG 18990* DSM 11853, Steinle RK1 Laboratory ﬁxed bed reactor, 2,6-dichlorophenole as sole energy source
R. eutropha
LMG 1194 RAL14, CCUG13796, DSM 515, Schlegel B19 USA, forest soil
LMG 1199T RAL15T, ATCC 17697T, CCUG 1776T, DSM 531T,
ICPB 3984T, NCIB 11842T
USA, soil
LMG 1201 RAL16, ATCC 17699, ATCC 23440,
CCUG 13797, DSM 428, NCIB 10442,
Schlegel H16
Go ttingen, Germany, source sludge
R. gilardii
LMG 5886T* API 141-2-84T, ATCC 700815T, Gilardi 4325T Whirlpool
R. mannitolytica
LMG 6866T NCIB 10805T St. Thomas’ Hospital, London, UK, 1971, blood
LMG 19090 LBV407, UCL310 GUH, 1998, recurrent meningitis
LMG 19091 RAL13, LBV371, GUH 98 06 3523 GUH, 1998, abdominal haematoma
LMG 19092 PSE061, GUH S90 03985 GUH, 1990, sputum
R. paucula
LMG 3244T ATCC 700817T, CCUG 12507T, CDC E6793T Oregon, USA, human respiratory tract
LMG 3515 CCUG 12411, CCUG 12505, CDC E8967, LMG 3245 Georgia, USA, sputum
R. pickettii
LMG 7001* CCUG 3314, Pickett K-214 USA, Sephadex eluate
LMG 7002* CCUG 3316, LMG 7146, Pickett K-279
LMG 7008* CCUG 2165 Go teborg, Sweden, 1973, urine
LMG 7145* CCUG 3315, Pickett K-232
R. pickettii biovar Va-1
LMG 7005 CCUG 1467, CDC A5832, PSE056
LMG 7014 RAL02, CCUG 12491, Gilardi GLG 3963 Blood
LMG 7015 RAL03, CCUG 12492, Gilardi GLG 3905 Blood
LMG 7160 RAL01, CIP 74.22, CIP R866 Blood culture
LMG 19083 ML7, RAL05 Soil, Japan
LMG 19084 PSE058, GUH S89 04031 GUH, 1989, sputum
LMG 19086 PSE060, GUH S89 04266 GUH, 1989, sputum
LMG 19088 ML10, RAL06 Soil, Japan
R. pickettii biovar Va-2
ATCC 27512 WG076, Pickett K-550 Patient with tracheotomy, 1973
LMG 5942T ATCC 27511T, CCUG 3318T, CIP 73.23T, ICPB 3981T, JCM 5969T,
NCTC 11149T, Pickett K-288T, PSE055T, WG071T
Los Angeles, CA, USA, patient with tracheotomy
LMG 19085 RAL12, GUH 99 03 4045 GUH, 1999, nebulizer
R. solanacearum
LMG 2299T RAL17T, CCUG 14272T, DSM 9544T,
JCM 10489T, Kelman 60-1T, NCPPB 325T
USA, Lycopersicon esculentum
LMG 2303 RAL18, NCPPB 078 Honduras
Ralstonia sp.
LMG 19087 YL13, RAL07 Japan, soil
LMG 19089 MC5, RAL04 Japan, soil
* Strain was only included in SDS-PAGE of whole-cell proteins.
was performed on an ABI 310 sequencer using the ABI Big
Dye cycle sequencing reaction kit with AmpliTaq FS DNA
polymerase (Perkin Elmer) with primers described pre-
viously (Coenye et al., 1999). Analysis of the sequences and
clustering was done by using GC version 4.1
(Applied Maths).
DNA base composition. DNA was degraded enzymatically
into nucleosides as described by Mesbah et al. (1989). The
nucleoside mixture obtained was then separated by HPLC
using a Waters Symmetry Shield C8 column thermo-







40) with 15% acetonitrile. Non-methylated lambda phage
DNA (Sigma-Aldrich) was used as the calibration reference.
DNA–DNA hybridizations. DNA–DNA hybridizations were
performed with photobiotin-labelled probes in microplate
wells as described by Ezaki et al. (1989), using an HTS7000
Bio Assay Reader (Perkin Elmer) for the ﬂuorescence
measurements (excitation ﬁlter of 360 nm, emission ﬁlter of
465 nm). The optimal renaturation temperature was de-
termined according to the equation of De Ley et al. (1970).
PAGE of cell proteins. Cells were grown for 48 h on TSA at
37 C. SDS protein extracts were prepared and electro-
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Table 2 Phenotypic characteristics useful in the differentiation of the Ralstonia species
.................................................................................................................................................................................................................................................................................................................
The following taxa were included in the analysis : 1, R. mannitolytica strains LMG 6866T, LMG 19090, LMG 19091 and LMG
19092; 2, R. pickettii biovar Va-1 strains LMG 7014, LMG 7015, LMG 7160, LMG 19083, LMG 19084, LMG 19086 and LMG
19088; 3, R. pickettii biovar Va-2 strains ATCC 27512, LMG 5942T and LMG 19085; 4, Ralstonia sp. strain LMG 19089; 5,
Ralstonia sp. strain LMG 19087; 6, R. solanacearum strains LMG 2299T and LMG 2303; 7, R. eutropha strains LMG 1194, LMG
1199T and LMG 1201; 8, R. paucula strains LMG 3515 and LMG 3244T ; and 9, R. gilardii. Data for R. gilardii were taken from
Coenye et al. (1999). , Resistant ; , susceptible ; , not known. Growth is scored as: , variable ;, all strains positive; (),
weakly positive;, all strains negative.
Characteristic 1 2 3 4 5 6 7 8 9
Flagellation Polar 1 Polar 1 Polar 1 Polar 1 Polar 1 None Peritrichal Peritrichal Polar 1
Reaction to:
Colistin         
Desferrioxamine         
Viability on TSA at room
temperature
 6 d  6 d  6 d  6 d  6 d  6 d  21 d  21 d 
Growth at 42 C         
Catalase   *      
Oxidase  * *      
Alkaline phosphatase (Rosco)        † ‡
Pyrrolidonyl arylamidase         
Phenylalanine deaminase § §  §     
Urease         
Nitrate reduction         
Tween 80 hydrolysis         
Production of acid from:
-Arabinose         
-Arabitol         
Glucose         
Inositol         
Lactose         
Maltose         
Mannitol         
Sucrose         
-Xylose         
Alkalinization of :
Acetate         
Allantoin        
Citrate         
Galacturonate         
Lactate         
Maleate     ()    
Malonate         
Mucate         
Oxalate         
Tartrate         
Assimilation of :
3-Hydroxybenzoate         
Caprate         
Propionate         
Suberate         
*Negative according to Vandamme et al. (1999).
†Negative with Rosco tablets, containing nitrophenyl phosphate as the substrate. Vandamme et al. (1999) reported a positive
reaction, using API ZYM (naphthyl phosphate as the substrate). In this study, all strains tested with API ZYM were positive.
‡Tested with API ZYM.
§Phenylalanine deaminase reactions were diﬃcult to interpret (weakly positive) and very variable.
phoresed according to Pot et al. (1994) and the collected data
were interpreted as described byVauterin &Vauterin (1992).
The similarity between all pairs of electrophoresis patterns
was calculated by the Pearson product-moment correlation
coeﬃcient, expressed as a percentage.
Determination of cellular fatty acid composition. Cellular
fatty acids were extracted from cells grown for 48 h on TSA
at 37 C. The fatty acid analysis was performed at 45–210 C
by using a capillary column CP-Sil 88 (Chrompack In-
ternational) and a Delsi DI 200 chromatograph (Intersmat)
equippedwith split-splitness injection and a ﬂame-ionization
detector. The results were expressed as relative percentages




Strain LMG 19090, obtained from patient 1, was
isolated on Burkholderia cepacia selective medium
(Mast Diagnostics), containing 100 mg ticarcillin l−
and 300 U polymyxin B ml−. Testing with API 20NE
resulted initially in identiﬁcation as P. ﬂuorescens
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Table 3 Cellular fatty acid composition (mol%)
Taxon Strains 16:19cis 16:0 18:111cis 14:0
R. mannitolytica LMG 6866T, LMG 19090, LMG 19091 30–38 21–30 7–15 5–7
R. pickettii biovar Va-1 LMG 7160, LMG 7014, LMG 19084 41–42 26–28 13–15 10
R. solanacearum LMG 2299T, LMG 2303 41–42 26–33 9–13 6–10
R. eutropha LMG 1194, LMG 1199T, LMG 1201 41–46 27–30 14–18 4–6
R. paucula LMG 3515, LMG 3244T 42–44 22–23 17–20 6–7
Table 4 DNA GC content and DNA–DNA binding values of strains examined
Taxon GC content (mol%) DNA–DNA binding with DNA from (%):
1 2 3 4 5 6 7 8 9
1. R. mannitolytica LMG 6866T 662 100
2. R. mannitolytica LMG 19090 662 88 100
3. R. mannitolytica LMG 19091 662 86 100 100
4. R. pickettii biovar Va-2 LMG 5942T 640 58   100
5. R. pickettii biovar Va-2 LMG 19085 641 53 48 52 85 100
6. Ralstonia sp. LMG 19089 651 56 58 57 64 64 100
7. R. pickettii biovar Va-1 LMG 19083 641 46   57 62 66 100
8. R. pickettii biovar Va-1 LMG 19088 641 50   61 61 68 100 100
9. Ralstonia sp. LMG 19087 640 50   63 63 71 65 69 100
, Not done.
(proﬁle code 0 054 555). Strain LMG 19091, obtained
from patient 2, had been identiﬁed previously as P.
ﬂuorescens (API proﬁle code 0 045 555). Strain LMG
19092 (PSE061) was isolated in 1990 from the sputum
of a neonate during an outbreak in the paediatric
department and had been identiﬁed at that time as R.
pickettii. The combined features of biochemical
characteristics and colistin resistance indicated that
these isolates were strains of R. mannitolytica sp. nov.
(formerly Ralstonia pickettii biovar 3‘ thomasii ’)
(Clark et al., 1984; Gilligan, 1995).
The biochemical characteristics useful for the diﬀeren-
tiation of Ralstonia species are summarized in Table 2.
The three clinical R. mannitolytica strains were motile
by a single polar ﬂagellum, while motility was not
observed for the culture collection R. mannitolytica
type strain LMG 6866T. During this study, it was
observed that freshly isolated strains were very motile
and that motility decreased upon prolonged pres-
ervation and subculture. The type strain of R.
mannitolytica, LMG 6866T, was non-motile, possibly
as a consequence of prolonged preservation.
All four strains grew at 30, 37 and 42 C and were
viable for less than 6 d on TSA at room temperature.
Oxidase and catalase were positive. Theywere resistant
to desferrioxamine, O:129 and colistin. No acid was
produced from ethylene glycol. Urease, pyrrolidonyl
arylamidase (Rosco), Tween esterase and phenyl-
alanine deaminase were positive. Nitrate reduction,
indole and hydrogen sulﬁde production, alkaline
phosphatase (Rosco), arginine dihydrolase, lysine and
ornithine decarboxylases and aesculin and gelatin
hydrolysis were negative. Acid was produced oxi-
datively from glucose, -arabinose, lactose, maltose,
mannitol, -arabitol and -xylose. Alkalinization oc-
curred on minimal mineral agar with acetate, serine,
malonate, β-alanine, 4-aminobutyrate, azelate, suc-
cinate, fumarate, butyrate, formate, malate, mucate,
galacturonate, citrate, histidine and lactate, but not
with acetamide, adipate, alginate, allantoin, amyg-
dalin, -arginine, benzoate, -ornithine, maleate or
tartrate.
Testing by means of API 20NE, API 50CH and ID
32GN indicated that the strains assimilated acetate,N-
acetylglucosamine, -alanine, -arabinose, -arabitol,
4-hydroxybenzoate, 3-hydroxybutyrate, caprate, cit-
rate, fructose, galactose, gluconate, glucose, 2-keto-
gluconate, glycerol, histidine, -lactate, malate,
malonate, mannitol, -proline, propionate, serine,
suberate and -xylose, but not adipate, amygdalin, -
fucose, glycogen, inositol, itaconate, 5-ketogluconate,
maltose, mannose, melibiose, phenylacetate, rham-
nose, ribose, sucrose, salicin, -sorbitol or 3-hydroxy-
benzoate and conﬁrmed the absence of nitrate re-
duction.
Using the API ZYM system, the following enzymes
were detected: C4 esterase, C8 esterase-lipase, C14
lipase, leucine arylamidase, acidic and alkaline phos-
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Table 5 16S rDNA sequences included in this study
Taxon 16S rDNA accession no.
No. of nucleotides
sequenced Reference(s)
[P.] syzygii AB021403 1513 –
[P.] syzygii LMG 10661T AJ270252 469 This study
[P.] syzygii LMG 6970 AJ270253 464 This study
[P.] syzygii LMG 10662 AJ270254 463 This study
[P.] syzygii LMG 6969 AJ270255 449 This study
R. eutropha M32021 1511 –
R. gilardii AF076645 1451 Coenye et al. (1999)
R. mannitolytica LMG 19091 AJ270256 1453 This study
R. mannitolytica LMG 19090 AJ270257 1450 This study
R. mannitolytica LMG 19092 AJ271437 517 This study
R. mannitolytica LMG 6866T AJ270258 1449 This study
R. paucula AF085226 1484 Vandamme et al. (1999)
R. pickettii bv. Va-1 LMG 7160 AJ270260 1450 This study
R. pickettii bv. Va-1 LMG 19083 AB013428 441 This study, Suyama et al. (1998)
R. pickettii bv. Va-1 LMG 19088 AB013429 447 This study, Suyama et al. (1998)
R. pickettii bv. Va-1 LMG 19084 AJ270261 342 This study
R. pickettii bv. Va-1 LMG 7015 AJ249848 458 This study
R. pickettii bv. Va-1 LMG 7005 AJ270262 424 This study
R. pickettii bv. Va-1 LMG 7014 AJ270264 472 This study
R. pickettii bv. Va-1 LMG 19086 AJ270263 439 This study
R. pickettii bv. Va-1 X70348 294 Seal et al. (1993)
R. pickettii AB004790 1468 –
R. pickettii bv. Va-2 LMG 5942T AJ270265 474 This study
R. pickettii bv. Va-2 LMG 5942T S55004 970 Yabuuchi et al. (1992)
R. pickettii bv. Va-2 ATCC 27512 X67042 1417 Li et al. (1993)
R. pickettii bv. Va-2 LMG 19085 AJ270266 450 This study
R. pickettii bv. Va-2 X70349 294 Seal et al. (1993)
R. solanacearum X67036 1434 Li et al. (1993)
Ralstonia sp. LMG 19089 AJ270259 1455 This study, Suyama et al. (1998)
Ralstonia sp. LMG 19087 AB01438 447 This study, Suyama et al. (1998)
CDC group IVc-2 strain AF098288 1495 Moissenet et al. (1999)
CDC group IVc-2 strain AF067657 1527 Osterhout et al. (1998)
Alcaligenes faecalis M22508 1475 Dewhirst et al. (1989)
Brevundimonas diminuta M59064 1445 –
Burkholderia andropogonis X67037 1435 Li et al. (1993)
Burkholderia caryophylli X67039 1420 Li et al. (1993)
Burkholderia cepacia M22518 1473 Dewhirst et al. (1989)
Burkholderia gladioli X67038 1434 Li et al. (1993)
Burkholderia mallei S55008 378 Yabuuchi et al. (1992)
Burkholderia mallei S55000 962 Yabuuchi et al. (1992)
Comamonas testosteroni M11224 1563 Yang et al. (1985)
Pseudomonas aeruginosa X06684 1537 Toschka et al. (1988)
bv., Biovar.
phatase and phosphoamidase. Valine arylamidase,
cystine arylamidase, trypsin, α-chymotrypsin, α- and
β-galactosidase, β-glucuronidase,α- and β-glucosidase,
N-acetyl-β-glucosaminidase, α-mannosidase and α-
fucosidase were not detected.
Cellular fatty acid composition
The cellular fatty acid composition was determined for
R. mannitolytica strains LMG 6866T, LMG 19090 and
LMG 19091. Table 3 presents the data in comparison
with those obtained for other Ralstonia species. The
principal components for the R. mannitolytica strains
were 16:1cis (range 30–36 mol%) and 16:0 (range
21–30 mol%), with 7–15 mol% of 18:1cis and 5–7
mol% of 14:0.
DNA GC content
The DNA GC content for all three R. mannitolytica
strains tested was 662 mol% (Table 4), which was
higher than the values obtained for the fourR. pickettii
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Fig. 1. Unweighted pair group method with averages (UPGMA) cluster analysis of the 16S rDNA sequences. Accession
numbers indicated with asterisks refer to sequences determined in this study. The allocation of strains to either R.
pickettii biovar Va-1 or Va-2 was done by testing acid production from maltose and lactose using OF medium: both
positive for R. pickettii biovar Va-1 and both negative for R. pickettii biovar Va-2 (Pickett, 1994).
strains (640–641%) and for the two unnamed
Ralstonia strains (640 and 651%).
16S rDNA sequence determination and total DNA
homology
The 16S rDNA sequences included in the analysis are
listed in Table 5. The 16S rDNA sequences of the three
clinical strains LMG 19090, LMG 19091 and LMG
19092 were identical and clustered at more than 995%
sequence similarity with the R. mannitolytica type
strain, LMG6866T (Fig. 1).DNA–DNAhybridization
conﬁrmed that these three strains belonged to the same
species (Table 4).
Closest to this group, with a 16S rDNA sequence
similarity of more than 99%, was strain LMG 19089
(MC5), which was originally isolated from a brown
lowland soil (pH 60) near the sandy bank of the Kinu
river, Hama, Mitsukaido-Shi, Ibaraki Prefecture,
Japan, and which was found to degrade poly(hexa-
methylene carbonate) and poly(ε-caprolactone) and to
accumulate poly(3-hydroxybutyrate) granules inside
the cells (Suyama et al., 1998). However, the level of
DNA–DNA hybridization with three R. mannitolytica
strains was only 56–58% (Table 4), so it can be
concluded that this strain probably belongs to a
separate, as-yet unclassiﬁed species.
The R. solanacearum 16S rDNA sequence (GenBank
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100908070
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R. pickettii biovar Va-1 LMG 19089
Ralstonia sp. LMG 19089
R. pickettii biovar Va-1 LMG 7005
R. pickettii LMG 7001
R. pickettii LMG 7002
R. pickettii biovar Va-2 LMG 5942T
R. pickettii biovar Va-2 LMG 7145
R. mannitolytica LMG 19090
R. mannitolytica LMG 19092
R. mannitolytica LMG 6866T
R. mannitolytica LMG 19091
R. gilardii LMG 5886T
R. eutropha LMG 1199
R. paucula LMG 3244T
R. pickettii biovar Va-2 LMG 19085
R. solanacearum LMG 2299T
R. basilensis LMG 18990T
Molecular mass (kDa)
.................................................................................................................................................................................................................................................................................................................
Fig. 2. Digitized representation of normalized SDS-PAGE protein proﬁles of different Ralstonia species and a dendrogram
derived from the UPGMA linkage of correlation coefﬁcients between the SDS-PAGE protein proﬁles of the strains
studied. The zones indicated by arrowheads corresponding to molecular masses of approximately 60 and 80 kDa were
omitted from the clustering.
accession no. X67036) clustered at more than 99%
similarity with the sequences obtained for the [P.]
syzygii strains LMG 6969, LMG 6970, LMG 10661T
and LMG 10662 (Fig. 1). LMG 19089 and the R.
mannitolytica strains clustered with R. solana-
cearum[P.] syzygii at less than 98% rDNA sequence
similarity. The 16S rDNA sequences for the R.
pickettii biovar Va-1 and Va-2 strains clustered
at 96% similarity versus the LMG 19089–R.
mannitolytica–R. solanacearum[P.] syzygii cluster.
The sequences of R. paucula, R. gilardii and Ralstonia
eutropha strains apparently formed a separate cluster
at a similarity of less than 96% to R. pickettii, R.
solanacearum[P.] syzygii, strain LMG 19089 and R.
mannitolytica. The available 16S rDNA sequences of
Ralstonia group CDC IVc-2 strains [GenBank ac-
cession nos AF098288 (Moissenet et al., 1999) and
AF067657 (Osterhout et al., 1998)] were found to be
100% identical to that of a R. paucula strain
(Vandamme et al., 1999; GenBank accession no.
AF085226). Sequence determination of the 5 end of
the 16S rDNA revealed that the three R. pickettii
strains found to produce no acid from maltose and
lactose (i.e. R. pickettii biovar Va-2 strains) diﬀered
from the eight maltose and lactose acidiﬁcation-
positive R. pickettii strains (i.e. R. pickettii biovar Va-
1 strains) at two positions. At Escherichia coli position
259, the A observed for R. pickettii biovar Va-2 is
replaced by G for R. pickettii biovar Va-1. The other
transition is at E. coli position 269, at which the T in
the 16S rDNA sequence of R. pickettii biovar Va-2 is
replaced by an A in R. pickettii biovar Va-1. The
diﬀerences in biochemistry and 16S rDNA sequence
are corroborated by the DNA–DNA hybridization
data, since the two Japanese soil isolates (LMG 19083
and LMG 19088), which were identiﬁed as R. pickettii
biovar Va-1 according to 16S rDNA sequence and
biochemical characteristics, showed only 57–62%
DNA relatedness to the two R. pickettii biovar Va-2
strains included in the DNA–DNA hybridization
studies (Table 4).
PAGE of cell proteins
SDS-PAGE largely conﬁrmed the 16S rDNA sequence
and the DNA–DNA hybridization data. Strains LMG
6866T, LMG 19090 and LMG 19091 belonged to a
cluster with internal similarity of more than 80%, well
separated from all other reference and non-reference
strains. This grouping was only obtained when two
small zones at 60 kDa (
1 kDa) and 80 kDa
(
1 kDa), which contained a heavy protein band in
the patterns of strains LMG 19090 and LMG 19091,
were excluded from the similarity calculations (Fig. 2).
DISCUSSION
Clinical relevance of R. mannitolytica
A limited number of cases of hospital outbreaks
with ‘Pseudomonas thomasii ’ and R. pickettii biovar
3‘ thomasii ’ isolates have been reported in the litera-
ture (Baird et al., 1976; Phillips et al., 1972; Dowsett,
1972; Pan et al., 1992). The ﬁrst report (Phillips et al.,
1972) dealt with bacteraemia and bacteriuria in 25
patients due to the administration of parenteral ﬂuids
prepared at the hospital pharmacy, where deionized
water contaminated with ‘P. thomasii ’ had been used
(Phillips et al., 1972; Phillips &Eykyn, 1972). Pan et al.
(1992) reported that 23 of 39 R. pickettii isolates from
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an epidemic involving 24 patients that was caused by
contaminated saline solution (prepared by the hospital
pharmacy) belonged to ‘P. thomasii ’.
The clinical importance of R. mannitolytica may have
been overlooked, possibly due to misidentiﬁcation as
P. ﬂuorescens, which does not lead to further investi-
gation since this organism is usually considered to be a
contaminant. Indeed, after strain LMG19090, initially
identiﬁed asP. ﬂuorescens (API proﬁle code 0 054 555),
had been recognized as R. mannitolytica because of
colistin resistance and further biochemical testing, we
studied retrospectively the only other strain (LMG
19091) in the GUH collection that had been stored as
P. ﬂuorescens (API proﬁle code 0 045 555) and could
identify it also as R. mannitolytica. Thus, micro-
biologists should consider the possibility of an identi-
ﬁcation as R. mannitolytica for colistin-resistant P.
ﬂuorescens isolates. Strain LMG 19092 belonged to a
collection of strains that had been catalogued pre-
viously as belonging to an R. pickettii outbreak at the
GUH in 1990 and thus adds to the number of
nosocomial outbreaks caused by R. mannitolytica.
Differentiation of R. mannitolytica at the species and
genus level
The distinctiveness of R. mannitolytica and R. pickettii
biovar Va-1 and biovar Va-2 has been recognized
previously. Although the study of King et al. (1979)
was not conclusive and failed to establish ‘P. thomasii ’
as a valid species, Costas et al. (1990) concluded that
SDS-PAGE of whole-cell proteins provided clear
evidence that R. pickettii and ‘P. thomasii ’ were
separate taxa, a ﬁnding conﬁrmed by this study. On
the other hand, Pan et al. (1992) reported that HPLC
analysis of cell wall fatty acids could not distinguish
R. pickettii biovar Va-1 from R. pickettii biovar
3‘ thomasii ’, ﬁndings also conﬁrmed by this study.
Several clear phenotypic diﬀerences exist between R.
mannitolytica and the other Ralstonia species. R.
mannitolytica can be diﬀerentiated from the other
Ralstonia species, except forRalstonia sp. strains LMG
19089 (RAL04MC5) and LMG 19087 (RAL07
YL13), through its assimilationacidiﬁcation of man-
nitol and -arabitol. R. mannitolytica strains diﬀer
from R. pickettii and R. solanacearum by their re-
sistance towards desferrioxamine and fromR. pickettii
because of their lack of alkalinization of tartrate and of
nitrate reductase. The R. pickettii biovars Va-1 and
Va-2 diﬀer from each other by the lack of acid
production from maltose and lactose for R. pickettii
biovar Va-2 strains. TheR. solanacearum strains tested
could be diﬀerentiated from other species by
acidiﬁcationassimilation of inositol and sucrose and
lack of pyrrolidonyl arylamidase and of assimilation
of caprate, malonate, propionate, suberate, acetate
and lactate. R. eutropha strains were positive for
alkaline phosphatase (Rosco) and assimilation of 3-
hydroxybenzoate but did not alkalinize mucate, in
contrast to the other Ralstonia species. R. paucula
strains diﬀered from R. eutropha and R. gilardii by
strong urease production and from R. eutropha (no
data available for R. gilardii) by alkalinization of
mucate but not of adipate and allantoin. Strains of R.
mannitolytica were previously reported to be adonitol
and ethanol acidiﬁcation-negative, like the R. pickettii
biovars Va-1 and Va-2, and cellobiose-positive, like R.
pickettii biovar Va-1 (Pickett, 1994).
Yabuuchi et al. (1995) pointed to the diﬃculty of
establishing reliable features to diﬀerentiate Ralstonia
from Burkholderia at the generic level and stated that
the three Ralstonia species (R. pickettii, R. eutropha
and R. solanacearum) did not assimilate the carbo-
hydrates galactose, mannitol, mannose or sorbitol,
while the 11 Burkholderia species did. However, R.
mannitolytica also assimilates and acidiﬁes mannitol.
As a consequence, diﬀerentiation between R.
mannitolytica and B. cepacia genomovar II strains,
which do not decarboxylate lysine or acidify sucrose
(Vandamme et al., 1997), is diﬃcult, since R.
mannitolytica and B. cepacia both produce acid from
the same carbohydrates (with the exception of sucrose:
87% of B. cepacia strains are positive, whereas R.
mannitolytica strains are negative) and since R.
mannitolytica strains are unable to reduce nitrates,
with B. cepacia strains unable to reduce nitrate to
molecular nitrogen andwith one-third of theB. cepacia
strains reducing nitrate only to nitrite. Diﬀerentiation
is only possible by means of a positive pyrrolidonyl
arylamidase test for R. mannitolytica. Furthermore, in
the routine clinical laboratory,R.mannitolytica can be
diﬀerentiated from P. ﬂuorescens and Pseudomonas
aeruginosa by a negative pyoverdin test and from P.
ﬂuorescens by its inability to grow on Salmonella
Shigella agar and by a negative arginine dihydrolase
test.
The Japanese environmental isolates LMG 19087 and
LMG 19089 were phenotypically indistinguishable
from each other, but according to 16S rDNA sequence
and DNA–DNA hybridization studies they belong to
two separate, as-yet undescribed Ralstonia species.
LMG 19089 clusters most closely to R. mannitolytica
according to its partially determined 16S rDNA
sequence. In SDS-PAGE, it clusters close toR. pickettii
biovar Va-1. Both strains can be diﬀerentiated fromR.
mannitolytica only by their ability to reduce nitrate and
LMG 19087 also by lack of growth at 42 C. LMG
19087 falls within the R. pickettii biovar Va-1 cluster
according to its 16S rDNA sequence.
The Japanese environmental isolates LMG 19083 and
LMG 19088 could be identiﬁed biochemically and
according to 16S rDNA sequence and SDS-PAGE
proﬁle as genuine R. pickettii biovar Va-1 strains.
R. pickettii biovars Va-1 and Va-2 are easily dis-
tinguishable biochemically and some unambiguous
16S rDNA sequence diﬀerences are present, as shown
in this study. DNA–DNAhybridization, as carried out
here, separates the two representatives of each group
tested, although Pickett & Greenwood (1980) found
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84% DNA homology between a Va-1 strain and the
type strain ofR. pickettii (which is a Va-2 group strain)
and Ralston et al. (1973) found 90% binding at 71 C
between Va-1 and Va-2 strains. In the SDS-PAGE
clustering of whole-cell proteins, theR. pickettii strains
seem somewhat heterogeneous, without clear-cut de-
lineation between biovar Va-1 and biovar Va-2 strains.
Comparative 16S rDNA sequence analysis indicates
that two sublineages may be discriminated within the
genus Ralstonia, with the R. eutropha lineage on the
one hand, which is composed of R. eutropha, R.
paucula and R. gilardii, and the R. pickettii lineage on
the other hand, with R. pickettii, R. solanacearum, R.
mannitolytica and [P.] syzygii. This genotypic dis-
crimination is supported by at least some phenotypic
diﬀerences. Members of the R. eutropha lineage are
colistin susceptible, do not produce acids from carbo-
hydrates, assimilate oxalate but not galacturonate and
have peritrichous ﬂagella in contrast tomembers of the
R. pickettii lineage, which are colistin resistant, have a
polar ﬂagellum and have biochemical characteristics
distinct from those mentioned for the R. eutropha
lineage. They also diﬀer in viability on TSA at room
temperature, with viability of at most 6 d for the R.
pickettii lineage and at least 21 d for the R. eutropha
lineage. Incomplete data are available for R. gilardii,
which belongs to the R. eutropha lineage according to
16S rDNA sequence analysis, although it was reported
to be monotrichous (Coenye et al., 1999). Further
studies, also including R. gilardii and R. basilensis, will
indicate whether these ﬁndings can be conﬁrmed.
Description of Ralstonia mannitolytica sp. nov.
Ralstonia mannitolytica (man.ni.toly.ti.ca. N.L. adj.
mannitolytica cleaving mannitol).
The species accommodates the Ralstonia pickettii
biovar 3‘ thomasii ’ strains and at least some of the
strains known as ‘Pseudomonas thomasii ’. Cells are
Gram-negative, non-sporulating rods that are motile
by means of one polar ﬂagellum (motility was not
observed for the culture collection R. mannitolytica
type strain, LMG 6866T). Aerobic growth is observed
at 30, 37 and 42 C and strains are viable for less than
6 d onTSA at room temperature. Catalase and oxidase
tests are positive. Nitrate and nitrite are not reduced.
Strains are resistant to desferrioxamine, O:129 and
colistin. No acid is produced from ethylene glycol.
Urease, pyrrolidonyl arylamidase (Rosco), Tween
esterase and phenylalanine deaminase tests are posi-
tive. Indole and hydrogen sulﬁde production, alkaline
phosphatase (Rosco), arginine dihydrolase, lysine and
ornithine decarboxylases, aesculin and gelatin hydro-
lysis tests are negative. Acid is produced oxidatively
from glucose, -arabinose, lactose, maltose, mannitol,
-arabitol and -xylose. Alkalinization occurs on
minimal mineral agar with acetate, serine, malonate,
β-alanine, 4-aminobutyrate, azelate, succinate,
fumarate, butyrate, formate, malate, mucate, galactu-
ronate, citrate, histidine and lactate, but not with
acetamide, adipate, alginate, allantoin, amygdalin, -
arginine, benzoate, -ornithine, maleate or tartrate.
Testing by means of API 20NE, API 50CH and ID
32GN indicates that the strains assimilate acetate, N-
acetylglucosamine, -alanine, -arabinose, -arabitol,
4-hydroxybenzoate, 3-hydroxybutyrate, caprate, cit-
rate, fructose, galactose, gluconate, glucose, 2-
ketogluconate, glycerol, histidine, -lactate, malate,
malonate, mannitol, -proline, propionate, serine,
suberate and -xylose, but not adipate, amygdalin, -
fucose, glycogen, inositol, itaconate, 5-ketogluconate,
maltose, mannose, melibiose, phenylacetate, rham-
nose, ribose, sucrose, salicin, -sorbitol or 3-
hydroxybenzoate. Using the API ZYM system, the
following enzymes are detected: C4 esterase, C8
esterase-lipase, C14 lipase, leucine arylamidase, acidic
and alkaline phosphatase and phosphoamidase. Valine
arylamidase, cystine arylamidase, trypsin, α-chymo-
trypsin, α- and β-galactosidase, β-glucuronidase, α-
and β-glucosidase, N-acetyl-β-glucosaminidase, α-
mannosidase and α-fucosidase are not detected. The
following cellular fatty acid components are present :
16:1cis (range 30–38 mol%), 16:0 (21–30 mol%),
18:1cis (7–15 mol%) and 14:0 (5–7 mol%). The
DNA GC content is 662 mol%.
The type strain is LMG 6866T (deposited as
‘Pseudomonas thomasii ’ in 1972) (NCIB 10805T)
(Phillips et al., 1972). TheR.mannitolytica strains used
in this study have been deposited in the BCCMLMG
Bacteria Collection (Laboratorium voor Micro-
biologie Ghent, Belgium) as LMG 19090, LMG 19091
and LMG 19092.
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Two clinical cases of infection with Ralstonia mannitolilytica are described: a recurrent meningitis on an
implanted intraventricular catheter and an infected hemoperitoneum as a complication of a cholangiocarci-
noma. The strains were ﬁrst misidentiﬁed as Pseudomonas ﬂuorescens and Burkholderia cepacia. Further testing
lead to the identiﬁcation as Ralstonia pickettii biovar 3/“thomasii,” which was recently shown to represent a
separate species, R. mannitolilytica (List editor N. Weiss, Int. J. Syst. Evol. Microbiol. 51:795–796, 2001),
originally described as R. mannitolytica (De Baere et al., Int. J. Syst. Evol. Microbiol. 51:547–558, 2001). R.
mannitolilytica can be distinguished from all described Ralstonia species by its acidiﬁcation of D-arabitol and
mannitol and by its lack of nitrate reduction and of alkalinization of tartrate. In order to determine the true
prevalence of infections with this species, colistin-resistant “P. ﬂuorescens” strains and strains growing on B.
cepacia selective medium deserve further attention.
CASE REPORTS
Case report 1. In 1997, a Caucasian woman, 38 years old,
presented with fever of unknown origin. At the age of 17 she
had received a ventriculoatrial draining for hydrocephalia after
an intracerebral hematoma. Twenty years later, after a local-
ized epileptic insult, further neurological testing and imaging
pointed to a diagnosis of cavernous hemangiomas, for which
she was treated surgically. The nonfunctional ventricular drain
was partially removed, leaving the intrathoracic part in place.
Postoperatively, the patient developed meningitis. Culture re-
mained negative, and the patient was treated with 2 g of ceftri-
axone intravenously (i.v.) twice daily during 2 weeks. Two days
after antibiotic therapy was stopped, the meningitis recurred.
Culture of the liquor yielded a gram-negative bacillus that
could grow on Burkholderia cepacia selective medium (Mast
Diagnostics, Merseyside, United Kingdom) and therefore was
ﬁrst identiﬁed as B. cepacia. The same organism was cultured
from the removed intracerebral catheter segment. Ceftriaxone
(2 g i.v. twice per day) was started, and ciproﬂoxacin (400 mg
i.v. thrice per day) was added. Fever subsided and liquor cul-
tures remained negative.
In February 1998, the patient presented in a private hospital
with a generalized epileptic insult and high fever (39.5°C) and
was treated with amoxicillin and clavulanic acid. The fever
subsided, and the single blood culture, positive for “Pseudo-
monas ﬂuorescens,” was considered contaminated. From
March 1998 onwards, the patient had repeatedly febrile epi-
sodes and lost 10 kg of weight. Blood cultures were not per-
formed. In November 1998, the patient was admitted in the
same private hospital for high fever and tonic-clonic insults.
Seven blood cultures were found positive for “P. ﬂuorescens,”
and the patient was referred to the Ghent University Hospital
for removal of the endovascular catheter segment. Cultures of
the removed catheter were positive and were identiﬁed as
Ralstonia pickettii biovar 3/“thomasii.” Retrospectively, it was
shown that this was also the correct identiﬁcation for the “P.
ﬂuorescens” isolates that had been obtained from the private
hospital. The strain was resistant to ampicillin, gentamicin,
temocillin, and aztreonam but was susceptible to cotrimox-
azole, piperacilin, cefuroxime, cefotaxime, ceftazidime, imi-
penem, and quinolones. The patient was treated, according to
the susceptibility testing results, with cotrimoxazole and doxy-
cycline. Since then, the patient has been doing well.
Case report 2. In December 1997, primary cholangiocarci-
noma with extensive hepatic involvement was diagnosed in a
32-year-old woman. Chemotherapy with cis-platinum and
5-ﬂuoroacil was started with good clinical response and im-
provement of the hepatic lesions. Six months later, the patient
was seen in the surgery department for partial resection of the
liver in order to reduce the tumor mass and to improve the
effect of chemotherapy. One week after the resection, comput-
erized axial tomography (CAT) scanning revealed that the
Kehr drain was leaking into the abdomen. A hemoperitoneum
was diagnosed, and a review of the abdomen revealed bleeding
of the right vena subhepatica. Intraoperatively, a specimen was
taken from the hematoma for culture. After enrichment in
thioglycolate broth, Enterococcus sp. and a gram-negative non-
fermenting bacillus were isolated. Three days after review, the
patient developed fever with peaks up to 39°C and antibio-
therapy with cefuroxime was started. Abdominal drainage ﬂuid
culture yielded the same gram-negative nonfermenter. This
strain was resistant to ampicillin, gentamicin, colimycin, and
temocillin but susceptible to cotrimoxazole, cefuroxime, and
quinolones. Despite cefuroxime treatment, fever persisted and
metronidazole was added. A CAT scan of the abdomen
showed an excessive amount of free abdominal ﬂuid. One week
later, small numbers of the nonfermenter and of Enterococcus
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sp. could still be isolated from the abdominal drainage ﬂuid.
Antibiotherapy was switched to piperacillin and tazobactam,
and a new abdominal drain was placed. As the patient re-
mained febrile, drug fever was suspected and antibiotics were
stopped. A subsequent ﬂuid specimen again grew Enterococcus
sp. and a gram-negative, nonfermenting bacillus, later identi-
ﬁed as R. mannitolilytica. The patient’s condition improved
very slowly, and ﬁnally the patient was discharged from the
hospital knowing that new intrahepatic lesions were detected
on CAT scan.
Strain LMG 19090, obtained from patient 1, was isolated on
conventional media and could grow on Burkholderia cepacia
selective medium, containing 100 mg of ticarcillin/liter and 300
U of polymyxin B/ml. API 20NE (BioMe´rieux, Marcy l’Etoile,
France) testing identiﬁed the strain as P. ﬂuorescens (proﬁle
code 0 054 555). Because of colistin resistance, this strain was
studied in more detail (3, 7, 13, 14), which led to an identiﬁ-
cation as R. pickettii biovar 3/“thomasii.”
The further data gathered by means of polyphasic taxonomy
led to the description of this biovar as a separate species,
named R. mannitolilytica, referring to its characteristic acidiﬁ-
cation of mannitol, unlike all other described Ralstonia species
(5). The original spelling of the speciﬁc epithet “mannitolytica”
(5) was corrected to “mannitolilytica” (8).
In retrospect, strain LMG 19091 from patient 2, which had
been identiﬁed previously as P. ﬂuorescens (API 20NE proﬁle
code 0 045 555), and strain LMG 6866T, isolated at St.
Thomas’ Hospital (London, United Kingdom) during an out-
break and deposited as “Pseudomonas thomasii” in 1972
(NCIB 10805) (11, 12), could both be identiﬁed as R. manni-
tolilytica.
The GC content for all three R. mannitolilytica strains
tested was 66.2 mol%, which is higher than the values for R.
pickettii (64.0 to 64.1%) (5). The 16S rDNA sequences of the
clinical strains (GenBank accession numbers AJ270256 and
AJ270257) were identical and clustered at more than 99.5%
sequence similarity with the R. mannitolilytica type strain LMG
6866T (GenBank accession number AJ270258) (5). The 16S
rDNA sequences for the R. pickettii biovar Va-1 and Va-2
strains clustered at 96% similarity versus R. mannitolilytica.
DNA hybridization conﬁrmed that the two clinical strains and
the type strain belonged to a separate species (5). When tRNA
PCR was performed (1, 9), all three strains had a PCR frag-
ment of 108.4 bp (standard deviation, 0.06 bp), in combination
with one or two other variably present fragments. The obtained
tRNA PCR ﬁngerprints were sufﬁciently discriminative for us
to recognize each strain as being R. mannitolilytica.
The two clinical R. mannitolilytica strains were motile by a
single polar ﬂagellum, while motility was not observed for the
culture collection R. mannitolilytica type strain LMG 6866T. It
was observed that freshly isolated strains were very motile and
that motility decreased upon prolonged preservation and sub-
culture, which could explain the nonmotility of the type strain.
All three strains grew at 30, 37, and 42°C and were viable for
less than 6 days on tryptic soy agar (Becton Dickinson, Cock-
eysville, Md.) at 25°C. Oxidase and catalase were positive.
They were resistant to desferrioxamine, O:129, and colistin. No
acid was produced from ethylene glycol. Urease, pyrrolidonyl
arylamidase (Rosco, Taastrup, Denmark), Tween esterase, and
phenylalanine deaminase were positive. Acid was oxidatively
produced from glucose, L-arabinose, lactose, maltose, manni-
tol, D-arabitol, and D-xylose. Alkalinization occurred on mini-
mal mineral agar with acetate, serine, malonate, -alanine,
4-aminobutyrate, azelate, succinate, fumarate, butyrate, for-
mate, malate, mucate, galacturonate, citrate, histidine, and
lactate but not with acetamide, adipate, alginate, allantoin,
amygdalin, L-arginine, benzoate, L-ornithine, maleate, and tar-
trate (5).
In the routine clinical laboratory, R. mannitolilytica can be
differentiated from P. ﬂuorescens and Pseudomonas aeruginosa
by a negative pyoverdin test, by its inability to grow on salmo-
nella-shigella agar, and by a negative arginine dihydrolase test
(Table 1). Growth on B. cepacia selective medium pointed to
an identiﬁcation as B. cepacia. Differentiation from B. cepacia,
especially from the genomovar II strains (i.e., Burkholderia
multivorans), which do not decarboxylate lysine or acidify su-













Reduction of nitrate     /  V 
Reduction of nitrite    /    
Colistin susceptibility R R R S S S R R
Desferrioxamine susceptibility R S S R R R R/S S
Acidiﬁcation of sucrose     V  / 
Acidiﬁcation of mannitol    V V V  
Acidiﬁcation of D-arabitol     ND ND ND ND
Pyrrolidone peptidase    V V   
Trypsinb        
Arginine dihydrolase        
Lysine decarboxylase       / V
Alkalinization of tartrate    ND ND ND ND ND
Pyoverdin production    /    
Growth on salmonella-shigella agar    /    ND
a ND, not done; /, majority of strains positive; /, majority of strains negative; R, resistant; S, susceptible, and V, variable.
b Trypsin  benzyl arginine arylamidase.
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crose (15), is difﬁcult and is only possible by means of a positive
pyrrolidonyl arylamidase test for R. mannitolilytica.
Finally, several clear phenotypic differences exist between
R. mannitolilytica and the other Ralstonia species (Table 1). R.
mannitolilytica can be differentiated from the other described
Ralstonia species through its assimilation and acidiﬁcation of
mannitol and D-arabitol. R. mannitolilytica strains differ from
R. pickettii and Ralstonia solanacearum by their resistance to-
wards desferrioxamine and from R. pickettii because of their
lack of alkalinization of tartrate and of nitrate reductase.
Strains of R. mannitolilytica were previously reported to be
adonitol and ethanol acidiﬁcation negative, like the R. pickettii
biovars Va-1 and Va-2, and cellobiose positive, like R. pickettii
biovar Va-1 (13).
A limited number of cases of hospital outbreaks with “P.
thomasii” and R. pickettii biovar 3/“thomasii” isolates have
been reported in the literature (2, 6, 10, 11). The ﬁrst report
(12) dealt with bacteremia and bacteriuria in 25 patients due to
parenteral ﬂuids prepared with deionized water contaminated
with “P. thomasii” (11, 12). Pan et al. (10) reported that 23 of
39 R. pickettii isolates of an epidemic involving 24 patients that
was caused by contaminated saline solution (prepared by the
hospital pharmacy) belonged to “P. thomasii.” A pseudo-out-
break has been described as well (4). Although no serious
non-outbreak-related infections have been described thus far,
the clinical importance of R. mannitolilytica may have been
overlooked, possibly due to misidentiﬁcation as P. ﬂuorescens,
B. multivorans, and/or R. pickettii.
We reported two cases of infection with R. mannitolilytica,
ﬁrst identiﬁed as P. ﬂuorescens and/or B. cepacia. Colistin-
resistant “P. ﬂuorescens” isolates and strains growing on B.
cepacia selective medium should be considered to be possibly
R. mannitolilytica, a species that was formerly known as R.
pickettii biovar 3/“thomasii” and that can be differentiated from
P. ﬂuorescens by its colistin resistance and its absence of argi-
nine dihydrolase activity, from B. cepacia and B. multivorans by
its pyrrolidonyl peptidase activity, and from other Ralstonia
species by the acidiﬁcation of mannitol. Correct identiﬁcation
of this organism may be of importance, since appropriate treat-
ment was postponed in at least case 1, due to misidentiﬁcation
as P. ﬂuorescens and B. cepacia, pointing to the presence of a
contaminant and also obscuring the long-term presence of the
same bacterial organism.
We thank Leen Van Simaey and Catharine De Ganck for excellent
technical assistance.
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Case of Catheter Sepsis with Ralstonia gilardii in a Child with
Acute Lymphoblastic Leukemia
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Acute lymphoblastic leukemia was diagnosed in a 7-year-old girl. Two months after insertion of a central
venous catheter, she developed fever and complained of headache and abdominal pain. Physical examination
revealed no focus of infection. A gram-negative nonfermenting bacillus was recurrently cultured from blood.
Extensive biochemical testing and 16S ribosomal DNA sequencing led to the identiﬁcation of Ralstonia gilardii.
CASE REPORT
Acute lymphoblastic leukemia (ALL) was diagnosed in a
7-year-old girl in May 2000, and treatment was initiated ac-
cording to the EORTC-CLCG-58951 protocol for children
with very-low-risk ALL. The girl achieved hematologic remis-
sion after induction chemotherapy. A central venous catheter
was inserted in June 2000. The girl tolerated the treatment
uneventfully until September 2000, when, during a course of
chemotherapy (high-dose methotrexate), she developed spik-
ing fever as high as 40°C. She complained of headache and
abdominal pain and vomited twice. Physical examination re-
vealed no focus of infection. The leucocyte count was 5,800/ml,
with an absolute neutrophil count of 4,760/ml and elevated
C-reactive protein (87 mg/dl). The chemotherapy was stopped,
and the girl was treated with intravenous (i.v.) ampicillin (100
mg/kg of body weight/day). One day later blood cultures grew
gram-negative bacilli, and (i.v.) netromycin (7.5 mg/kg/day)
treatment was added. The spiking fever disappeared and the
girl’s health improved.
A gram-negative nonfermenting bacillus was isolated and
found to be resistant to ampicillin, piperacillin, aztreonam,
gentamicin, and tobramycin and susceptible to cefuroxime,
ceftriaxone, ceftazidime, imipenem, co-trimoxazole, oﬂoxacin,
and amikacin. The girl was treated as an outpatient with i.v.
ceftriaxone (100 mg/kg/day) once daily for 4 more days. Thirty-
six hours after the ceftriaxone treatment was stopped, she
again developed spiking fever, and i.v. ceftriaxone (100 mg/kg/
day) was restarted in combination with i.v. amikacin (15 mg/
kg/day). Again, a gram-negative nonfermenting bacillus was
cultured from blood. The girl showed an allergic reaction to
ceftriaxone with rash and pruritus, and the ceftriaxone was
replaced with i.v. ciproﬂoxacin (20 mg/kg/day). The spiking
fever disappeared again, and amikacin and ciproﬂoxacin i.v.
treatment was given for 7 more days. Blood cultures remained
negative, and the central venous catheter was not removed.
Three months later the intensive chemotherapy was completed
and the girl was doing well. The catheter was removed on
January 8 2001. No nonfermenting gram-negative bacilli were
cultured from the tip.
Discussion. The gram-negative bacillus was isolated in pure
culture from all eight FAN aerobic blood cultures and from
one of the eight BacT/Alert anaerobic cultures (Organon
Teknika, Turnhout, Belgium), collected over a period of 10
days. Initial identiﬁcation based on the API20NE system (bio-
Me´rieux, Marcy l’Etoile, France) yielded code 1000474, lead-
ing to an identiﬁcation as Alcaligenes faecalis, Comamonas
acidovorans or Comamonas testosteronii, or Pseudomonas al-
caligenes or Pseudomonas pseudoalcaligenes. However, more
elaborate biochemical testing led to the identiﬁcation of the
organism as Ralstonia gilardii. The strain in the present case
report (designated GUH 00 09 2123); another clinical isolate
of R. gilardii (UCL NF 926), isolated from a cerebrospinal ﬂuid
in 1977, without further information on clinical relevance; and
three reference strains (LMG 5886T, LMG 15537, and LMG
3400) were tested extensively. The bacteria were motile with
peritrichous ﬂagella, grew at 42°C, and were viable for more
than 15 days on tryptic soy agar (TSA) at room temperature.
Positive reactions were observed for catalase; oxidase; alkaline
phosphatase (tablets; Rosco, Taastrup, Denmark); Simmons
citrate; and alkalinization of acetate, allantoin, lactate, and
mucate on Simmons base agar. The strains were negative or
very weakly positive for pyrrolidonyl arylamidase (Rosco) and
gave a delayed positive result for alkalinization of maleate on
Simmons base agar. All ﬁve strains were susceptible to colistin
and resistant to desferrioxamine. Negative reactions were ob-
served for Tween 80 hydrolysis (read after 5 days); urease;
phenylalanine deaminase; nitrite reduction; esculin and gelatin
hydrolysis; arginine dihydrolase; ornithine decarboxylase; ly-
sine decarboxylase; hydrogen disulﬁde (H2S) and indole pro-
duction; acidiﬁcation of glucose, saccharose, maltose, manni-
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tol, arabitol, L-arabinose, inositol, lactose, and D-xylose; and
alkalinization on Simmons base agar of galacturonate.
Variable reactions were observed for alkalinization of mal-
onate, oxalate, and tartrate on Simmons base agar. Nitrate
reduction tested by conventional methods was positive only for
strains NF933 and LMG 3400, and it was additionally positive
for strain LMG 15537, when tested with the API20NE system.
Reactions on ID32GN (BioMe´rieux) were positive for utili-
zation of itaconate (n  5), suberate (n  5), acetate (n  5),
lactate (n  5), L-alanine (n  4), propionate (n  1), caprate
(n  5), valerate (n  3), citrate (n  1), histidine (n  3),
3-hydroxybutyrate (n  5), 3-hydroxybenzoate (n  5), and
proline (n  5). Reactions in the API20NE system (bio-
Me´rieux) were positive for gluconate (n  5), caprate (n  5),
and malate (n  5) and were variable for adipate (n  3) and
citrate (n  1). This biochemical proﬁle was consistent with an
identiﬁcation as R. gilardii (2, 3). It should be mentioned that
all strains were found to have multiperitrichous ﬂagella instead
of a single polar ﬂagellum as described previously (2). Table 1
summarizes the phenotypic characteristics used to differentiate
R. gilardii from other oxidase-positive, motile, asaccharolytic,
nonfermenting gram-negative rods.
Sequencing of 1,466 bp of the 16S rRNA gene was carried
out as described previously (6) for the case report strain. The
sequence obtained contained six ambiguities, which could not
be resolved upon repeated sequencing and which are probably
caused by the presence of multiple 16S rRNA operons with
slightly differing sequences. Comparison to all known se-
quences of the GenBank by using the Blast program (http:
//www.ncbi.nlm.nih.gov/blast) resulted in a 98% similarity with
two Ralstonia species strains (AF239160 and AY005039), and
a Ralstonia paucula strain (AF067657). The only R. gilardii
sequence present (LMG 5886T [AF076645]) was only fourth in
choice. This relatively low similarity could be largely explained
by the fact that the sequence of the R. gilardii type strain
(AF076645) contained 18 ambiguities. After detailed visual
analysis of the sequences, only seven true mismatches were
left, which raised the similarity to the highest observed, con-
ﬁrming the biochemical identiﬁcation.
Using primers aimed at the ampliﬁcation of tRNA inter-
genic spacer regions (1, 4, 5), no ampliﬁcation signal could be
obtained, as is the case for most Ralstonia species (unpublished
results). Therefore, tRNA-PCR appears not to be useful for
the identiﬁcation of most Ralstonia species.
R. gilardii may be of more clinical importance than is cur-
rently assumed but may have been largely overlooked due to
identiﬁcation problems and due to previously poor taxonomy.
Indeed, the original publication describing this species (2)
mentions several clinical strains that had been isolated from
cerebrospinal ﬂuid (n  2), bone marrow (n  1) and a fu-
runcle (n 1), without reference to published reports. A strain
isolated from cerebrospinal ﬂuid back in 1977 was present in
our collection, and a new case of R. gilardii sepsis is reported
here.
In summary, a gram-negative motile, nonfermenting, asac-
charolytic bacillus with a positive oxidase and alkaline
posphatase reaction that is susceptible to colistin can be sus-
pected to be R. gilardii and should warrant further identiﬁca-
tion, especially among the nonsaccharolytic nonfermenters.
Nucleotide sequence accession number. The sequence ob-
tained for the present strain has been assigned GenBank ac-
cession no. AJ306571.
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Flagellation Peritrichous Peritrichous Peritrichous Peritrichous Peritrichous Peritrichous Polar, tuft Polar, tuft Polar, single
Reduction of:
Nitrate V        
Nitrite         
Susceptibility to:
Colistin (10–g disk) S S S S S S S S R
Desferrioxamine R R R S R R R S S
Production of:
Pyrrolidone peptidase /w       / /
Alkaline phosphatase
(Rosco)
/w        
Urea hydrolysis         
a Symbols:, positive;, negative;/, majority of strains negative;w, weak reaction;/w, negative or weakly positive. Abbreviations: V, variable; S, susceptible;
R, resistant.
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VII. General discussion. 
1. The introduction of DNA-fingerprinting techniques in a routine clinical microbiology
laboratory.
Culture is  - still – irreplaceable in the bacteriology and mycology laboratory because of its 
easiness for detection and because cultured microorganisms are still needed for antibiotic
(antifungal) susceptibility testing (Vaneechoutte and Van Eldere, 1997).
This was the starting consideration to develop molecular techniques for the identification of 
cultured bacteria and fungi. Because applicability of these techniques in a routine clinical 
laboratory was an essential part of the aim, the PCR assays must be aimed at whatever 
organism present in the sample, but the number of primer sets should be kept minimal. This 
necessitates the use of broad-range or universal amplifications. 
To identify organisms, variability between different species must be obtained, which can be 
done by fingerprinting PCR, resulting in fragment combinations obtained directly after PCR 
or after post-amplification manipulation.
Three different techniques were introduced or updated and evaluated. 
The first technique used was ARDRA, which has the 16S rRNA gene as the universally 
present target (Wilson et al., 1990) containing enough variability for discrimination between 
most bacterial species. Moreover, this gene is the basis for current phylogeny studies (Woese,
1987), so that the classification obtained by ARDRA could be correlated with the current 
taxonomy.
ARDRA was applicated for the species identification of mycobacteria.
This technique was already in use in our laboratory (Vaneechoutte et al., 1993), but the 
changes in culture devices required an update and re-evaluation of the technique. The liquid 
culture systems (Bactec (BD) and MB/BacT (Organon Teknika) are faster than solid culture 
(Löwenstein-Jensen) but contain more often contaminating growth, or contaminating bacterial 
DNA. Choosing a new primer pair more specific for the members of the genus 
Mycobacterium solved the problem of culture contamination with non-mycobacterial DNA. 
Furthermore, a simplified and more efficient DNA-extraction method was developed, the 
number of species was increased and a complete overview of all possible ARDRA patterns 
that can be encountered for Mycobacterium species was constructed, based on computer
assisted restriction digestion of published 16S rRNA gene sequences. 
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A three-year evaluation indicated that all except three isolates could be correctly identified 
solely by this technique in an average time of 36 hours. The three isolates that could not be 
identified directly gave a fingerprint not present in the database. After identification of those 
isolates by other means (e.g. 16S rRNA sequencing), a species name could be linked to the 
unknown fingerprint, enabling identification of future isolates presenting this same
fingerprint.
The experience with ARDRA for mycobacteria illustrates how the possibility to expand and 
adopt a library to new findings and/or taxonomic developments without redesigning the 
technology is a major advantage of DNA-fingerprinting techniques in general. 
tRNA-PCR is a more broad-ranged PCR, proposed already 10 years ago as a universal 
fingerprinting PCR (Welsh and McClelland, 1991). The primers are a consensus, 
complementary to the edges of over 500 known tRNA gene sequences which are highly 
conserved in the bacterial world.
The major problem for using tRNA-PCR for routine identification is the interpretation of the 
obtained fingerprints. Analysis of the amplification products on a capillary electrophoresis 
system (Vaneechoutte et al., 1998) results in digital fingerprints, which are also very precise 
(up to one base pair differences can be detected). A software program (BaseHopper) 
especially designed for this purpose (Ir. Paul Baele, University Ghent), enables to correlate 
the fingerprint of an unknown isolate to a library of fingerprints obtained for reference strains. 
Digitalizing fingerprints results also in exchangeability of the obtained data, and evaluation of 
the interlaboratory reproducibility indicated that using the same capillary electrophoresis 
systems (ABI Prism 310) and analysis parameters, the data and libraries are exchangeable
(Baele et al., 2001). 
The application is very successful for a majority of genera: Staphylococcus (Maes et al.,
1997); Listeria (Vaneechoutte et al., 1998); Enterococcus (Baele et al., 2000); Streptococcus
(Baele et al., 2001) and Lactobacillus (Baele et al., 2002). However for certain genera (e.g. 
Ralstonia, Corynebacterium) the fingerprints consist sometimes of only one or a few bands.
Our major attempt was to construct a library containing all possible clinical species. 
Unpublished preliminary data show that identification of routine clinical isolates is promising.
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For a total of 313 isolates, identification both with the routine biochemical testing and with 
tRNA-PCR was carried out. 224 identifications (71.6%) were found in agreement. For 19 
isolates (6%) the routine methods were found to be correct or more discriminatory, and in 70 
cases (22%) tRNA-PCR was better than routine methods with regard to correctness and 
discriminatory power, e.g. because it could identify Enterococcus, Staphylococcus and
Streptococcus sp. and non-fermenting Gram negatives rapidly to the species level
(unpublished data). 
Current problems of identification with tRNA-PCR are frequently caused by insufficiencies of 
the library (missing the species fingerprint of the unknown) or by taxonomical vagueness. 
Besides the bacteria also yeast and molds are clinical isolates, which can be identified by 
DNA-fingerprinting techniques. The technique published by Turenne  (Turenne et al., 1999) 
was adapted to our current settings. We expanded the library of Turenne, adapted it to the 
usage of dTTP in stead of dUTP, and especially we developed a simple and very fast 
boiling/freezing DNA-extraction, and showed that it can replace the very laborious and time-
consuming DNA-extraction methods generally used for yeasts. 
Labeling the ITS2-PCR forward primer with another fluorescent dye than the tRNA-PCR 
forward primer enabled us to analyze fingerprints of a bacterial species and a fungal species at 
the same time. The current setting can maximally identify 36 bacterial and 36 fungal isolates 
during one day with still one fluorescent dye not used; so another 36 organism can be 
identified. The capacity of multiple capillary devices (e.g. ABI Prism 3100 (Applied 
Biosystems), SEQ 8000 (Beckman Coulter)) already exceeds that needed in a routine 
laboratory.
2. The use of the DNA-based identification techniques, leading to newly or infrequently 
encountered species.
The developed DNA-fingerprinting techniques result mostly in rapid and precise 
identifications, and using these techniques on large numbers of isolates leads sometimes to 
unknown fingerprints. Further investigation can indicate that either the species was not 
present in the library (with the tRNA-PCR library containing at present approximately 500 
species and the ITS2-library 26 clinical important yeast species), or that we deal with a 
previously unknown species. 
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Use of ARDRA on a large collection of clinical isolates belonging to the genus Acinetobacter,
made it possible to delineate certain groups of strains presenting a unique fingerprint not yet 
seen. Extensive biochemical analysis of those strains gave characteristics indicating the
presence of a new species. For further confirmation a polyphasic approach was followed 
using for example 16S rRNA gene sequencing and DNA-DNA hybridizations, leading to the 
description of new species (Vaneechoutte et al., 1999; Nemec et al., 2001).
An important advantage of a digitized technique like tRNA-PCR is that it easily
provides an overview of the isolated species, such that frequently encountered organism can 
be noticed. The technician using only morphological and biochemical tests will not further
identify clinically infrequent isolates, or has not the test to do so and thus will miss a final
identification. The use of ARDRA led to a case report on M. interjectum, ITS2 revealed the 
presence of formerly not encountered Dekkera bruxellensis, and the use of tRNA allowed the 
description of  several species, for example: Enterococcus cecorum (De Baere et al., 2000), 
Moraxella atlantae (De Baere et al., 2002) and Leclercia adecarboxylata (De Baere et al.,
2001).
3. The advantages and disadvantages for clinical applications.
Introduction
We have tried to show how culture will remain an indispensable tool in the clinical
bacteriology laboratory, also in the distant future, if only because it will remain impossible to 
cover all the different resistance mechanisms in a genotypic manner. As such, primary
identification using selective and non-selective media will remain the start of routine
bacteriological examinations. The experience of a clinical microbiologist in deciding which 
colonies should be studied further will remain indispensable, and the primary culture medium
will continue to supply with a semi-quantitative measure of the different organisms present, 
something which will remain difficult with genotypic approaches, even with real time PCR. 
As mentioned above, also susceptibility testing will remain based on culture, if only for 
practical reasons. One can then ask whether it might be useful to replace current phenotypic
identification of the different colonies by a genotypic approach, as has been pursued for over 
a decade at our research laboratory. To answer that question, one should carefully analyse the 
different parameters used to evaluate the usefulness of routinely applicable techniques. 
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Evaluation of different parameters to compare the routine applicability of phenotypic and 
genotypic identification:
x Speed. Phenotypic identification of organisms like E. coli and P. aeruginosa is 
obtained within hours, while it can take days to weeks for anaerobic bacteria and 
nonfermenters, and often no identification can be obtained. Genotypic identification 
using tRNA-PCR takes 6 hours to one day for whatever organisms is studied. 
x Cost. Calculations have shown that the cost of tRNA-PCR and ITS2-PCR is about 2-3 
Euro, a price which is certainly competitive with phenotypic identification.
x Discriminatory power. tRNA-PCR has definitely a higher discriminatory power for 
Enterococcus, Staphylococcus, Streptococcus and Lactobacillus and performs much 
better for Gram-negative nonfermenting bacteria. Problems are encountered for the 
identification of Corynebacterium and Mycobacterium, and this might reflect the 
phylogenetic distance of this group of organisms. It should be noticed that ARDRA 
performs perfectly for Mycobacterium and Corynebacterium, and it is no major
disadvantage to need another simple genotypic technique for mycobacteria, since the 
phenotypic identification alternatives are more cumbersome and are only carried out in 
reference laboratories, and other genotypic alternatives are usually more laborious and 
expensive. Another possibility to solve this problem is the design of more universal 
tRNA-primers. The discriminatory power for Moraxella species is excellent, it is 
moderate for Acinetobacter and Pasteurellaceae and poor for Neisseria. Another 
problem is the impossibility for reliable differentiation between S. pneumoniae and the 
other S. mitis group species, although the problem is largely solved by the fact that S.
pneumoniae is already identified on the primary isolation plate by its optochin 
susceptibility. In general, a preliminary study of 500 routine isolates, identified with 
both phenotypic techniques and tRNA-PCR showed that the discriminatory power of 
the latter was higher. The discriminatory power of ITS2-PCR is higher than that of 
phenotypic identification. 
x Intraspecies variability. Using phenotypic techniques, one is often confronted with 
variability within a species. Apparently, this is also the case for tRNA-PCR. ITS2-
PCR shows less intraspecific variability. This has forced us to take up sometimes
several fingerprints for one species into the library. This might be a problem by 
blurring the boundaries between species, but on the other hand this ‘intraspecific 
variability’ also sometimes has been indicative for the presence of separate species 
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within one ‘species’. This was e.g. the case for Comamonas terrigena (Wauters et al.,
in press) and Enterobacter cloacae (in preparation). 
x Possibilities for automatisation. These genotypic identification techniques are 
automatizable to a large extent and one technician could identify up to 50 strains per 
day, with only 50% hands on time.
x Technical simplicity. An advantage of the genotypic approaches is that, whatever 
species is studied, the handling remains the same (briefly: DNA-extraction, PCR, 
electrophoresis, software based comparison of the obtained fingerprints with the 
library), and the manipulations can be learned within a week. To the contrary, 
phenotypic identification requires serious technical expertise, many different reagents, 
and many different decision trees, depending upon the organism one is dealing with. It 
should be noticed that, also with regard to quality control of the laboratory, one can 
envisage that it is much simpler to establish QC for a limited number of genotypic 
techniques (without the use of living material), than for a whole array of biological 
assays, requiring also standard organisms and standard culture conditions for these. 
x Interlaboratory reproduciblity. During this study it was sufficiently shown that the 
tRNA and ITS2-fingerprints obtained in one laboratory can be compared with those
obtained in another laboratory (Baele et al., 2001, De Baere et al. 2002). At several 
further occasions it was possible to identify strains for which a fingerprint was 
obtained in one laboratory, by using a library composed of fingerprints obtained at
another laboratory. Also see ‘Future prospects’ on how to increase reproducibility. 
Interlaboratory reproducibility of phenotypic techniques might be estimated to be
high, although problems may occur since each laboratory uses its own variations and 
combinations of phenotypic techniques. 
x Reliability. The obtained identifications should be reliable, i.e. no misidentifications
should be obtained, and in case an organism has not yet been encountered previously, 
no identification should be obtained. Using tRNA-PCR, the latter was the case for 
several species which we observed for the first time in our laboratory (e.g. Moraxella
atlantae, Leclercia adecarboxylata). In a preliminary comparative study (using 500 
routine strains), the reliability of tRNA-PCR was found to be higher than that of 
phenotypic identification. For example, on several occasions, strains were identified as
K. pneumoniae in the routine laboratory, while tRNA-PCR yielded E. aerogenes as an
identification, later confirmed by 16S rDNA sequence determination. ITS2-PCR, for 
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which identification is based on the length of only one fragment is more prone to 
misidentification, E.g. Pichia anomala, has a ITS2-fragment size that differes less then
1bp difference from Cryptococcus neoformans.
x Flexibility. When previously not encountered species have been studied, and a final 
identification has obtained, e.g. by means of 16S rDNA sequence determination, it is 
possible to simply add the new fingerprint to the library, such that further isolates will 
be identifiable.
x Need for specialized equipment. The DNA-fingerprinting techniques used in this 
study rely on precise size determination. This can only be obtained with specialized 
electrophoresis equipment. This might be a drawback, although one should keep in 
mind that current phenotypic identification machines cost more and moreover that the 
fluorescent electrophoresis equipment used here (e.g. ABI310) can also be applied for 
typing bacteria, for sequence determination and for other, non microbiological,
fingerprinting techniques (e.g. as used in medical genetics). 
4. Future prospects.
It is possible to develop tRNA-PCR and ITS-PCR as practically applicable techniques, aimed
at identification of cultured bacteria and fungi, in the clinical laboratory. For example, one 
could devise commercially prepared, ready made microplates containing PCR mixture and the 
appropriate primers, such that, starting from a single colony and after a brief and simple
DNA-extraction, an amplification reaction can be performed. This approach would not only 
simplify the handling and shorten the hands on time, but would also increase the 
interlaboratory reproducibility. Transfer of the amplification products to another 
microtiterplate, containing the size markers in the DNA-denaturing formamide mixture, is 
than a matter of minutes with a minimum of hands on time. Using multiple capillary
electrophoresis for the size determination of the amplified DNA-fragments (i.e. intergenic 
tRNA spacers for the bacteria or ITS2 fragments for the yeasts) one can obtain tens of 
fingerprints within a few hours after picking the individual colonies. Final identification of the 
obtained fingerprints with an already existing, and continuously refined and expanding, 
library, can be performed in an automated fashion as well. The remainder of the colony used 
for genotypic identification, can be used for susceptibility testing. We think, given the results 
obtained in this study, that this approach certainly might compete with current phenotypic 
identification with regard to cost, speed and discriminatory capacity. Of course, phenotypic 
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identification is making continuously progress, and fully automated identification machines
(like Vitek or Phoenix) are on the market, although currently fifty percent of the cultures need 
an extra overnight incubation in order to obtain sufficient inoculum for a reliable 
identification. The future will show whether one of these or still other techniques will be used. 
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VIII. Summary 
Since the description of the polymerase chain reaction and the introduction of a thermostable 
polymerase, some 15 years ago, most research in bacterial and mycological diagnostics has 
been invested in the application of detection of these organisms, directly from clinical 
samples. The fact that such applications have been applied and commercially developed only 
for a few slow growing organisms, like Mycobacterium tuberculosis, indicates that broad-
range application of PCR-based detection struggles with several problems in bacteriology and 
mycology. Not only are bacterial and fungal culture techniques reasonably fast and easy and 
do they provide with semi-quantitative information on a vast array of different organisms,
culture is also needed for susceptibility testing of the detected organisms, since it remains
impossible to cover all the resistance genes with DNA-techniques in a practical manner,
despite the development of DNA-arrays. Thus, even if DNA-based detection was possible,
it would not circumvent culture, which still would be necessary for susceptibility testing. 
Although culture for detection cannot be circumvented, one can wonder whether phenotypic 
identification can be replaced by PCR-based DNA-fingerprinting techniques aimed at 
identification of cultured micro-organisms. Indeed, phenotypic identification has several 
shortcomings, such as the requirement for a combination of different approaches (serology, 
morphology, biochemistry) and different tests, the sometimes limited discriminatory power 
and considerable experience. 
In this doctoral work we updated and introduced PCR-based DNA-fingerprinting for 
mycobacteria (ARDRA), bacteria in general (tRNA-PCR) and yeasts (ITS2-PCR). 
The number of species identifiable with these techniques was expanded, the techniques were 
standardized and were applied to the identification of clinical bacterial and fungal isolates. 
Whenever discrepancies were observed between routine phenotypic identification and the 
molecular identification, DNA-sequencing was carried out of the 16S rRNA-gene or the 
ITS2-region. This led to the continuous expansion and refinement of the fingerprint libraries 




Sinds de publicatie van de polymerase ketting reactie en de introductie van een thermostabiel 
polymerase, zo’n 15 jaar geleden, werd het merendeel van het onderzoek in bacteriële en 
mycologische diagnostiek gericht naar de detectie van deze organismen, rechtstreeks uit het 
staal. Het feit dat deze toepassingen, net als de commercieel ontwikkelde testen, enkel gericht
zijn op een klein aantal traag groeiende organismen, zoals Mycobacterium tuberculosis, geeft 
aan dat meer algemeen gericht toepassingen van PCR-gebaseerde detectie te kampen hebben 
met ernstige problemen in de bacteriologie en mycologie.
Naast het feit dat bacteriële en mycologische kweek relatief eenvoudig en snel is, is er ook 
nog de bijkomend semi-kwantitatieve informatie bekomen voor een zeer uiteenlopende
verscheidenheid van organismen. Tevens is kweek nog steeds noodzakelijk voor de 
antibiotica (of antifungica) gevoeligheidsbepalingen van gedetecteerde organismen, daar het 
nog steeds onmogelijk lijkt alle mogelijke resistentie genen te controleren met praktisch 
haalbare DNA-technieken, zelfs ondanks de ontwikkeling van DNA-arrays.
Niettegenstaande echter dat kweek onvervangbaar blijkt te zijn voor detectie, kan men zich 
afvragen of het niet mogelijk zou zijn de fenotypische identificatie te vervangen door PCR-
gebaseerde DNA-fingerprinting technieken voor de identificatie van gekweekte organismen.
Er zijn inderdaad tekortkomingen aan de fenotypische identificatie zoals de behoefte aan een 
combinatie van verschillende benaderingen (serologie, morfologie en biochemie) en testen, 
alsook het soms beperkt discriminerend vermogen.
In dit doctoraatswerk werden PCR-gebaseerde DNA-fingerprinting technieken ofwel herzien 
ofwel geïntroduceerd voor de identificatie van mycobacteriën (ARDRA), bacteriën in het 
algemeen (tRNA-PCR) en gisten (ITS2-PCR).
The aantal species identificeerbaar met deze technieken werd uitgebreid, de technieken
werden gestandaardiseerd en toegepast voor de identificatie van klinisch isolaten (bacteriën en 
gisten). Wanneer er geen overeenstemming was tussen de routinematig gebruikte 
fenotypische identificatie en de moleculaire identificatie werd ofwel 16S rRNA of gen ofwel 
ITS2 sequentiebepaling uitgevoerd, teneinde de juiste identificatie te bekomen, welke dan 
weer leidde tot de continue uitbreiding en verfijning van de fingerprint bibliotheek. Tevens
leidde dit in sommige gevallen tot het opmerken en beschrijven van nieuwe of heel 
uitzonderlijk voorkomende species. 
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VIII. Résumé 
Depuis la publication de la réaction en chaîne de polymerase (PCR) et l’introduction d’une 
polymerase thermostable, il y a 15 ans environ, la plus grande partie de la recherche dans le 
domaine du diagnostic bactérien et mycologique a été orientée vers la détection de ces 
organismes sans passer par l’ étape de culture. Le fait que ces techniques ne soient 
développées commercialement que pour un nombre limité d’organismes à croissance lente 
comme Mycobacterium tuberculosis, indique qu’une application plus généralisée de la 
détection basée sur la PCR rencontre plusieurs problèmes.
Les techniques de culture bactérienne et mycologique sont non seulement raisonnablement
rapides et faciles et nous fournissent une information semi-quantitative concernant une grande 
série d’organismes, la culture est nécessaire aussi pour tester la sensibilité (antibiotique (ou 
antifongique)) des organismes détectés. En effet il est toujours impossible pratiquement de 
contrôler tous les gènes de résistance avec des techniques PCR, malgré le développement de 
‘arrays d’ADN’.
Dès lors, même si la détection basée sur ADN était possible, la culture resterait indispensable 
pour tester la sensibilité. 
Bien que la culture ne puisse pas être éliminée pour la détection, on peut cependant se 
demander si l’identification phénotypique ne pourrait pas être remplacée par des techniques 
d’empreintes génétiques par PCR, afin d’identifier les micro-organismes cultivés. 
L’identification phénotypique présente effectivement plusieurs imperfections comme le 
besoin d’une combinaison d’approches (sérologie, morphologie, biochimie) et de tests 
différents, et qui sont de pouvoir discriminatoire souvent limité.
Dans ce doctorat nous avons adapté et introduit des techniques d’empreinte génétique ADN 
basées sur la technique de PCR pour l’identification de mycobacteries (ARDRA), bactéries en 
général (tRNA-PCR) et de levures (ITS2-PCR). 
Le nombre d’espèces identifiables par ces techniques a été augmenté, les techniques ont été 
standardisées et appliquées à l’identification d’isolats cliniques bactériens et mycologiques.
Dans le cas de non concordance entre l’identification phénotypique routinière et 
l’identification moléculaire, la détermination de séquences a été faite sur les gènes 16S rRNA 
ou ITS-2. Cela a contribué à la création d’une banque de données d’empreintes génétique 
constamment complétée et raffinée. En plus dans quelques cas, on a pu réaliser la description 
d’espèces nouvelles ou très rares. 
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